id	sid	tid	token	lemma	pos
ct-10840	1	1	1	1	NUM
ct-10840	1	2	contact	contact	PROPN
ct-10840	1	3	alexandria	alexandria	PROPN
ct-10840	1	4	horner	horner	PROPN
ct-10840	1	5	alexandria.horner@colostate.edu	alexandria.horner@colostate.edu	PROPN
ct-10840	1	6	©	©	PROPN
ct-10840	1	7	2024	2024	NUM
ct-10840	1	8	the	the	DET
ct-10840	1	9	author(s	author(s	NOUN
ct-10840	1	10	)	)	PUNCT
ct-10840	1	11	.	.	PUNCT
ct-10840	2	1	this	this	PRON
ct-10840	2	2	is	be	AUX
ct-10840	2	3	an	an	DET
ct-10840	2	4	open	open	ADJ
ct-10840	2	5	access	access	NOUN
ct-10840	2	6	article	article	NOUN
ct-10840	2	7	distributed	distribute	VERB
ct-10840	2	8	under	under	ADP
ct-10840	2	9	the	the	DET
ct-10840	2	10	terms	term	NOUN
ct-10840	2	11	of	of	ADP
ct-10840	2	12	the	the	DET
ct-10840	2	13	creative	creative	ADJ
ct-10840	2	14	commons	common	NOUN
ct-10840	2	15	attribution	attribution	NOUN
ct-10840	2	16	-	-	PUNCT
ct-10840	2	17	noncommercial	noncommercial	ADJ
ct-10840	2	18	4.0	4.0	NUM
ct-10840	2	19	international	international	ADJ
ct-10840	2	20	license	license	NOUN
ct-10840	2	21	(	(	PUNCT
ct-10840	2	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NOUN
ct-10840	2	23	)	)	PUNCT
ct-10840	2	24	,	,	PUNCT
ct-10840	2	25	permitting	permit	VERB
ct-10840	2	26	all	all	DET
ct-10840	2	27	noncommercial	noncommercial	ADJ
ct-10840	2	28	use	use	NOUN
ct-10840	2	29	,	,	PUNCT
ct-10840	2	30	distribution	distribution	NOUN
ct-10840	2	31	,	,	PUNCT
ct-10840	2	32	and	and	CCONJ
ct-10840	2	33	reproduction	reproduction	NOUN
ct-10840	2	34	in	in	ADP
ct-10840	2	35	any	any	DET
ct-10840	2	36	medium	medium	NOUN
ct-10840	2	37	,	,	PUNCT
ct-10840	2	38	provided	provide	VERB
ct-10840	2	39	the	the	DET
ct-10840	2	40	original	original	ADJ
ct-10840	2	41	work	work	NOUN
ct-10840	2	42	is	be	AUX
ct-10840	2	43	properly	properly	ADV
ct-10840	2	44	cited	cite	VERB
ct-10840	2	45	.	.	PUNCT
ct-10840	3	1	citation	citation	NOUN
ct-10840	3	2	:	:	PUNCT
ct-10840	3	3	clinical	clinical	ADJ
ct-10840	3	4	theriogenology	theriogenology	NOUN
ct-10840	3	5	2024	2024	NUM
ct-10840	3	6	,	,	PUNCT
ct-10840	3	7	16	16	NUM
ct-10840	3	8	,	,	PUNCT
ct-10840	3	9	10840	10840	NUM
ct-10840	3	10	,	,	PUNCT
ct-10840	3	11	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	3	12	case	case	NOUN
ct-10840	3	13	report	report	VERB
ct-10840	3	14	management	management	NOUN
ct-10840	3	15	of	of	ADP
ct-10840	3	16	a	a	DET
ct-10840	3	17	granulosa	granulosa	NOUN
ct-10840	3	18	-	-	PUNCT
ct-10840	3	19	theca	theca	NOUN
ct-10840	3	20	cell	cell	NOUN
ct-10840	3	21	tumor	tumor	NOUN
ct-10840	3	22	in	in	ADP
ct-10840	3	23	a	a	DET
ct-10840	3	24	female	female	ADJ
ct-10840	3	25	rottweiler	rottweiler	NOUN
ct-10840	3	26	alexandria	alexandria	PROPN
ct-10840	3	27	horner	horner	PROPN
ct-10840	3	28	,	,	PUNCT
ct-10840	3	29	a	a	DET
ct-10840	3	30	greg	greg	PROPN
ct-10840	3	31	burns	burn	NOUN
ct-10840	3	32	,	,	PUNCT
ct-10840	3	33	a	a	DET
ct-10840	3	34	mac	mac	PROPN
ct-10840	3	35	harris	harris	PROPN
ct-10840	3	36	,	,	PUNCT
ct-10840	3	37	b	b	PROPN
ct-10840	3	38	jenny	jenny	PROPN
ct-10840	3	39	sones	sones	PROPN
ct-10840	3	40	,	,	PUNCT
ct-10840	3	41	a	a	DET
ct-10840	3	42	fiona	fiona	PROPN
ct-10840	3	43	hollinsheada	hollinsheada	PROPN
ct-10840	3	44	adepartment	adepartment	PROPN
ct-10840	3	45	of	of	ADP
ct-10840	3	46	clinical	clinical	ADJ
ct-10840	3	47	sciences	science	NOUN
ct-10840	3	48	,	,	PUNCT
ct-10840	3	49	college	college	NOUN
ct-10840	3	50	of	of	ADP
ct-10840	3	51	veterinary	veterinary	ADJ
ct-10840	3	52	medicine	medicine	NOUN
ct-10840	3	53	and	and	CCONJ
ct-10840	3	54	biomedical	biomedical	ADJ
ct-10840	3	55	sciences	sciences	PROPN
ct-10840	3	56	,	,	PUNCT
ct-10840	3	57	colorado	colorado	PROPN
ct-10840	3	58	 	 	SPACE
ct-10840	3	59	state	state	NOUN
ct-10840	3	60	 	 	SPACE
ct-10840	3	61	university	university	NOUN
ct-10840	3	62	,	,	PUNCT
ct-10840	3	63	fort	fort	PROPN
ct-10840	3	64	collins	collins	PROPN
ct-10840	3	65	,	,	PUNCT
ct-10840	3	66	co	co	PROPN
ct-10840	3	67	,	,	PUNCT
ct-10840	3	68	usa	usa	PROPN
ct-10840	3	69	bdepartment	bdepartment	PROPN
ct-10840	3	70	of	of	ADP
ct-10840	3	71	microbiology	microbiology	NOUN
ct-10840	3	72	,	,	PUNCT
ct-10840	3	73	immunology	immunology	NOUN
ct-10840	3	74	&	&	CCONJ
ct-10840	3	75	pathology	pathology	PROPN
ct-10840	3	76	,	,	PUNCT
ct-10840	3	77	college	college	NOUN
ct-10840	3	78	 	 	SPACE
ct-10840	3	79	of	of	ADP
ct-10840	3	80	veterinary	veterinary	ADJ
ct-10840	3	81	medicine	medicine	NOUN
ct-10840	3	82	and	and	CCONJ
ct-10840	3	83	biomedical	biomedical	ADJ
ct-10840	3	84	sciences	sciences	PROPN
ct-10840	3	85	,	,	PUNCT
ct-10840	3	86	colorado	colorado	PROPN
ct-10840	3	87	state	state	PROPN
ct-10840	3	88	university	university	PROPN
ct-10840	3	89	,	,	PUNCT
ct-10840	3	90	fort	fort	PROPN
ct-10840	3	91	collins	collins	PROPN
ct-10840	3	92	,	,	PUNCT
ct-10840	3	93	co	co	PROPN
ct-10840	3	94	,	,	PUNCT
ct-10840	3	95	usa	usa	PROPN
ct-10840	3	96	abstract	abstract	PROPN
ct-10840	3	97	a	a	DET
ct-10840	3	98	4	4	NUM
ct-10840	3	99	-	-	PUNCT
ct-10840	3	100	year	year	NOUN
ct-10840	3	101	,	,	PUNCT
ct-10840	3	102	multiparous	multiparous	ADJ
ct-10840	3	103	rottweiler	rottweiler	ADJ
ct-10840	3	104	female	female	ADJ
ct-10840	3	105	dog	dog	NOUN
ct-10840	3	106	,	,	PUNCT
ct-10840	3	107	was	be	AUX
ct-10840	3	108	presented	present	VERB
ct-10840	3	109	for	for	ADP
ct-10840	3	110	breeding	breed	VERB
ct-10840	3	111	management	management	NOUN
ct-10840	3	112	.	.	PUNCT
ct-10840	4	1	dog	dog	NOUN
ct-10840	4	2	had	have	VERB
ct-10840	4	3	clinical	clinical	ADJ
ct-10840	4	4	signs	sign	NOUN
ct-10840	4	5	of	of	ADP
ct-10840	4	6	proestrus	proestrus	NOUN
ct-10840	4	7	and	and	CCONJ
ct-10840	4	8	estrus	estrus	VERB
ct-10840	4	9	for	for	ADP
ct-10840	4	10	>	>	X
ct-10840	4	11	6	6	NUM
ct-10840	4	12	weeks	week	NOUN
ct-10840	4	13	,	,	PUNCT
ct-10840	4	14	including	include	VERB
ct-10840	4	15	cornification	cornification	NOUN
ct-10840	4	16	of	of	ADP
ct-10840	4	17	vaginal	vaginal	ADJ
ct-10840	4	18	epithelium	epithelium	NOUN
ct-10840	4	19	and	and	CCONJ
ct-10840	4	20	low	low	ADJ
ct-10840	4	21	circulating	circulate	VERB
ct-10840	4	22	progesterone	progesterone	NOUN
ct-10840	4	23	concentrations	concentration	NOUN
ct-10840	4	24	(	(	PUNCT
ct-10840	4	25	<	<	X
ct-10840	4	26	2	2	NUM
ct-10840	4	27	ng	ng	PROPN
ct-10840	4	28	/	/	SYM
ct-10840	4	29	ml	ml	NOUN
ct-10840	4	30	)	)	PUNCT
ct-10840	4	31	.	.	PUNCT
ct-10840	5	1	transabdominal	transabdominal	ADJ
ct-10840	5	2	ultrasonography	ultrasonography	NOUN
ct-10840	5	3	of	of	ADP
ct-10840	5	4	the	the	DET
ct-10840	5	5	reproductive	reproductive	ADJ
ct-10840	5	6	tract	tract	NOUN
ct-10840	5	7	and	and	CCONJ
ct-10840	5	8	measurement	measurement	NOUN
ct-10840	5	9	of	of	ADP
ct-10840	5	10	circulating	circulate	VERB
ct-10840	5	11	hormones	hormone	NOUN
ct-10840	5	12	(	(	PUNCT
ct-10840	5	13	antimüllerian	antimüllerian	ADJ
ct-10840	5	14	hormone	hormone	NOUN
ct-10840	5	15	,	,	PUNCT
ct-10840	5	16	inhibin	inhibin	PROPN
ct-10840	5	17	-	-	PUNCT
ct-10840	5	18	b	b	NOUN
ct-10840	5	19	,	,	PUNCT
ct-10840	5	20	and	and	CCONJ
ct-10840	5	21	progesterone	progesterone	NOUN
ct-10840	5	22	)	)	PUNCT
ct-10840	5	23	suggested	suggest	VERB
ct-10840	5	24	granulosa	granulosa	NOUN
ct-10840	5	25	-	-	PUNCT
ct-10840	5	26	theca	theca	NOUN
ct-10840	5	27	cell	cell	NOUN
ct-10840	5	28	tumor	tumor	NOUN
ct-10840	5	29	.	.	PUNCT
ct-10840	6	1	affected	affect	VERB
ct-10840	6	2	ovary	ovary	NOUN
ct-10840	6	3	was	be	AUX
ct-10840	6	4	removed	remove	VERB
ct-10840	6	5	via	via	ADP
ct-10840	6	6	laparoscopy	laparoscopy	NOUN
ct-10840	6	7	.	.	PUNCT
ct-10840	7	1	histopathology	histopathology	NOUN
ct-10840	7	2	confirmed	confirm	VERB
ct-10840	7	3	granulosa	granulosa	PROPN
ct-10840	7	4	-	-	PUNCT
ct-10840	7	5	theca	theca	NOUN
ct-10840	7	6	cell	cell	NOUN
ct-10840	7	7	tumor	tumor	NOUN
ct-10840	7	8	;	;	PUNCT
ct-10840	7	9	dog	dog	NOUN
ct-10840	7	10	resumed	resume	VERB
ct-10840	7	11	cyclicity	cyclicity	NOUN
ct-10840	7	12	4	4	NUM
ct-10840	7	13	months	month	NOUN
ct-10840	7	14	after	after	ADP
ct-10840	7	15	surgery	surgery	NOUN
ct-10840	7	16	,	,	PUNCT
ct-10840	7	17	had	have	VERB
ct-10840	7	18	normal	normal	ADJ
ct-10840	7	19	estrus	estrus	NOUN
ct-10840	7	20	and	and	CCONJ
ct-10840	7	21	was	be	AUX
ct-10840	7	22	successfully	successfully	ADV
ct-10840	7	23	mated	mate	VERB
ct-10840	7	24	with	with	ADP
ct-10840	7	25	a	a	DET
ct-10840	7	26	young	young	ADJ
ct-10840	7	27	stud	stud	NOUN
ct-10840	7	28	dog	dog	NOUN
ct-10840	7	29	.	.	PUNCT
ct-10840	8	1	dog	dog	NOUN
ct-10840	8	2	was	be	AUX
ct-10840	8	3	diagnosed	diagnose	VERB
ct-10840	8	4	pregnant	pregnant	ADJ
ct-10840	8	5	(	(	PUNCT
ct-10840	8	6	30	30	NUM
ct-10840	8	7	days	day	NOUN
ct-10840	8	8	after	after	SCONJ
ct-10840	8	9	lh	lh	PROPN
ct-10840	8	10	surge	surge	VERB
ct-10840	8	11	)	)	PUNCT
ct-10840	8	12	via	via	ADP
ct-10840	8	13	transabdominal	transabdominal	ADJ
ct-10840	8	14	ultrasonography	ultrasonography	NOUN
ct-10840	8	15	;	;	PUNCT
ct-10840	8	16	4	4	NUM
ct-10840	8	17	amniotic	amniotic	ADJ
ct-10840	8	18	sacs	sac	NOUN
ct-10840	8	19	were	be	AUX
ct-10840	8	20	detected	detect	VERB
ct-10840	8	21	,	,	PUNCT
ct-10840	8	22	and	and	CCONJ
ct-10840	8	23	3	3	NUM
ct-10840	8	24	grew	grow	VERB
ct-10840	8	25	to	to	ADP
ct-10840	8	26	term	term	NOUN
ct-10840	8	27	but	but	CCONJ
ct-10840	8	28	were	be	AUX
ct-10840	8	29	not	not	PART
ct-10840	8	30	viable	viable	ADJ
ct-10840	8	31	at	at	ADP
ct-10840	8	32	delivery	delivery	NOUN
ct-10840	8	33	(	(	PUNCT
ct-10840	8	34	via	via	ADP
ct-10840	8	35	cesarian	cesarian	ADJ
ct-10840	8	36	surgery	surgery	NOUN
ct-10840	8	37	)	)	PUNCT
ct-10840	8	38	.	.	PUNCT
ct-10840	9	1	keywords	keyword	NOUN
ct-10840	9	2	:	:	PUNCT
ct-10840	9	3	persistent	persistent	ADJ
ct-10840	9	4	estrus	estrus	NOUN
ct-10840	9	5	,	,	PUNCT
ct-10840	9	6	granulosa	granulosa	NOUN
ct-10840	9	7	-	-	PUNCT
ct-10840	9	8	theca	theca	NOUN
ct-10840	9	9	cell	cell	NOUN
ct-10840	9	10	tumor	tumor	NOUN
ct-10840	9	11	,	,	PUNCT
ct-10840	9	12	laparoscopic	laparoscopic	NOUN
ct-10840	9	13	ovariectomy	ovariectomy	NOUN
ct-10840	9	14	background	background	NOUN
ct-10840	9	15	ovarian	ovarian	ADJ
ct-10840	9	16	tumors	tumor	NOUN
ct-10840	9	17	are	be	AUX
ct-10840	9	18	rare	rare	ADJ
ct-10840	9	19	in	in	ADP
ct-10840	9	20	mammals	mammal	NOUN
ct-10840	9	21	,	,	PUNCT
ct-10840	9	22	but	but	CCONJ
ct-10840	9	23	among	among	ADP
ct-10840	9	24	domestic	domestic	ADJ
ct-10840	9	25	animals	animal	NOUN
ct-10840	9	26	,	,	PUNCT
ct-10840	9	27	they	they	PRON
ct-10840	9	28	appear	appear	VERB
ct-10840	9	29	to	to	PART
ct-10840	9	30	be	be	AUX
ct-10840	9	31	most	most	ADV
ct-10840	9	32	common	common	ADJ
ct-10840	9	33	in	in	ADP
ct-10840	9	34	female	female	ADJ
ct-10840	9	35	dogs	dog	NOUN
ct-10840	9	36	and	and	CCONJ
ct-10840	9	37	cows.1–5	cows.1–5	NOUN
ct-10840	9	38	primary	primary	ADJ
ct-10840	9	39	ovarian	ovarian	ADJ
ct-10840	9	40	tumors	tumor	NOUN
ct-10840	9	41	can	can	AUX
ct-10840	9	42	be	be	AUX
ct-10840	9	43	categorized	categorize	VERB
ct-10840	9	44	into	into	ADP
ct-10840	9	45	3	3	NUM
ct-10840	9	46	groups	group	NOUN
ct-10840	9	47	;	;	PUNCT
ct-10840	9	48	epithelial	epithelial	ADJ
ct-10840	9	49	,	,	PUNCT
ct-10840	9	50	germ	germ	NOUN
ct-10840	9	51	cell	cell	NOUN
ct-10840	9	52	,	,	PUNCT
ct-10840	9	53	and	and	CCONJ
ct-10840	9	54	sex	sex	NOUN
ct-10840	9	55	cord	cord	NOUN
ct-10840	9	56	-	-	PUNCT
ct-10840	9	57	stromal	stromal	ADJ
ct-10840	9	58	.	.	PUNCT
ct-10840	10	1	granulosatheca	granulosatheca	NOUN
ct-10840	10	2	cell	cell	NOUN
ct-10840	10	3	tumors	tumor	NOUN
ct-10840	10	4	(	(	PUNCT
ct-10840	10	5	gct	gct	PROPN
ct-10840	10	6	)	)	PUNCT
ct-10840	10	7	are	be	AUX
ct-10840	10	8	sex	sex	NOUN
ct-10840	10	9	cord	cord	NOUN
ct-10840	10	10	-	-	PUNCT
ct-10840	10	11	stromal	stromal	ADJ
ct-10840	10	12	cell	cell	NOUN
ct-10840	10	13	-	-	PUNCT
ct-10840	10	14	based	base	VERB
ct-10840	10	15	ovarian	ovarian	ADJ
ct-10840	10	16	tumors	tumor	NOUN
ct-10840	10	17	that	that	PRON
ct-10840	10	18	account	account	VERB
ct-10840	10	19	for	for	ADP
ct-10840	10	20	0.5	0.5	NUM
ct-10840	10	21	to	to	PART
ct-10840	10	22	1.2	1.2	NUM
ct-10840	10	23	%	%	NOUN
ct-10840	10	24	of	of	ADP
ct-10840	10	25	all	all	DET
ct-10840	10	26	canine	canine	NOUN
ct-10840	10	27	tumors	tumor	NOUN
ct-10840	10	28	.	.	PUNCT
ct-10840	11	1	gcts	gct	NOUN
ct-10840	11	2	arise	arise	NOUN
ct-10840	11	3	from	from	ADP
ct-10840	11	4	granulosa	granulosa	NOUN
ct-10840	11	5	cell	cell	NOUN
ct-10840	11	6	cords	cord	NOUN
ct-10840	11	7	of	of	ADP
ct-10840	11	8	atretic	atretic	ADJ
ct-10840	11	9	follicles5	follicles5	NOUN
ct-10840	11	10	and	and	CCONJ
ct-10840	11	11	are	be	AUX
ct-10840	11	12	not	not	PART
ct-10840	11	13	locally	locally	ADV
ct-10840	11	14	invasive	invasive	ADJ
ct-10840	11	15	;	;	PUNCT
ct-10840	11	16	however	however	ADV
ct-10840	11	17	,	,	PUNCT
ct-10840	11	18	in	in	ADP
ct-10840	11	19	10	10	NUM
ct-10840	11	20	to	to	PART
ct-10840	11	21	20	20	NUM
ct-10840	11	22	%	%	NOUN
ct-10840	11	23	of	of	ADP
ct-10840	11	24	cases	case	NOUN
ct-10840	11	25	they	they	PRON
ct-10840	11	26	can	can	AUX
ct-10840	11	27	metastasize.2,5	metastasize.2,5	VERB
ct-10840	11	28	a	a	DET
ct-10840	11	29	mass	mass	ADJ
ct-10840	11	30	effect	effect	NOUN
ct-10840	11	31	of	of	ADP
ct-10840	11	32	the	the	DET
ct-10840	11	33	gct	gct	PROPN
ct-10840	11	34	causing	cause	VERB
ct-10840	11	35	clinical	clinical	ADJ
ct-10840	11	36	signs	sign	NOUN
ct-10840	11	37	is	be	AUX
ct-10840	11	38	very	very	ADV
ct-10840	11	39	uncommon	uncommon	ADJ
ct-10840	11	40	.	.	PUNCT
ct-10840	12	1	however	however	ADV
ct-10840	12	2	,	,	PUNCT
ct-10840	12	3	gcts	gct	NOUN
ct-10840	12	4	can	can	AUX
ct-10840	12	5	be	be	AUX
ct-10840	12	6	challenging	challenge	VERB
ct-10840	12	7	to	to	PART
ct-10840	12	8	diagnose	diagnose	VERB
ct-10840	12	9	as	as	SCONJ
ct-10840	12	10	they	they	PRON
ct-10840	12	11	do	do	AUX
ct-10840	12	12	not	not	PART
ct-10840	12	13	always	always	ADV
ct-10840	12	14	have	have	VERB
ct-10840	12	15	the	the	DET
ct-10840	12	16	classical	classical	ADJ
ct-10840	12	17	honeycomb	honeycomb	NOUN
ct-10840	12	18	-	-	PUNCT
ct-10840	12	19	like	like	ADJ
ct-10840	12	20	appearance	appearance	NOUN
ct-10840	12	21	that	that	PRON
ct-10840	12	22	is	be	AUX
ct-10840	12	23	recognizable	recognizable	ADJ
ct-10840	12	24	via	via	ADP
ct-10840	12	25	ultrasonography.6	ultrasonography.6	PROPN
ct-10840	12	26	most	most	ADJ
ct-10840	12	27	gcts	gct	NOUN
ct-10840	12	28	are	be	AUX
ct-10840	12	29	unilateral	unilateral	ADJ
ct-10840	12	30	in	in	ADP
ct-10840	12	31	all	all	DET
ct-10840	12	32	species	specie	NOUN
ct-10840	12	33	,	,	PUNCT
ct-10840	12	34	although	although	SCONJ
ct-10840	12	35	bilateral	bilateral	ADJ
ct-10840	12	36	tumors	tumor	NOUN
ct-10840	12	37	were	be	AUX
ct-10840	12	38	described	describe	VERB
ct-10840	12	39	in	in	ADP
ct-10840	12	40	a	a	DET
ct-10840	12	41	female	female	NOUN
ct-10840	12	42	dog.5	dog.5	VERB
ct-10840	12	43	the	the	DET
ct-10840	12	44	most	most	ADV
ct-10840	12	45	common	common	ADJ
ct-10840	12	46	presentation	presentation	NOUN
ct-10840	12	47	associated	associate	VERB
ct-10840	12	48	with	with	ADP
ct-10840	12	49	canine	canine	NOUN
ct-10840	12	50	gcts	gct	NOUN
ct-10840	12	51	are	be	AUX
ct-10840	12	52	signs	sign	NOUN
ct-10840	12	53	of	of	ADP
ct-10840	12	54	estrus	estrus	NOUN
ct-10840	12	55	that	that	PRON
ct-10840	12	56	persist	persist	VERB
ct-10840	12	57	for	for	ADP
ct-10840	12	58	>	>	X
ct-10840	12	59	6	6	NUM
ct-10840	12	60	weeks.7	weeks.7	NOUN
ct-10840	12	61	clinical	clinical	ADJ
ct-10840	12	62	signs	sign	NOUN
ct-10840	12	63	of	of	ADP
ct-10840	12	64	persistent	persistent	ADJ
ct-10840	12	65	estrus	estrus	NOUN
ct-10840	12	66	are	be	AUX
ct-10840	12	67	associated	associate	VERB
ct-10840	12	68	with	with	ADP
ct-10840	12	69	constant	constant	ADJ
ct-10840	12	70	secretion	secretion	NOUN
ct-10840	12	71	of	of	ADP
ct-10840	12	72	estrogen	estrogen	NOUN
ct-10840	12	73	and	and	CCONJ
ct-10840	12	74	include	include	VERB
ct-10840	12	75	behavioral	behavioral	ADJ
ct-10840	12	76	signs	sign	NOUN
ct-10840	12	77	such	such	ADJ
ct-10840	12	78	as	as	ADP
ct-10840	12	79	standing	stand	VERB
ct-10840	12	80	/	/	SYM
ct-10840	12	81	sexual	sexual	ADJ
ct-10840	12	82	reflexes	reflex	NOUN
ct-10840	12	83	(	(	PUNCT
ct-10840	12	84	flagging	flagging	ADJ
ct-10840	12	85	and	and	CCONJ
ct-10840	12	86	postural	postural	ADJ
ct-10840	12	87	changes	change	NOUN
ct-10840	12	88	)	)	PUNCT
ct-10840	12	89	,	,	PUNCT
ct-10840	12	90	receptiveness	receptiveness	NOUN
ct-10840	12	91	to	to	ADP
ct-10840	12	92	intact	intact	ADJ
ct-10840	12	93	males	male	NOUN
ct-10840	12	94	,	,	PUNCT
ct-10840	12	95	and	and	CCONJ
ct-10840	12	96	anatomical	anatomical	ADJ
ct-10840	12	97	changes	change	NOUN
ct-10840	12	98	,	,	PUNCT
ct-10840	12	99	including	include	VERB
ct-10840	12	100	vulvar	vulvar	NOUN
ct-10840	12	101	swelling	swelling	NOUN
ct-10840	12	102	and	and	CCONJ
ct-10840	12	103	serosanguineous	serosanguineous	ADJ
ct-10840	12	104	vulvar	vulvar	NOUN
ct-10840	12	105	discharges.3–5,8–12	discharges.3–5,8–12	NOUN
ct-10840	12	106	however	however	ADV
ct-10840	12	107	,	,	PUNCT
ct-10840	12	108	clinical	clinical	ADJ
ct-10840	12	109	signs	sign	NOUN
ct-10840	12	110	associated	associate	VERB
ct-10840	12	111	with	with	ADP
ct-10840	12	112	estrogen	estrogen	NOUN
ct-10840	12	113	can	can	AUX
ct-10840	12	114	also	also	ADV
ct-10840	12	115	be	be	AUX
ct-10840	12	116	associated	associate	VERB
ct-10840	12	117	with	with	ADP
ct-10840	12	118	normal	normal	ADJ
ct-10840	12	119	physiologic	physiologic	ADJ
ct-10840	12	120	cyclicity	cyclicity	NOUN
ct-10840	12	121	,	,	PUNCT
ct-10840	12	122	ovarian	ovarian	ADJ
ct-10840	12	123	remnant	remnant	NOUN
ct-10840	12	124	syndrome	syndrome	NOUN
ct-10840	12	125	,	,	PUNCT
ct-10840	12	126	ovarian	ovarian	ADJ
ct-10840	12	127	cyst(s	cyst(s	NOUN
ct-10840	12	128	)	)	PUNCT
ct-10840	12	129	,	,	PUNCT
ct-10840	12	130	ovulation	ovulation	NOUN
ct-10840	12	131	failure	failure	NOUN
ct-10840	12	132	,	,	PUNCT
ct-10840	12	133	and	and	CCONJ
ct-10840	12	134	exposure	exposure	NOUN
ct-10840	12	135	to	to	ADP
ct-10840	12	136	exogenous	exogenous	ADJ
ct-10840	12	137	sources	source	NOUN
ct-10840	12	138	of	of	ADP
ct-10840	12	139	estrogen	estrogen	NOUN
ct-10840	12	140	.	.	PUNCT
ct-10840	12	141	 	 	SPACE
ct-10840	13	1	diagnosis	diagnosis	NOUN
ct-10840	13	2	of	of	ADP
ct-10840	13	3	gct	gct	PROPN
ct-10840	13	4	has	have	AUX
ct-10840	13	5	also	also	ADV
ct-10840	13	6	been	be	AUX
ct-10840	13	7	previously	previously	ADV
ct-10840	13	8	reported	report	VERB
ct-10840	13	9	in	in	ADP
ct-10840	13	10	ovariohysterectomized	ovariohysterectomize	VERB
ct-10840	13	11	dogs	dog	NOUN
ct-10840	13	12	with	with	ADP
ct-10840	13	13	concurrent	concurrent	ADJ
ct-10840	13	14	ovarian	ovarian	ADJ
ct-10840	13	15	remnant	remnant	NOUN
ct-10840	13	16	syndrome.13	syndrome.13	NOUN
ct-10840	13	17	-	-	PUNCT
ct-10840	13	18	15	15	NUM
ct-10840	13	19	therefore	therefore	ADV
ct-10840	13	20	,	,	PUNCT
ct-10840	13	21	determination	determination	NOUN
ct-10840	13	22	of	of	ADP
ct-10840	13	23	when	when	SCONJ
ct-10840	13	24	clinical	clinical	ADJ
ct-10840	13	25	signs	sign	NOUN
ct-10840	13	26	of	of	ADP
ct-10840	13	27	estrus	estrus	NOUN
ct-10840	13	28	begin	begin	VERB
ct-10840	13	29	,	,	PUNCT
ct-10840	13	30	and	and	CCONJ
ct-10840	13	31	ongoing	ongoing	ADJ
ct-10840	13	32	vaginal	vaginal	ADJ
ct-10840	13	33	cytology	cytology	NOUN
ct-10840	13	34	and	and	CCONJ
ct-10840	13	35	serum	serum	NOUN
ct-10840	13	36	progesterone	progesterone	NOUN
ct-10840	13	37	measurements	measurement	NOUN
ct-10840	13	38	are	be	AUX
ct-10840	13	39	required	require	VERB
ct-10840	13	40	to	to	PART
ct-10840	13	41	facilitate	facilitate	VERB
ct-10840	13	42	differentiation	differentiation	NOUN
ct-10840	13	43	of	of	ADP
ct-10840	13	44	a	a	DET
ct-10840	13	45	gct	gct	PROPN
ct-10840	13	46	from	from	ADP
ct-10840	13	47	other	other	ADJ
ct-10840	13	48	causes	cause	NOUN
ct-10840	13	49	of	of	ADP
ct-10840	13	50	estrogen	estrogen	NOUN
ct-10840	13	51	-	-	PUNCT
ct-10840	13	52	associated	associate	VERB
ct-10840	13	53	conditions	condition	NOUN
ct-10840	13	54	.	.	PUNCT
ct-10840	14	1	long	long	ADJ
ct-10840	14	2	-	-	PUNCT
ct-10840	14	3	term	term	NOUN
ct-10840	14	4	exposure	exposure	NOUN
ct-10840	14	5	to	to	ADP
ct-10840	14	6	estrogen	estrogen	NOUN
ct-10840	14	7	arising	arise	VERB
ct-10840	14	8	from	from	ADP
ct-10840	14	9	continuous	continuous	ADJ
ct-10840	14	10	secretion	secretion	NOUN
ct-10840	14	11	of	of	ADP
ct-10840	14	12	steroid	steroid	NOUN
ct-10840	14	13	hormones	hormone	NOUN
ct-10840	14	14	from	from	ADP
ct-10840	14	15	neoplastic	neoplastic	ADJ
ct-10840	14	16	granulosa	granulosa	NOUN
ct-10840	14	17	cells	cell	NOUN
ct-10840	14	18	of	of	ADP
ct-10840	14	19	a	a	DET
ct-10840	14	20	gct	gct	PROPN
ct-10840	14	21	can	can	AUX
ct-10840	14	22	have	have	VERB
ct-10840	14	23	detrimental	detrimental	ADJ
ct-10840	14	24	effects	effect	NOUN
ct-10840	14	25	on	on	ADP
ct-10840	14	26	bone	bone	NOUN
ct-10840	14	27	marrow	marrow	NOUN
ct-10840	14	28	and	and	CCONJ
ct-10840	14	29	uterine	uterine	ADJ
ct-10840	14	30	tissue	tissue	NOUN
ct-10840	14	31	,	,	PUNCT
ct-10840	14	32	resulting	result	VERB
ct-10840	14	33	in	in	ADP
ct-10840	14	34	anemia	anemia	NOUN
ct-10840	14	35	and	and	CCONJ
ct-10840	14	36	infertility	infertility	NOUN
ct-10840	14	37	,	,	PUNCT
ct-10840	14	38	respectively.3	respectively.3	PROPN
ct-10840	14	39	-	-	PUNCT
ct-10840	14	40	5,8	5,8	NUM
ct-10840	14	41	-	-	SYM
ct-10840	14	42	12	12	NUM
ct-10840	14	43	exposure	exposure	NOUN
ct-10840	14	44	to	to	ADP
ct-10840	14	45	sustained	sustained	ADJ
ct-10840	14	46	elevated	elevated	ADJ
ct-10840	14	47	concentrations	concentration	NOUN
ct-10840	14	48	of	of	ADP
ct-10840	14	49	estrogen	estrogen	NOUN
ct-10840	14	50	affects	affect	VERB
ct-10840	14	51	the	the	DET
ct-10840	14	52	hematopoietic	hematopoietic	ADJ
ct-10840	14	53	system	system	NOUN
ct-10840	14	54	in	in	ADP
ct-10840	14	55	3	3	NUM
ct-10840	14	56	stages	stage	NOUN
ct-10840	14	57	:	:	PUNCT
ct-10840	14	58	a	a	DET
ct-10840	14	59	brief	brief	ADJ
ct-10840	14	60	increase	increase	NOUN
ct-10840	14	61	in	in	ADP
ct-10840	14	62	platelets	platelet	NOUN
ct-10840	14	63	followed	follow	VERB
ct-10840	14	64	by	by	ADP
ct-10840	14	65	severe	severe	ADJ
ct-10840	14	66	thrombocytopenia	thrombocytopenia	PROPN
ct-10840	14	67	,	,	PUNCT
ct-10840	14	68	then	then	ADV
ct-10840	14	69	development	development	NOUN
ct-10840	14	70	of	of	ADP
ct-10840	14	71	bone	bone	NOUN
ct-10840	14	72	marrow	marrow	NOUN
ct-10840	14	73	granulocyte	granulocyte	ADJ
ct-10840	14	74	hyperplasia	hyperplasia	NOUN
ct-10840	14	75	with	with	ADP
ct-10840	14	76	neutrophilia	neutrophilia	PROPN
ct-10840	14	77	and	and	CCONJ
ct-10840	14	78	,	,	PUNCT
ct-10840	14	79	finally	finally	ADV
ct-10840	14	80	,	,	PUNCT
ct-10840	14	81	bone	bone	NOUN
ct-10840	14	82	marrow	marrow	NOUN
ct-10840	14	83	recovery	recovery	NOUN
ct-10840	14	84	or	or	CCONJ
ct-10840	14	85	aplasia	aplasia	NOUN
ct-10840	14	86	,	,	PUNCT
ct-10840	14	87	dependent	dependent	ADJ
ct-10840	14	88	on	on	ADP
ct-10840	14	89	the	the	DET
ct-10840	14	90	magnitude	magnitude	NOUN
ct-10840	14	91	of	of	ADP
ct-10840	14	92	hormonal	hormonal	ADJ
ct-10840	14	93	insult.16,17	insult.16,17	ADJ
ct-10840	14	94	gcts	gct	NOUN
ct-10840	14	95	can	can	AUX
ct-10840	14	96	also	also	ADV
ct-10840	14	97	produce	produce	VERB
ct-10840	14	98	progesterone	progesterone	NOUN
ct-10840	14	99	that	that	PRON
ct-10840	14	100	in	in	ADP
ct-10840	14	101	combination	combination	NOUN
ct-10840	14	102	with	with	ADP
ct-10840	14	103	estrogen	estrogen	NOUN
ct-10840	14	104	,	,	PUNCT
ct-10840	14	105	causes	cause	VERB
ct-10840	14	106	stimulation	stimulation	NOUN
ct-10840	14	107	of	of	ADP
ct-10840	14	108	endometrial	endometrial	ADJ
ct-10840	14	109	growth	growth	NOUN
ct-10840	14	110	,	,	PUNCT
ct-10840	14	111	proliferation	proliferation	NOUN
ct-10840	14	112	,	,	PUNCT
ct-10840	14	113	and	and	CCONJ
ct-10840	14	114	glandular	glandular	ADJ
ct-10840	14	115	secretions.8	secretions.8	PRON
ct-10840	14	116	direct	direct	ADJ
ct-10840	14	117	exposure	exposure	NOUN
ct-10840	14	118	to	to	ADP
ct-10840	14	119	these	these	DET
ct-10840	14	120	steroid	steroid	NOUN
ct-10840	14	121	hormones	hormone	NOUN
ct-10840	14	122	results	result	NOUN
ct-10840	14	123	in	in	ADP
ct-10840	14	124	the	the	DET
ct-10840	14	125	development	development	NOUN
ct-10840	14	126	of	of	ADP
ct-10840	14	127	cystic	cystic	ADJ
ct-10840	14	128	endometrial	endometrial	ADJ
ct-10840	14	129	hyperplasia	hyperplasia	NOUN
ct-10840	14	130	(	(	PUNCT
ct-10840	14	131	ceh	ceh	PROPN
ct-10840	14	132	)	)	PUNCT
ct-10840	14	133	,	,	PUNCT
ct-10840	14	134	which	which	PRON
ct-10840	14	135	not	not	PART
ct-10840	14	136	only	only	ADV
ct-10840	14	137	increases	increase	VERB
ct-10840	14	138	the	the	DET
ct-10840	14	139	risk	risk	NOUN
ct-10840	14	140	of	of	ADP
ct-10840	14	141	developing	develop	VERB
ct-10840	14	142	a	a	DET
ct-10840	14	143	life	life	NOUN
ct-10840	14	144	-	-	PUNCT
ct-10840	14	145	threatening	threaten	VERB
ct-10840	14	146	pyometra	pyometra	NOUN
ct-10840	14	147	but	but	CCONJ
ct-10840	14	148	can	can	AUX
ct-10840	14	149	lead	lead	VERB
ct-10840	14	150	to	to	ADP
ct-10840	14	151	sub	sub	VERB
ct-10840	14	152	/	/	NOUN
ct-10840	14	153	infertility	infertility	NOUN
ct-10840	14	154	through	through	ADP
ct-10840	14	155	early	early	ADJ
ct-10840	14	156	embryonic	embryonic	ADJ
ct-10840	14	157	loss	loss	NOUN
ct-10840	14	158	and	and	CCONJ
ct-10840	14	159	impaired	impaired	ADJ
ct-10840	14	160	placentation.8,18,19	placentation.8,18,19	NOUN
ct-10840	14	161	bioassay	bioassay	NOUN
ct-10840	14	162	panels	panel	NOUN
ct-10840	14	163	of	of	ADP
ct-10840	14	164	reproductive	reproductive	ADJ
ct-10840	14	165	hormones	hormone	NOUN
ct-10840	14	166	in	in	ADP
ct-10840	14	167	mares	mare	NOUN
ct-10840	14	168	and	and	CCONJ
ct-10840	14	169	cows	cow	NOUN
ct-10840	14	170	are	be	AUX
ct-10840	14	171	routinely	routinely	ADV
ct-10840	14	172	used	use	VERB
ct-10840	14	173	to	to	PART
ct-10840	14	174	help	help	VERB
ct-10840	14	175	differentiate	differentiate	VERB
ct-10840	14	176	ovarian	ovarian	ADJ
ct-10840	14	177	mailto:alexandria.horner@colostate.edu	mailto:alexandria.horner@colostate.edu	NOUN
ct-10840	15	1	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	PROPN
ct-10840	15	2	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	PROPN
ct-10840	15	3	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	15	4	2	2	NUM
ct-10840	15	5	citation	citation	NOUN
ct-10840	15	6	:	:	PUNCT
ct-10840	15	7	clinical	clinical	ADJ
ct-10840	15	8	theriogenology	theriogenology	NOUN
ct-10840	15	9	2024	2024	NUM
ct-10840	15	10	,	,	PUNCT
ct-10840	15	11	16	16	NUM
ct-10840	15	12	,	,	PUNCT
ct-10840	15	13	10840	10840	NUM
ct-10840	15	14	,	,	PUNCT
ct-10840	15	15	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	15	16	pathology	pathology	NOUN
ct-10840	15	17	and	and	CCONJ
ct-10840	15	18	diseases	disease	NOUN
ct-10840	15	19	.	.	PUNCT
ct-10840	16	1	increased	increase	VERB
ct-10840	16	2	serum	serum	NOUN
ct-10840	16	3	concentrations	concentration	NOUN
ct-10840	16	4	of	of	ADP
ct-10840	16	5	antimüllerian	antimüllerian	ADJ
ct-10840	16	6	hormone	hormone	NOUN
ct-10840	16	7	(	(	PUNCT
ct-10840	16	8	amh	amh	PROPN
ct-10840	16	9	)	)	PUNCT
ct-10840	16	10	,	,	PUNCT
ct-10840	16	11	inhibin	inhibin	PROPN
ct-10840	16	12	b	b	PROPN
ct-10840	16	13	and/or	and/or	CCONJ
ct-10840	16	14	testosterone	testosterone	NOUN
ct-10840	16	15	,	,	PUNCT
ct-10840	16	16	all	all	PRON
ct-10840	16	17	produced	produce	VERB
ct-10840	16	18	by	by	ADP
ct-10840	16	19	granulosa	granulosa	NOUN
ct-10840	16	20	cells	cell	NOUN
ct-10840	16	21	,	,	PUNCT
ct-10840	16	22	have	have	AUX
ct-10840	16	23	been	be	AUX
ct-10840	16	24	demonstrated	demonstrate	VERB
ct-10840	16	25	to	to	PART
ct-10840	16	26	be	be	AUX
ct-10840	16	27	useful	useful	ADJ
ct-10840	16	28	biomarkers	biomarker	NOUN
ct-10840	16	29	for	for	ADP
ct-10840	16	30	identifying	identify	VERB
ct-10840	16	31	functional	functional	ADJ
ct-10840	16	32	gcts	gct	NOUN
ct-10840	16	33	in	in	ADP
ct-10840	16	34	cows	cow	NOUN
ct-10840	16	35	and	and	CCONJ
ct-10840	16	36	mares.20–25	mares.20–25	NOUN
ct-10840	16	37	in	in	ADP
ct-10840	16	38	mares	mare	NOUN
ct-10840	16	39	,	,	PUNCT
ct-10840	16	40	amh	amh	PROPN
ct-10840	16	41	secretion	secretion	PROPN
ct-10840	16	42	can	can	AUX
ct-10840	16	43	be	be	AUX
ct-10840	16	44	identified	identify	VERB
ct-10840	16	45	in	in	ADP
ct-10840	16	46	normal	normal	ADJ
ct-10840	16	47	growing	grow	VERB
ct-10840	16	48	and	and	CCONJ
ct-10840	16	49	small	small	ADJ
ct-10840	16	50	antral	antral	ADJ
ct-10840	16	51	follicles.26	follicles.26	NOUN
ct-10840	16	52	however	however	ADV
ct-10840	16	53	,	,	PUNCT
ct-10840	16	54	studies	study	NOUN
ct-10840	16	55	comparing	compare	VERB
ct-10840	16	56	normal	normal	ADJ
ct-10840	16	57	ovarian	ovarian	ADJ
ct-10840	16	58	function	function	NOUN
ct-10840	16	59	with	with	ADP
ct-10840	16	60	gcts	gct	NOUN
ct-10840	16	61	determined	determine	VERB
ct-10840	16	62	that	that	SCONJ
ct-10840	16	63	bioactive	bioactive	PROPN
ct-10840	16	64	amh	amh	PROPN
ct-10840	16	65	was	be	AUX
ct-10840	16	66	more	more	ADV
ct-10840	16	67	strongly	strongly	ADV
ct-10840	16	68	expressed	express	VERB
ct-10840	16	69	in	in	ADP
ct-10840	16	70	mares	mare	NOUN
ct-10840	16	71	with	with	ADP
ct-10840	16	72	gct.20,26	gct.20,26	NOUN
ct-10840	16	73	elevated	elevate	VERB
ct-10840	16	74	serum	serum	NOUN
ct-10840	16	75	concentrations	concentration	NOUN
ct-10840	16	76	of	of	ADP
ct-10840	16	77	inhibin	inhibin	ADJ
ct-10840	16	78	and	and	CCONJ
ct-10840	16	79	testosterone	testosterone	NOUN
ct-10840	16	80	are	be	AUX
ct-10840	16	81	present	present	ADJ
ct-10840	16	82	in	in	ADP
ct-10840	16	83	87	87	NUM
ct-10840	16	84	and	and	CCONJ
ct-10840	16	85	67	67	NUM
ct-10840	16	86	%	%	NOUN
ct-10840	16	87	of	of	ADP
ct-10840	16	88	mares	mare	NOUN
ct-10840	16	89	with	with	ADP
ct-10840	16	90	a	a	DET
ct-10840	16	91	gct	gct	PROPN
ct-10840	16	92	,	,	PUNCT
ct-10840	16	93	respectively.25–28	respectively.25–28	PROPN
ct-10840	16	94	inhibin	inhibin	PROPN
ct-10840	16	95	b	b	PROPN
ct-10840	16	96	isoform	isoform	NOUN
ct-10840	16	97	is	be	AUX
ct-10840	16	98	the	the	DET
ct-10840	16	99	only	only	ADJ
ct-10840	16	100	isoform	isoform	NOUN
ct-10840	16	101	of	of	ADP
ct-10840	16	102	inhibin	inhibin	NOUN
ct-10840	16	103	that	that	PRON
ct-10840	16	104	reliably	reliably	ADV
ct-10840	16	105	indicates	indicate	VERB
ct-10840	16	106	ovarian	ovarian	ADJ
ct-10840	16	107	neoplasia	neoplasia	NOUN
ct-10840	16	108	in	in	ADP
ct-10840	16	109	mares.22	mares.22	NOUN
ct-10840	16	110	when	when	SCONJ
ct-10840	16	111	amh	amh	PROPN
ct-10840	16	112	,	,	PUNCT
ct-10840	16	113	inhibin	inhibin	PROPN
ct-10840	16	114	b	b	NOUN
ct-10840	16	115	and	and	CCONJ
ct-10840	16	116	testosterone	testosterone	NOUN
ct-10840	16	117	are	be	AUX
ct-10840	16	118	used	use	VERB
ct-10840	16	119	together	together	ADV
ct-10840	16	120	as	as	ADP
ct-10840	16	121	a	a	DET
ct-10840	16	122	screening	screen	VERB
ct-10840	16	123	panel	panel	NOUN
ct-10840	16	124	in	in	ADP
ct-10840	16	125	mares	mare	NOUN
ct-10840	16	126	,	,	PUNCT
ct-10840	16	127	100	100	NUM
ct-10840	16	128	%	%	NOUN
ct-10840	16	129	sensitivity	sensitivity	NOUN
ct-10840	16	130	is	be	AUX
ct-10840	16	131	achieved.23	achieved.23	ADV
ct-10840	16	132	unfortunately	unfortunately	ADV
ct-10840	16	133	,	,	PUNCT
ct-10840	16	134	a	a	DET
ct-10840	16	135	screening	screen	VERB
ct-10840	16	136	panel	panel	NOUN
ct-10840	16	137	for	for	ADP
ct-10840	16	138	canine	canine	PROPN
ct-10840	16	139	gct	gct	PROPN
ct-10840	16	140	has	have	AUX
ct-10840	16	141	not	not	PART
ct-10840	16	142	yet	yet	ADV
ct-10840	16	143	been	be	AUX
ct-10840	16	144	established	establish	VERB
ct-10840	16	145	.	.	PUNCT
ct-10840	17	1	previous	previous	ADJ
ct-10840	17	2	studies	study	NOUN
ct-10840	17	3	reported	report	VERB
ct-10840	17	4	serum	serum	NOUN
ct-10840	17	5	concentrations	concentration	NOUN
ct-10840	17	6	of	of	ADP
ct-10840	17	7	amh	amh	PROPN
ct-10840	17	8	in	in	ADP
ct-10840	17	9	dogs	dog	NOUN
ct-10840	17	10	with	with	ADP
ct-10840	17	11	gcts	gct	NOUN
ct-10840	17	12	to	to	PART
ct-10840	17	13	range	range	VERB
ct-10840	17	14	from	from	ADP
ct-10840	17	15	1.12	1.12	NUM
ct-10840	17	16	to	to	ADP
ct-10840	17	17	≥	≥	PROPN
ct-10840	17	18	23	23	NUM
ct-10840	17	19	ng	ng	PROPN
ct-10840	17	20	/	/	SYM
ct-10840	17	21	ml.21,29,30	ml.21,29,30	PROPN
ct-10840	17	22	at	at	ADP
ct-10840	17	23	the	the	DET
ct-10840	17	24	time	time	NOUN
ct-10840	17	25	of	of	ADP
ct-10840	17	26	this	this	DET
ct-10840	17	27	report	report	NOUN
ct-10840	17	28	,	,	PUNCT
ct-10840	17	29	no	no	DET
ct-10840	17	30	studies	study	NOUN
ct-10840	17	31	were	be	AUX
ct-10840	17	32	identified	identify	VERB
ct-10840	17	33	regarding	regard	VERB
ct-10840	17	34	the	the	DET
ct-10840	17	35	use	use	NOUN
ct-10840	17	36	of	of	ADP
ct-10840	17	37	inhibin	inhibin	ADJ
ct-10840	17	38	-	-	PUNCT
ct-10840	17	39	b	b	NOUN
ct-10840	17	40	serum	serum	NOUN
ct-10840	17	41	concentrations	concentration	NOUN
ct-10840	17	42	for	for	ADP
ct-10840	17	43	canine	canine	NOUN
ct-10840	17	44	gcts	gct	NOUN
ct-10840	17	45	diagnosis	diagnosis	NOUN
ct-10840	17	46	.	.	PUNCT
ct-10840	18	1	as	as	ADP
ct-10840	18	2	a	a	DET
ct-10840	18	3	result	result	NOUN
ct-10840	18	4	,	,	PUNCT
ct-10840	18	5	no	no	DET
ct-10840	18	6	reference	reference	NOUN
ct-10840	18	7	range	range	NOUN
ct-10840	18	8	has	have	AUX
ct-10840	18	9	been	be	AUX
ct-10840	18	10	established	establish	VERB
ct-10840	18	11	.	.	PUNCT
ct-10840	19	1	testosterone	testosterone	NOUN
ct-10840	19	2	has	have	AUX
ct-10840	19	3	also	also	ADV
ct-10840	19	4	not	not	PART
ct-10840	19	5	been	be	AUX
ct-10840	19	6	reported	report	VERB
ct-10840	19	7	as	as	ADP
ct-10840	19	8	a	a	DET
ct-10840	19	9	bioassay	bioassay	NOUN
ct-10840	19	10	in	in	ADP
ct-10840	19	11	the	the	DET
ct-10840	19	12	dog	dog	NOUN
ct-10840	19	13	for	for	ADP
ct-10840	19	14	gct	gct	PROPN
ct-10840	19	15	diagnosis	diagnosis	NOUN
ct-10840	19	16	and	and	CCONJ
ct-10840	19	17	was	be	AUX
ct-10840	19	18	not	not	PART
ct-10840	19	19	measured	measure	VERB
ct-10840	19	20	in	in	ADP
ct-10840	19	21	this	this	DET
ct-10840	19	22	case	case	NOUN
ct-10840	19	23	.	.	PUNCT
ct-10840	20	1	currently	currently	ADV
ct-10840	20	2	,	,	PUNCT
ct-10840	20	3	in	in	ADP
ct-10840	20	4	dogs	dog	NOUN
ct-10840	20	5	,	,	PUNCT
ct-10840	20	6	measurement	measurement	NOUN
ct-10840	20	7	of	of	ADP
ct-10840	20	8	amh	amh	PROPN
ct-10840	20	9	and	and	CCONJ
ct-10840	20	10	inhibin	inhibin	PROPN
ct-10840	20	11	needs	need	VERB
ct-10840	20	12	to	to	PART
ct-10840	20	13	be	be	AUX
ct-10840	20	14	interpreted	interpret	VERB
ct-10840	20	15	in	in	ADP
ct-10840	20	16	conjunction	conjunction	NOUN
ct-10840	20	17	with	with	ADP
ct-10840	20	18	other	other	ADJ
ct-10840	20	19	clinical	clinical	ADJ
ct-10840	20	20	and	and	CCONJ
ct-10840	20	21	diagnostic	diagnostic	ADJ
ct-10840	20	22	findings	finding	NOUN
ct-10840	20	23	(	(	PUNCT
ct-10840	20	24	e.g.	e.g.	ADV
ct-10840	20	25	ovarian	ovarian	ADJ
ct-10840	20	26	anatomical	anatomical	ADJ
ct-10840	20	27	changes	change	NOUN
ct-10840	20	28	on	on	ADP
ct-10840	20	29	ultrasonography	ultrasonography	NOUN
ct-10840	20	30	)	)	PUNCT
ct-10840	20	31	for	for	ADP
ct-10840	20	32	a	a	DET
ct-10840	20	33	presumptive	presumptive	ADJ
ct-10840	20	34	diagnosis	diagnosis	NOUN
ct-10840	20	35	of	of	ADP
ct-10840	20	36	gct.20,21	gct.20,21	PROPN
ct-10840	20	37	ultrasonographic	ultrasonographic	ADJ
ct-10840	20	38	examination	examination	NOUN
ct-10840	20	39	of	of	ADP
ct-10840	20	40	the	the	DET
ct-10840	20	41	ovaries	ovary	NOUN
ct-10840	20	42	is	be	AUX
ct-10840	20	43	a	a	DET
ct-10840	20	44	valuable	valuable	ADJ
ct-10840	20	45	screening	screening	NOUN
ct-10840	20	46	and	and	CCONJ
ct-10840	20	47	diagnostic	diagnostic	ADJ
ct-10840	20	48	tool	tool	NOUN
ct-10840	20	49	for	for	ADP
ct-10840	20	50	determining	determine	VERB
ct-10840	20	51	the	the	DET
ct-10840	20	52	presence	presence	NOUN
ct-10840	20	53	of	of	ADP
ct-10840	20	54	pathological	pathological	ADJ
ct-10840	20	55	changes	change	NOUN
ct-10840	20	56	associated	associate	VERB
ct-10840	20	57	with	with	ADP
ct-10840	20	58	ovarian	ovarian	ADJ
ct-10840	20	59	parenchyma	parenchyma	NOUN
ct-10840	20	60	in	in	ADP
ct-10840	20	61	many	many	ADJ
ct-10840	20	62	species.20	species.20	NOUN
ct-10840	20	63	previous	previous	ADJ
ct-10840	20	64	publications	publication	NOUN
ct-10840	20	65	in	in	ADP
ct-10840	20	66	dogs	dog	NOUN
ct-10840	20	67	have	have	AUX
ct-10840	20	68	demonstrated	demonstrate	VERB
ct-10840	20	69	that	that	SCONJ
ct-10840	20	70	ovarian	ovarian	ADJ
ct-10840	20	71	tumors	tumor	NOUN
ct-10840	20	72	,	,	PUNCT
ct-10840	20	73	particularly	particularly	ADV
ct-10840	20	74	gcts	gct	NOUN
ct-10840	20	75	,	,	PUNCT
ct-10840	20	76	have	have	VERB
ct-10840	20	77	a	a	DET
ct-10840	20	78	wide	wide	ADJ
ct-10840	20	79	range	range	NOUN
ct-10840	20	80	of	of	ADP
ct-10840	20	81	alterations	alteration	NOUN
ct-10840	20	82	to	to	ADP
ct-10840	20	83	echogenicity	echogenicity	NOUN
ct-10840	20	84	and	and	CCONJ
ct-10840	20	85	shape.6	shape.6	NOUN
ct-10840	20	86	in	in	ADP
ct-10840	20	87	this	this	DET
ct-10840	20	88	case	case	NOUN
ct-10840	20	89	report	report	NOUN
ct-10840	20	90	,	,	PUNCT
ct-10840	20	91	we	we	PRON
ct-10840	20	92	discuss	discuss	VERB
ct-10840	20	93	the	the	DET
ct-10840	20	94	steps	step	NOUN
ct-10840	20	95	taken	take	VERB
ct-10840	20	96	to	to	PART
ct-10840	20	97	diagnose	diagnose	VERB
ct-10840	20	98	gct	gct	PROPN
ct-10840	20	99	at	at	ADP
ct-10840	20	100	a	a	DET
ct-10840	20	101	very	very	ADV
ct-10840	20	102	early	early	ADJ
ct-10840	20	103	stage	stage	NOUN
ct-10840	20	104	of	of	ADP
ct-10840	20	105	development	development	NOUN
ct-10840	20	106	in	in	ADP
ct-10840	20	107	a	a	DET
ct-10840	20	108	young	young	ADJ
ct-10840	20	109	,	,	PUNCT
ct-10840	20	110	genetically	genetically	ADV
ct-10840	20	111	valuable	valuable	ADJ
ct-10840	20	112	breeding	breeding	NOUN
ct-10840	20	113	female	female	ADJ
ct-10840	20	114	dog	dog	NOUN
ct-10840	20	115	and	and	CCONJ
ct-10840	20	116	a	a	DET
ct-10840	20	117	novel	novel	ADJ
ct-10840	20	118	treatment	treatment	NOUN
ct-10840	20	119	approach	approach	NOUN
ct-10840	20	120	to	to	PART
ct-10840	20	121	remove	remove	VERB
ct-10840	20	122	the	the	DET
ct-10840	20	123	ovarian	ovarian	ADJ
ct-10840	20	124	tumor	tumor	NOUN
ct-10840	20	125	whilst	whilst	SCONJ
ct-10840	20	126	maintaining	maintain	VERB
ct-10840	20	127	fertility	fertility	NOUN
ct-10840	20	128	.	.	PUNCT
ct-10840	21	1	case	case	NOUN
ct-10840	21	2	presentation	presentation	NOUN
ct-10840	21	3	a	a	DET
ct-10840	21	4	4	4	NUM
ct-10840	21	5	-	-	PUNCT
ct-10840	21	6	year	year	NOUN
ct-10840	21	7	,	,	PUNCT
ct-10840	21	8	multiparous	multiparous	ADJ
ct-10840	21	9	rottweiler	rottweiler	ADJ
ct-10840	21	10	female	female	ADJ
ct-10840	21	11	dog	dog	NOUN
ct-10840	21	12	,	,	PUNCT
ct-10840	21	13	was	be	AUX
ct-10840	21	14	presented	present	VERB
ct-10840	21	15	7	7	NUM
ct-10840	21	16	days	day	NOUN
ct-10840	21	17	after	after	ADP
ct-10840	21	18	the	the	DET
ct-10840	21	19	onset	onset	NOUN
ct-10840	21	20	of	of	ADP
ct-10840	21	21	clinical	clinical	ADJ
ct-10840	21	22	signs	sign	NOUN
ct-10840	21	23	associated	associate	VERB
ct-10840	21	24	with	with	ADP
ct-10840	21	25	proestrus	proestrus	NOUN
ct-10840	21	26	(	(	PUNCT
ct-10840	21	27	i.e.	i.e.	X
ct-10840	21	28	bloody	bloody	ADJ
ct-10840	21	29	vulvar	vulvar	NOUN
ct-10840	21	30	discharge	discharge	NOUN
ct-10840	21	31	and	and	CCONJ
ct-10840	21	32	vulvar	vulvar	NOUN
ct-10840	21	33	edema	edema	NOUN
ct-10840	21	34	)	)	PUNCT
ct-10840	21	35	.	.	PUNCT
ct-10840	22	1	a	a	DET
ct-10840	22	2	routine	routine	ADJ
ct-10840	22	3	breeding	breeding	NOUN
ct-10840	22	4	examination	examination	NOUN
ct-10840	22	5	was	be	AUX
ct-10840	22	6	performed	perform	VERB
ct-10840	22	7	,	,	PUNCT
ct-10840	22	8	which	which	PRON
ct-10840	22	9	included	include	VERB
ct-10840	22	10	a	a	DET
ct-10840	22	11	complete	complete	ADJ
ct-10840	22	12	physical	physical	ADJ
ct-10840	22	13	examination	examination	NOUN
ct-10840	22	14	,	,	PUNCT
ct-10840	22	15	screening	screen	VERB
ct-10840	22	16	for	for	ADP
ct-10840	22	17	  	  	SPACE
ct-10840	22	18	brucella	brucella	NOUN
ct-10840	22	19	canis	canis	NOUN
ct-10840	22	20	(	(	PUNCT
ct-10840	22	21	brucella	brucella	PROPN
ct-10840	22	22	multiplex	multiplex	PROPN
ct-10840	22	23	,	,	PUNCT
ct-10840	22	24	cornell	cornell	PROPN
ct-10840	22	25	university	university	PROPN
ct-10840	22	26	,	,	PUNCT
ct-10840	22	27	ithaca	ithaca	PROPN
ct-10840	22	28	,	,	PUNCT
ct-10840	22	29	ny	ny	PROPN
ct-10840	22	30	)	)	PUNCT
ct-10840	22	31	.	.	PUNCT
ct-10840	23	1	additionally	additionally	ADV
ct-10840	23	2	,	,	PUNCT
ct-10840	23	3	complete	complete	ADJ
ct-10840	23	4	blood	blood	NOUN
ct-10840	23	5	count	count	NOUN
ct-10840	23	6	(	(	PUNCT
ct-10840	23	7	cbc	cbc	PROPN
ct-10840	23	8	)	)	PUNCT
ct-10840	23	9	and	and	CCONJ
ct-10840	23	10	chemistry	chemistry	NOUN
ct-10840	23	11	analyses	analysis	NOUN
ct-10840	23	12	were	be	AUX
ct-10840	23	13	performed	perform	VERB
ct-10840	23	14	.	.	PUNCT
ct-10840	24	1	no	no	DET
ct-10840	24	2	abnormal	abnormal	ADJ
ct-10840	24	3	findings	finding	NOUN
ct-10840	24	4	were	be	AUX
ct-10840	24	5	reported	report	VERB
ct-10840	24	6	.	.	PUNCT
ct-10840	25	1	starting	start	VERB
ct-10840	25	2	on	on	ADP
ct-10840	25	3	day	day	NOUN
ct-10840	25	4	8	8	NUM
ct-10840	25	5	(	(	PUNCT
ct-10840	25	6	from	from	ADP
ct-10840	25	7	the	the	DET
ct-10840	25	8	first	first	ADJ
ct-10840	25	9	signs	sign	NOUN
ct-10840	25	10	of	of	ADP
ct-10840	25	11	proestrus	proestrus	NOUN
ct-10840	25	12	observed	observe	VERB
ct-10840	25	13	by	by	ADP
ct-10840	25	14	the	the	DET
ct-10840	25	15	owner	owner	NOUN
ct-10840	25	16	)	)	PUNCT
ct-10840	25	17	,	,	PUNCT
ct-10840	25	18	blood	blood	NOUN
ct-10840	25	19	samples	sample	NOUN
ct-10840	25	20	were	be	AUX
ct-10840	25	21	obtained	obtain	VERB
ct-10840	25	22	every	every	DET
ct-10840	25	23	other	other	ADJ
ct-10840	25	24	day	day	NOUN
ct-10840	25	25	to	to	PART
ct-10840	25	26	measure	measure	VERB
ct-10840	25	27	serum	serum	NOUN
ct-10840	25	28	progesterone	progesterone	NOUN
ct-10840	25	29	concentrations	concentration	NOUN
ct-10840	25	30	(	(	PUNCT
ct-10840	25	31	immulite	immulite	ADJ
ct-10840	25	32	®	®	NOUN
ct-10840	25	33	1000	1000	NUM
ct-10840	25	34	immunoassay	immunoassay	NOUN
ct-10840	25	35	system	system	NOUN
ct-10840	25	36	,	,	PUNCT
ct-10840	25	37	colorado	colorado	PROPN
ct-10840	25	38	state	state	PROPN
ct-10840	25	39	university	university	PROPN
ct-10840	25	40	,	,	PUNCT
ct-10840	25	41	fort	fort	PROPN
ct-10840	25	42	collins	collins	PROPN
ct-10840	25	43	,	,	PUNCT
ct-10840	25	44	co	co	NOUN
ct-10840	25	45	)	)	PUNCT
ct-10840	25	46	and	and	CCONJ
ct-10840	25	47	vaginal	vaginal	ADJ
ct-10840	25	48	smears	smear	NOUN
ct-10840	25	49	were	be	AUX
ct-10840	25	50	taken	take	VERB
ct-10840	25	51	for	for	ADP
ct-10840	25	52	cytological	cytological	ADJ
ct-10840	25	53	evaluation	evaluation	NOUN
ct-10840	25	54	of	of	ADP
ct-10840	25	55	vaginal	vaginal	ADJ
ct-10840	25	56	epithelial	epithelial	ADJ
ct-10840	25	57	cells	cell	NOUN
ct-10840	25	58	every	every	DET
ct-10840	25	59	2nd	2nd	ADJ
ct-10840	25	60	or	or	CCONJ
ct-10840	25	61	3rd	3rd	ADJ
ct-10840	25	62	day	day	NOUN
ct-10840	25	63	to	to	PART
ct-10840	25	64	determine	determine	VERB
ct-10840	25	65	stage	stage	NOUN
ct-10840	25	66	of	of	ADP
ct-10840	25	67	estrus	estrus	NOUN
ct-10840	25	68	and	and	CCONJ
ct-10840	25	69	detect	detect	VERB
ct-10840	25	70	lh	lh	PROPN
ct-10840	25	71	surge	surge	NOUN
ct-10840	25	72	(	(	PUNCT
ct-10840	25	73	lh0	lh0	ADJ
ct-10840	25	74	)	)	PUNCT
ct-10840	25	75	.	.	PUNCT
ct-10840	26	1	this	this	PRON
ct-10840	26	2	was	be	AUX
ct-10840	26	3	performed	perform	VERB
ct-10840	26	4	,	,	PUNCT
ct-10840	26	5	as	as	SCONJ
ct-10840	26	6	is	be	AUX
ct-10840	26	7	routinely	routinely	ADV
ct-10840	26	8	done	do	VERB
ct-10840	26	9	,	,	PUNCT
ct-10840	26	10	to	to	PART
ct-10840	26	11	facilitate	facilitate	VERB
ct-10840	26	12	optimal	optimal	ADJ
ct-10840	26	13	timing	timing	NOUN
ct-10840	26	14	of	of	ADP
ct-10840	26	15	insemination	insemination	NOUN
ct-10840	26	16	(	(	PUNCT
ct-10840	26	17	>	>	SYM
ct-10840	26	18	 	 	SPACE
ct-10840	26	19	90	90	NUM
ct-10840	26	20	%	%	NOUN
ct-10840	26	21	superficial	superficial	ADJ
ct-10840	26	22	keratinized	keratinized	ADJ
ct-10840	26	23	vaginal	vaginal	ADJ
ct-10840	26	24	epithelial	epithelial	ADJ
ct-10840	26	25	cells	cell	NOUN
ct-10840	26	26	)	)	PUNCT
ct-10840	26	27	with	with	ADP
ct-10840	26	28	frozen	frozen	ADJ
ct-10840	26	29	-	-	PUNCT
ct-10840	26	30	thawed	thaw	VERB
ct-10840	26	31	canine	canine	NOUN
ct-10840	26	32	semen.31–35	semen.31–35	VERB
ct-10840	26	33	progesterone	progesterone	NOUN
ct-10840	26	34	concentrations	concentration	NOUN
ct-10840	26	35	ranged	range	VERB
ct-10840	26	36	from	from	ADP
ct-10840	26	37	0.90	0.90	NUM
ct-10840	26	38	-	-	SYM
ct-10840	26	39	1.85	1.85	NUM
ct-10840	26	40	ng	ng	PROPN
ct-10840	26	41	/	/	SYM
ct-10840	26	42	ml	ml	NOUN
ct-10840	26	43	but	but	CCONJ
ct-10840	26	44	never	never	ADV
ct-10840	26	45	exceeded	exceed	VERB
ct-10840	26	46	2	2	NUM
ct-10840	26	47	ng	ng	PROPN
ct-10840	26	48	/	/	SYM
ct-10840	26	49	ml	ml	PROPN
ct-10840	26	50	,	,	PUNCT
ct-10840	26	51	and	and	CCONJ
ct-10840	26	52	vaginal	vaginal	ADJ
ct-10840	26	53	cytology	cytology	NOUN
ct-10840	26	54	never	never	ADV
ct-10840	26	55	changed	change	VERB
ct-10840	26	56	from	from	ADP
ct-10840	26	57	>	>	SYM
ct-10840	26	58	90	90	NUM
ct-10840	26	59	%	%	NOUN
ct-10840	26	60	superficial	superficial	ADJ
ct-10840	26	61	cell	cell	NOUN
ct-10840	26	62	(	(	PUNCT
ct-10840	26	63	table	table	NOUN
ct-10840	26	64	)	)	PUNCT
ct-10840	26	65	.	.	PUNCT
ct-10840	27	1	table	table	NOUN
ct-10840	27	2	.	.	PUNCT
ct-10840	28	1	serum	serum	NOUN
ct-10840	28	2	progesterone	progesterone	NOUN
ct-10840	28	3	profile	profile	NOUN
ct-10840	28	4	and	and	CCONJ
ct-10840	28	5	vaginal	vaginal	ADJ
ct-10840	28	6	cytology	cytology	NOUN
ct-10840	28	7	day	day	NOUN
ct-10840	28	8	of	of	ADP
ct-10840	28	9	cycle	cycle	NOUN
ct-10840	28	10	from	from	ADP
ct-10840	28	11	onset	onset	NOUN
ct-10840	28	12	of	of	ADP
ct-10840	28	13	clinical	clinical	ADJ
ct-10840	28	14	signs	sign	NOUN
ct-10840	28	15	progesterone	progesterone	NOUN
ct-10840	28	16	concentrations	concentration	NOUN
ct-10840	28	17	(	(	PUNCT
ct-10840	28	18	ng	ng	NOUN
ct-10840	28	19	/	/	SYM
ct-10840	28	20	ml	ml	NOUN
ct-10840	28	21	)	)	PUNCT
ct-10840	28	22	vaginal	vaginal	ADJ
ct-10840	28	23	cytology	cytology	NOUN
ct-10840	28	24	(	(	PUNCT
ct-10840	28	25	percent	percent	NOUN
ct-10840	28	26	superficial	superficial	ADJ
ct-10840	28	27	cornification	cornification	NOUN
ct-10840	28	28	)	)	PUNCT
ct-10840	28	29	8	8	NUM
ct-10840	28	30	0.923	0.923	NUM
ct-10840	28	31	>	>	SYM
ct-10840	28	32	90	90	NUM
ct-10840	28	33	10	10	NUM
ct-10840	28	34	0.976	0.976	NUM
ct-10840	28	35	>	>	SYM
ct-10840	28	36	90	90	NUM
ct-10840	28	37	13	13	NUM
ct-10840	28	38	0.971	0.971	NUM
ct-10840	28	39	>	>	SYM
ct-10840	28	40	90	90	NUM
ct-10840	28	41	16	16	NUM
ct-10840	28	42	0.924	0.924	NUM
ct-10840	28	43	>	>	SYM
ct-10840	28	44	90	90	NUM
ct-10840	28	45	21	21	NUM
ct-10840	28	46	1.030	1.030	NUM
ct-10840	28	47	>	>	SYM
ct-10840	28	48	90	90	NUM
ct-10840	28	49	23	23	NUM
ct-10840	28	50	0.895	0.895	NUM
ct-10840	28	51	>	>	SYM
ct-10840	28	52	90	90	NUM
ct-10840	28	53	27	27	NUM
ct-10840	28	54	1.16	1.16	NUM
ct-10840	28	55	>	>	SYM
ct-10840	28	56	90	90	NUM
ct-10840	28	57	30	30	NUM
ct-10840	28	58	1.03	1.03	NUM
ct-10840	28	59	>	>	SYM
ct-10840	28	60	90	90	NUM
ct-10840	28	61	35	35	NUM
ct-10840	28	62	1.85	1.85	NUM
ct-10840	28	63	>	>	SYM
ct-10840	28	64	90	90	NUM
ct-10840	28	65	differential	differential	ADJ
ct-10840	28	66	diagnoses	diagnosis	NOUN
ct-10840	28	67	differential	differential	ADJ
ct-10840	28	68	diagnoses	diagnosis	NOUN
ct-10840	28	69	for	for	ADP
ct-10840	28	70	persistent	persistent	ADJ
ct-10840	28	71	estrus	estrus	NOUN
ct-10840	28	72	included	include	VERB
ct-10840	28	73	an	an	DET
ct-10840	28	74	anovulatory	anovulatory	NOUN
ct-10840	28	75	follicle	follicle	NOUN
ct-10840	28	76	/	/	SYM
ct-10840	28	77	ovulation	ovulation	NOUN
ct-10840	28	78	failure	failure	NOUN
ct-10840	28	79	,	,	PUNCT
ct-10840	28	80	an	an	DET
ct-10840	28	81	ovarian	ovarian	ADJ
ct-10840	28	82	follicular	follicular	ADJ
ct-10840	28	83	cyst	cyst	NOUN
ct-10840	28	84	,	,	PUNCT
ct-10840	28	85	exogenous	exogenous	ADJ
ct-10840	28	86	exposure	exposure	NOUN
ct-10840	28	87	to	to	ADP
ct-10840	28	88	estrogens	estrogen	NOUN
ct-10840	28	89	through	through	ADP
ct-10840	28	90	diet	diet	NOUN
ct-10840	28	91	,	,	PUNCT
ct-10840	28	92	oral	oral	ADJ
ct-10840	28	93	treatment	treatment	NOUN
ct-10840	28	94	,	,	PUNCT
ct-10840	28	95	or	or	CCONJ
ct-10840	28	96	inadvertent	inadvertent	ADJ
ct-10840	28	97	exposure	exposure	NOUN
ct-10840	28	98	to	to	ADP
ct-10840	28	99	human	human	ADJ
ct-10840	28	100	hormonal	hormonal	ADJ
ct-10840	28	101	creams	cream	NOUN
ct-10840	28	102	and	and	CCONJ
ct-10840	28	103	lastly	lastly	ADV
ct-10840	28	104	,	,	PUNCT
ct-10840	28	105	hormone	hormone	NOUN
ct-10840	28	106	-	-	PUNCT
ct-10840	28	107	secreting	secrete	VERB
ct-10840	28	108	ovarian	ovarian	ADJ
ct-10840	28	109	neoplasia	neoplasia	NOUN
ct-10840	28	110	(	(	PUNCT
ct-10840	28	111	e.g.	e.g.	ADV
ct-10840	28	112	gct).6,7,32,36,37	gct).6,7,32,36,37	VERB
ct-10840	28	113	intersex	intersex	ADJ
ct-10840	28	114	conditions	condition	NOUN
ct-10840	28	115	were	be	AUX
ct-10840	28	116	not	not	PART
ct-10840	28	117	considered	consider	VERB
ct-10840	28	118	as	as	ADP
ct-10840	28	119	a	a	DET
ct-10840	28	120	differential	differential	ADJ
ct-10840	28	121	diagnosis	diagnosis	NOUN
ct-10840	28	122	due	due	ADP
ct-10840	28	123	to	to	ADP
ct-10840	28	124	previous	previous	ADJ
ct-10840	28	125	history	history	NOUN
ct-10840	28	126	of	of	ADP
ct-10840	28	127	successful	successful	ADJ
ct-10840	28	128	litters.38,39	litters.38,39	NOUN
ct-10840	28	129	diagnosis	diagnosis	NOUN
ct-10840	28	130	initial	initial	ADJ
ct-10840	28	131	b	b	X
ct-10840	28	132	-	-	PUNCT
ct-10840	28	133	mode	mode	NOUN
ct-10840	28	134	ultrasonographic	ultrasonographic	ADJ
ct-10840	28	135	examination	examination	NOUN
ct-10840	28	136	(	(	PUNCT
ct-10840	28	137	canon	canon	NOUN
ct-10840	28	138	®	®	NOUN
ct-10840	28	139	tus	tus	PROPN
ct-10840	28	140	-	-	PUNCT
ct-10840	28	141	ai700	ai700	PROPN
ct-10840	28	142	ultrasound	ultrasound	NOUN
ct-10840	28	143	machine	machine	NOUN
ct-10840	28	144	with	with	ADP
ct-10840	28	145	a	a	DET
ct-10840	28	146	multi	multi	ADJ
ct-10840	28	147	-	-	ADJ
ct-10840	28	148	frequency	frequency	ADJ
ct-10840	28	149	micro	micro	NOUN
ct-10840	28	150	-	-	NOUN
ct-10840	28	151	convex	convex	ADJ
ct-10840	28	152	(	(	PUNCT
ct-10840	28	153	8m1c	8m1c	NUM
ct-10840	28	154	)	)	PUNCT
ct-10840	28	155	transducer	transducer	NOUN
ct-10840	28	156	)	)	PUNCT
ct-10840	28	157	of	of	ADP
ct-10840	28	158	the	the	DET
ct-10840	28	159	reproductive	reproductive	ADJ
ct-10840	28	160	tract	tract	NOUN
ct-10840	28	161	(	(	PUNCT
ct-10840	28	162	ovaries	ovary	NOUN
ct-10840	28	163	,	,	PUNCT
ct-10840	28	164	uterus	uterus	NOUN
ct-10840	28	165	)	)	PUNCT
ct-10840	28	166	was	be	AUX
ct-10840	28	167	performed	perform	VERB
ct-10840	28	168	on	on	ADP
ct-10840	28	169	day	day	NOUN
ct-10840	28	170	40	40	NUM
ct-10840	28	171	of	of	ADP
ct-10840	28	172	estrus	estrus	PROPN
ct-10840	28	173	.	.	PUNCT
ct-10840	29	1	enlarged	enlarge	VERB
ct-10840	29	2	(	(	PUNCT
ct-10840	29	3	19	19	NUM
ct-10840	29	4	-	-	SYM
ct-10840	29	5	21	21	NUM
ct-10840	29	6	mm	mm	NOUN
ct-10840	29	7	in	in	ADP
ct-10840	29	8	diameter	diameter	NOUN
ct-10840	29	9	)	)	PUNCT
ct-10840	29	10	left	leave	VERB
ct-10840	29	11	ovary	ovary	NOUN
ct-10840	29	12	had	have	VERB
ct-10840	29	13	a	a	DET
ct-10840	29	14	heterogeneous	heterogeneous	ADJ
ct-10840	29	15	hypoechoic	hypoechoic	ADJ
ct-10840	29	16	region	region	NOUN
ct-10840	29	17	within	within	ADP
ct-10840	29	18	the	the	DET
ct-10840	29	19	caudal	caudal	NOUN
ct-10840	29	20	pole	pole	NOUN
ct-10840	29	21	(	(	PUNCT
ct-10840	29	22	figure	figure	NOUN
ct-10840	29	23	1a	1a	NOUN
ct-10840	29	24	)	)	PUNCT
ct-10840	29	25	.	.	PUNCT
ct-10840	30	1	right	right	ADJ
ct-10840	30	2	ovary	ovary	NOUN
ct-10840	30	3	was	be	AUX
ct-10840	30	4	normal	normal	ADJ
ct-10840	30	5	in	in	ADP
ct-10840	30	6	appearance	appearance	NOUN
ct-10840	30	7	and	and	CCONJ
ct-10840	30	8	size	size	NOUN
ct-10840	30	9	(	(	PUNCT
ct-10840	30	10	figure	figure	NOUN
ct-10840	30	11	1b	1b	NUM
ct-10840	30	12	)	)	PUNCT
ct-10840	30	13	.	.	PUNCT
ct-10840	31	1	differentiation	differentiation	NOUN
ct-10840	31	2	between	between	ADP
ct-10840	31	3	an	an	DET
ct-10840	31	4	anovulatory	anovulatory	NOUN
ct-10840	31	5	follicle	follicle	NOUN
ct-10840	31	6	undergoing	undergo	VERB
ct-10840	31	7	luteinization	luteinization	NOUN
ct-10840	31	8	,	,	PUNCT
ct-10840	31	9	an	an	DET
ct-10840	31	10	ovarian	ovarian	ADJ
ct-10840	31	11	follicular	follicular	ADJ
ct-10840	31	12	cyst	cyst	NOUN
ct-10840	31	13	,	,	PUNCT
ct-10840	31	14	or	or	CCONJ
ct-10840	31	15	ovarian	ovarian	ADJ
ct-10840	31	16	neoplasia	neoplasia	NOUN
ct-10840	31	17	was	be	AUX
ct-10840	31	18	not	not	PART
ct-10840	31	19	possible	possible	ADJ
ct-10840	31	20	.	.	PUNCT
ct-10840	32	1	on	on	ADP
ct-10840	32	2	day	day	NOUN
ct-10840	32	3	57	57	NUM
ct-10840	32	4	,	,	PUNCT
ct-10840	32	5	progesterone	progesterone	NOUN
ct-10840	32	6	concentrations	concentration	NOUN
ct-10840	32	7	remained	remain	VERB
ct-10840	32	8	lower	low	ADJ
ct-10840	32	9	(	(	PUNCT
ct-10840	32	10	<	<	X
ct-10840	32	11	2	2	NUM
ct-10840	32	12	ng	ng	PROPN
ct-10840	32	13	/	/	SYM
ct-10840	32	14	ml	ml	PROPN
ct-10840	32	15	)	)	PUNCT
ct-10840	32	16	and	and	CCONJ
ct-10840	32	17	>	>	X
ct-10840	32	18	90	90	NUM
ct-10840	32	19	%	%	NOUN
ct-10840	32	20	vaginal	vaginal	ADJ
ct-10840	32	21	epithelial	epithelial	ADJ
ct-10840	32	22	cells	cell	NOUN
ct-10840	32	23	were	be	AUX
ct-10840	32	24	cornified	cornifie	VERB
ct-10840	32	25	.	.	PUNCT
ct-10840	33	1	another	another	DET
ct-10840	33	2	transabdominal	transabdominal	ADJ
ct-10840	33	3	ultrasonography	ultrasonography	NOUN
ct-10840	33	4	was	be	AUX
ct-10840	33	5	performed	perform	VERB
ct-10840	33	6	;	;	PUNCT
ct-10840	33	7	right	right	ADJ
ct-10840	33	8	ovary	ovary	NOUN
ct-10840	33	9	was	be	AUX
ct-10840	33	10	still	still	ADV
ct-10840	33	11	normal	normal	ADJ
ct-10840	33	12	in	in	ADP
ct-10840	33	13	appearance	appearance	NOUN
ct-10840	33	14	,	,	PUNCT
ct-10840	33	15	size	size	NOUN
ct-10840	33	16	with	with	ADP
ct-10840	33	17	ultrasonographic	ultrasonographic	ADJ
ct-10840	33	18	heterogenicity	heterogenicity	NOUN
ct-10840	33	19	and	and	CCONJ
ct-10840	33	20	had	have	VERB
ct-10840	33	21	no	no	DET
ct-10840	33	22	follicular	follicular	ADJ
ct-10840	33	23	activity	activity	NOUN
ct-10840	33	24	,	,	PUNCT
ct-10840	33	25	left	leave	VERB
ct-10840	33	26	ovary	ovary	NOUN
ct-10840	33	27	had	have	AUX
ct-10840	33	28	increased	increase	VERB
ct-10840	33	29	in	in	ADP
ct-10840	33	30	size	size	NOUN
ct-10840	33	31	(	(	PUNCT
ct-10840	33	32	19	19	NUM
ct-10840	33	33	-	-	SYM
ct-10840	33	34	21	21	NUM
ct-10840	33	35	to	to	PART
ct-10840	33	36	20	20	NUM
ct-10840	33	37	-	-	SYM
ct-10840	33	38	22	22	NUM
ct-10840	33	39	mm	mm	NOUN
ct-10840	33	40	)	)	PUNCT
ct-10840	33	41	and	and	CCONJ
ct-10840	33	42	the	the	DET
ct-10840	33	43	heterogeneous	heterogeneous	ADJ
ct-10840	33	44	hypoechoic	hypoechoic	ADJ
ct-10840	33	45	region	region	NOUN
ct-10840	33	46	within	within	ADP
ct-10840	33	47	caudal	caudal	NOUN
ct-10840	33	48	pole	pole	NOUN
ct-10840	33	49	was	be	AUX
ct-10840	33	50	still	still	ADV
ct-10840	33	51	present	present	ADJ
ct-10840	33	52	(	(	PUNCT
ct-10840	33	53	suspected	suspect	VERB
ct-10840	33	54	to	to	PART
ct-10840	33	55	be	be	AUX
ct-10840	33	56	neoplastic	neoplastic	ADJ
ct-10840	33	57	)	)	PUNCT
ct-10840	33	58	.	.	PUNCT
ct-10840	34	1	left	leave	VERB
ct-10840	34	2	ovary	ovary	NOUN
ct-10840	34	3	had	have	AUX
ct-10840	34	4	begun	begin	VERB
ct-10840	34	5	to	to	PART
ct-10840	34	6	take	take	VERB
ct-10840	34	7	on	on	ADP
ct-10840	34	8	a	a	DET
ct-10840	34	9	honeycomb	honeycomb	NOUN
ct-10840	34	10	-	-	PUNCT
ct-10840	34	11	like	like	ADJ
ct-10840	34	12	appearance	appearance	NOUN
ct-10840	34	13	(	(	PUNCT
ct-10840	34	14	figure	figure	NOUN
ct-10840	34	15	2	2	NUM
ct-10840	34	16	)	)	PUNCT
ct-10840	34	17	,	,	PUNCT
ct-10840	34	18	a	a	DET
ct-10840	34	19	common	common	ADJ
ct-10840	34	20	finding	finding	NOUN
ct-10840	34	21	with	with	ADP
ct-10840	34	22	gcts	gct	NOUN
ct-10840	34	23	in	in	ADP
ct-10840	34	24	mares.40	mares.40	NOUN
ct-10840	34	25	using	use	VERB
ct-10840	34	26	color	color	NOUN
ct-10840	34	27	doppler	doppler	NOUN
ct-10840	34	28	,	,	PUNCT
ct-10840	34	29	moderate	moderate	ADJ
ct-10840	34	30	peripheral	peripheral	ADJ
ct-10840	34	31	vascularity	vascularity	NOUN
ct-10840	34	32	and	and	CCONJ
ct-10840	34	33	a	a	DET
ct-10840	34	34	few	few	ADJ
ct-10840	34	35	small	small	ADJ
ct-10840	34	36	internal	internal	ADJ
ct-10840	34	37	vessels	vessel	NOUN
ct-10840	34	38	associated	associate	VERB
ct-10840	34	39	with	with	ADP
ct-10840	34	40	the	the	DET
ct-10840	34	41	heterogenous	heterogenous	ADJ
ct-10840	34	42	hypoechoic	hypoechoic	ADJ
ct-10840	34	43	structure	structure	NOUN
ct-10840	34	44	on	on	ADP
ct-10840	34	45	left	left	ADJ
ct-10840	34	46	ovary	ovary	NOUN
ct-10840	34	47	were	be	AUX
ct-10840	34	48	visualized	visualize	VERB
ct-10840	34	49	.	.	PUNCT
ct-10840	35	1	increased	increase	VERB
ct-10840	35	2	size	size	NOUN
ct-10840	35	3	,	,	PUNCT
ct-10840	35	4	level	level	NOUN
ct-10840	35	5	,	,	PUNCT
ct-10840	35	6	and	and	CCONJ
ct-10840	35	7	location	location	NOUN
ct-10840	35	8	of	of	ADP
ct-10840	35	9	angiogenesis	angiogenesis	NOUN
ct-10840	35	10	and	and	CCONJ
ct-10840	35	11	the	the	DET
ct-10840	35	12	honeycomb	honeycomb	NOUN
ct-10840	35	13	-	-	PUNCT
ct-10840	35	14	like	like	ADJ
ct-10840	35	15	appearance	appearance	NOUN
ct-10840	35	16	of	of	ADP
ct-10840	35	17	left	left	ADJ
ct-10840	35	18	ovary	ovary	NOUN
ct-10840	35	19	were	be	AUX
ct-10840	35	20	all	all	ADV
ct-10840	35	21	suggestive	suggestive	ADJ
ct-10840	35	22	of	of	ADP
ct-10840	35	23	gct	gct	PROPN
ct-10840	35	24	.	.	PROPN
ct-10840	36	1	at	at	ADP
ct-10840	36	2	each	each	DET
ct-10840	36	3	transabdominal	transabdominal	ADJ
ct-10840	36	4	ultrasonographic	ultrasonographic	ADJ
ct-10840	36	5	examination	examination	NOUN
ct-10840	36	6	,	,	PUNCT
ct-10840	36	7	uterus	uterus	NOUN
ct-10840	36	8	was	be	AUX
ct-10840	36	9	notably	notably	ADV
ct-10840	36	10	enlarged	enlarge	VERB
ct-10840	36	11	(	(	PUNCT
ct-10840	36	12	~	~	PUNCT
ct-10840	36	13	10.4	10.4	NUM
ct-10840	36	14	mm	mm	PROPN
ct-10840	36	15	diameter	diameter	NOUN
ct-10840	36	16	/	/	SYM
ct-10840	36	17	width	width	ADJ
ct-10840	36	18	/	/	SYM
ct-10840	36	19	thickness	thickness	NOUN
ct-10840	36	20	)	)	PUNCT
ct-10840	36	21	for	for	ADP
ct-10840	36	22	a	a	DET
ct-10840	36	23	young	young	ADJ
ct-10840	36	24	,	,	PUNCT
ct-10840	36	25	multiparous	multiparous	ADJ
ct-10840	36	26	dog	dog	NOUN
ct-10840	36	27	,	,	PUNCT
ct-10840	36	28	and	and	CCONJ
ct-10840	36	29	echogenic	echogenic	ADJ
ct-10840	36	30	changes	change	NOUN
ct-10840	36	31	(	(	PUNCT
ct-10840	36	32	cystic	cystic	ADJ
ct-10840	36	33	structures	structure	NOUN
ct-10840	36	34	)	)	PUNCT
ct-10840	36	35	observed	observe	VERB
ct-10840	36	36	throughout	throughout	ADP
ct-10840	36	37	the	the	DET
ct-10840	36	38	endometrium	endometrium	NOUN
ct-10840	36	39	(	(	PUNCT
ct-10840	36	40	figure	figure	NOUN
ct-10840	36	41	3	3	NUM
ct-10840	36	42	)	)	PUNCT
ct-10840	36	43	,	,	PUNCT
ct-10840	36	44	indicative	indicative	ADJ
ct-10840	36	45	of	of	ADP
ct-10840	36	46	cystic	cystic	ADJ
ct-10840	36	47	endometrial	endometrial	ADJ
ct-10840	36	48	hyperplasia	hyperplasia	NOUN
ct-10840	36	49	(	(	PUNCT
ct-10840	36	50	ceh).41	ceh).41	X
ct-10840	36	51	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	36	52	citation	citation	NOUN
ct-10840	36	53	:	:	PUNCT
ct-10840	36	54	clinical	clinical	ADJ
ct-10840	36	55	theriogenology	theriogenology	NOUN
ct-10840	36	56	2024	2024	NUM
ct-10840	36	57	,	,	PUNCT
ct-10840	36	58	16	16	NUM
ct-10840	36	59	,	,	PUNCT
ct-10840	36	60	10840	10840	NUM
ct-10840	36	61	,	,	PUNCT
ct-10840	36	62	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	36	63	3	3	NUM
ct-10840	36	64	on	on	ADP
ct-10840	36	65	day	day	NOUN
ct-10840	36	66	57	57	NUM
ct-10840	36	67	,	,	PUNCT
ct-10840	36	68	serum	serum	NOUN
ct-10840	36	69	was	be	AUX
ct-10840	36	70	submitted	submit	VERB
ct-10840	36	71	(	(	PUNCT
ct-10840	36	72	university	university	NOUN
ct-10840	36	73	of	of	ADP
ct-10840	36	74	california	california	PROPN
ct-10840	36	75	davis	davis	PROPN
ct-10840	36	76	,	,	PUNCT
ct-10840	36	77	davis	davis	PROPN
ct-10840	36	78	,	,	PUNCT
ct-10840	36	79	ca	ca	NOUN
ct-10840	36	80	)	)	PUNCT
ct-10840	36	81	for	for	ADP
ct-10840	36	82	inhibin	inhibin	NOUN
ct-10840	36	83	-	-	PUNCT
ct-10840	36	84	b	b	PROPN
ct-10840	36	85	(	(	PUNCT
ct-10840	36	86	al163	al163	PROPN
ct-10840	36	87	,	,	PUNCT
ct-10840	36	88	ansh	ansh	ADJ
ct-10840	36	89	labs	labs	PROPN
ct-10840	36	90	,	,	PUNCT
ct-10840	36	91	webster	webster	PROPN
ct-10840	36	92	,	,	PUNCT
ct-10840	36	93	tx	tx	PROPN
ct-10840	36	94	)	)	PUNCT
ct-10840	36	95	and	and	CCONJ
ct-10840	36	96	amh	amh	PROPN
ct-10840	37	1	(	(	PUNCT
ct-10840	37	2	canine	canine	PROPN
ct-10840	37	3	amh	amh	PROPN
ct-10840	37	4	al116	al116	PROPN
ct-10840	37	5	,	,	PUNCT
ct-10840	37	6	ansh	ansh	ADJ
ct-10840	37	7	labs	labs	PROPN
ct-10840	37	8	,	,	PUNCT
ct-10840	37	9	webster	webster	PROPN
ct-10840	37	10	tx	tx	PROPN
ct-10840	37	11	)	)	PUNCT
ct-10840	37	12	.	.	PUNCT
ct-10840	38	1	inhibin	inhibin	ADJ
ct-10840	38	2	concentrations	concentration	NOUN
ct-10840	38	3	were	be	AUX
ct-10840	38	4	182.4	182.4	NUM
ct-10840	38	5	pg	pg	NOUN
ct-10840	38	6	/	/	SYM
ct-10840	38	7	ml	ml	NOUN
ct-10840	38	8	,	,	PUNCT
ct-10840	38	9	and	and	CCONJ
ct-10840	38	10	amh	amh	PROPN
ct-10840	38	11	concentrations	concentration	NOUN
ct-10840	38	12	were	be	AUX
ct-10840	38	13	0.89	0.89	NUM
ct-10840	38	14	ng	ng	PROPN
ct-10840	38	15	/	/	SYM
ct-10840	38	16	ml	ml	PROPN
ct-10840	38	17	.	.	PUNCT
ct-10840	39	1	the	the	DET
ct-10840	39	2	laboratory	laboratory	NOUN
ct-10840	39	3	reported	report	VERB
ct-10840	39	4	that	that	SCONJ
ct-10840	39	5	amh	amh	PROPN
ct-10840	39	6	concentrations	concentration	NOUN
ct-10840	39	7	were	be	AUX
ct-10840	39	8	within	within	ADP
ct-10840	39	9	the	the	DET
ct-10840	39	10	normal	normal	ADJ
ct-10840	39	11	reference	reference	NOUN
ct-10840	39	12	range	range	VERB
ct-10840	39	13	for	for	ADP
ct-10840	39	14	an	an	DET
ct-10840	39	15	intact	intact	ADJ
ct-10840	39	16	dog	dog	NOUN
ct-10840	39	17	in	in	ADP
ct-10840	39	18	estrus	estrus	NOUN
ct-10840	39	19	(	(	PUNCT
ct-10840	39	20	0.12	0.12	NUM
ct-10840	39	21	to	to	ADP
ct-10840	39	22	>	>	SYM
ct-10840	39	23	12	12	NUM
ct-10840	39	24	ng/	ng/	ADJ
ct-10840	39	25	ml	ml	NOUN
ct-10840	39	26	)	)	PUNCT
ct-10840	39	27	.	.	PUNCT
ct-10840	40	1	however	however	ADV
ct-10840	40	2	,	,	PUNCT
ct-10840	40	3	there	there	PRON
ct-10840	40	4	is	be	VERB
ct-10840	40	5	currently	currently	ADV
ct-10840	40	6	no	no	DET
ct-10840	40	7	normal	normal	ADJ
ct-10840	40	8	reference	reference	NOUN
ct-10840	40	9	range	range	NOUN
ct-10840	40	10	for	for	ADP
ct-10840	40	11	canine	canine	NOUN
ct-10840	40	12	inhibin	inhibin	PROPN
ct-10840	40	13	,	,	PUNCT
ct-10840	40	14	but	but	CCONJ
ct-10840	40	15	concentrations	concentration	NOUN
ct-10840	40	16	detected	detect	VERB
ct-10840	40	17	were	be	AUX
ct-10840	40	18	considered	consider	VERB
ct-10840	40	19	highly	highly	ADV
ct-10840	40	20	elevated	elevated	ADJ
ct-10840	40	21	compared	compare	VERB
ct-10840	40	22	to	to	PART
ct-10840	40	23	equine	equine	VERB
ct-10840	40	24	normal	normal	ADJ
ct-10840	40	25	reference	reference	NOUN
ct-10840	40	26	range	range	NOUN
ct-10840	40	27	of	of	ADP
ct-10840	40	28	2	2	NUM
ct-10840	40	29	to	to	PART
ct-10840	40	30	100	100	NUM
ct-10840	40	31	pg	pg	NOUN
ct-10840	40	32	/	/	SYM
ct-10840	40	33	ml	ml	NOUN
ct-10840	40	34	.	.	PUNCT
ct-10840	40	35	progesterone	progesterone	NOUN
ct-10840	40	36	concentrations	concentration	NOUN
ct-10840	40	37	(	(	PUNCT
ct-10840	40	38	enzyme	enzyme	NOUN
ct-10840	40	39	immunoassay	immunoassay	NOUN
ct-10840	40	40	,	,	PUNCT
ct-10840	40	41	university	university	PROPN
ct-10840	40	42	of	of	ADP
ct-10840	40	43	california	california	PROPN
ct-10840	40	44	davis	davis	PROPN
ct-10840	40	45	)	)	PUNCT
ct-10840	40	46	were	be	AUX
ct-10840	40	47	9.3	9.3	NUM
ct-10840	40	48	ng	ng	PROPN
ct-10840	40	49	/	/	SYM
ct-10840	40	50	ml	ml	PROPN
ct-10840	40	51	.	.	PUNCT
ct-10840	41	1	cbc	cbc	NOUN
ct-10840	41	2	and	and	CCONJ
ct-10840	41	3	biochemistry	biochemistry	NOUN
ct-10840	41	4	revealed	reveal	VERB
ct-10840	41	5	nonregenerative	nonregenerative	ADJ
ct-10840	41	6	anemia	anemia	NOUN
ct-10840	41	7	,	,	PUNCT
ct-10840	41	8	severe	severe	ADJ
ct-10840	41	9	thrombocytopenia	thrombocytopenia	PROPN
ct-10840	41	10	,	,	PUNCT
ct-10840	41	11	and	and	CCONJ
ct-10840	41	12	leukopenia	leukopenia	PROPN
ct-10840	41	13	.	.	PUNCT
ct-10840	42	1	prothrombin	prothrombin	ADJ
ct-10840	42	2	time	time	NOUN
ct-10840	42	3	and	and	CCONJ
ct-10840	42	4	partial	partial	ADJ
ct-10840	42	5	thromboplastin	thromboplastin	NOUN
ct-10840	42	6	time	time	NOUN
ct-10840	42	7	were	be	AUX
ct-10840	42	8	unremarkable	unremarkable	ADJ
ct-10840	42	9	,	,	PUNCT
ct-10840	42	10	but	but	CCONJ
ct-10840	42	11	fibrinogen	fibrinogen	NOUN
ct-10840	42	12	was	be	AUX
ct-10840	42	13	elevated	elevate	VERB
ct-10840	42	14	.	.	PUNCT
ct-10840	43	1	biochemistry	biochemistry	NOUN
ct-10840	43	2	markers	marker	NOUN
ct-10840	43	3	,	,	PUNCT
ct-10840	43	4	including	include	VERB
ct-10840	43	5	fibrinogen	fibrinogen	NOUN
ct-10840	43	6	,	,	PUNCT
ct-10840	43	7	were	be	AUX
ct-10840	43	8	consistent	consistent	ADJ
ct-10840	43	9	with	with	ADP
ct-10840	43	10	chronic	chronic	ADJ
ct-10840	43	11	inflammation	inflammation	NOUN
ct-10840	43	12	associated	associate	VERB
ct-10840	43	13	with	with	ADP
ct-10840	43	14	myelosuppression	myelosuppression	NOUN
ct-10840	43	15	.	.	PUNCT
ct-10840	44	1	serum	serum	NOUN
ct-10840	44	2	estrogen	estrogen	NOUN
ct-10840	44	3	and	and	CCONJ
ct-10840	44	4	estradiol	estradiol	PROPN
ct-10840	44	5	concentrations	concentration	NOUN
ct-10840	44	6	were	be	AUX
ct-10840	44	7	not	not	PART
ct-10840	44	8	measured	measure	VERB
ct-10840	44	9	as	as	ADP
ct-10840	44	10	the	the	DET
ct-10840	44	11	cytological	cytological	ADJ
ct-10840	44	12	assessment	assessment	NOUN
ct-10840	44	13	of	of	ADP
ct-10840	44	14	vaginal	vaginal	ADJ
ct-10840	44	15	smears	smear	NOUN
ct-10840	44	16	remained	remain	VERB
ct-10840	44	17	at	at	ADP
ct-10840	44	18	>	>	X
ct-10840	44	19	90	90	NUM
ct-10840	44	20	%	%	NOUN
ct-10840	44	21	superficial	superficial	ADJ
ct-10840	44	22	/	/	SYM
ct-10840	44	23	cornified	cornifie	VERB
ct-10840	44	24	vaginal	vaginal	ADJ
ct-10840	44	25	epithelial	epithelial	ADJ
ct-10840	44	26	cells	cell	NOUN
ct-10840	44	27	.	.	PUNCT
ct-10840	45	1	based	base	VERB
ct-10840	45	2	on	on	ADP
ct-10840	45	3	these	these	DET
ct-10840	45	4	clinical	clinical	ADJ
ct-10840	45	5	,	,	PUNCT
ct-10840	45	6	ultrasonographic	ultrasonographic	NOUN
ct-10840	45	7	,	,	PUNCT
ct-10840	45	8	and	and	CCONJ
ct-10840	45	9	endocrine	endocrine	ADJ
ct-10840	45	10	results	result	NOUN
ct-10840	45	11	,	,	PUNCT
ct-10840	45	12	a	a	DET
ct-10840	45	13	preliminary	preliminary	ADJ
ct-10840	45	14	diagnosis	diagnosis	NOUN
ct-10840	45	15	of	of	ADP
ct-10840	45	16	gct	gct	PROPN
ct-10840	45	17	was	be	AUX
ct-10840	45	18	made	make	VERB
ct-10840	45	19	.	.	PUNCT
ct-10840	46	1	due	due	ADP
ct-10840	46	2	to	to	ADP
ct-10840	46	3	the	the	DET
ct-10840	46	4	development	development	NOUN
ct-10840	46	5	of	of	ADP
ct-10840	46	6	nonregenerative	nonregenerative	ADJ
ct-10840	46	7	anemia	anemia	NOUN
ct-10840	46	8	,	,	PUNCT
ct-10840	46	9	it	it	PRON
ct-10840	46	10	was	be	AUX
ct-10840	46	11	decided	decide	VERB
ct-10840	46	12	that	that	SCONJ
ct-10840	46	13	immediate	immediate	ADJ
ct-10840	46	14	surgical	surgical	ADJ
ct-10840	46	15	removal	removal	NOUN
ct-10840	46	16	of	of	ADP
ct-10840	46	17	left	left	ADJ
ct-10840	46	18	ovary	ovary	NOUN
ct-10840	46	19	was	be	AUX
ct-10840	46	20	necessary	necessary	ADJ
ct-10840	46	21	to	to	PART
ct-10840	46	22	eliminate	eliminate	VERB
ct-10840	46	23	the	the	DET
ct-10840	46	24	source	source	NOUN
ct-10840	46	25	of	of	ADP
ct-10840	46	26	estrogen	estrogen	NOUN
ct-10840	46	27	and	and	CCONJ
ct-10840	46	28	to	to	PART
ct-10840	46	29	confirm	confirm	VERB
ct-10840	46	30	our	our	PRON
ct-10840	46	31	diagnosis	diagnosis	NOUN
ct-10840	46	32	.	.	PUNCT
ct-10840	47	1	no	no	DET
ct-10840	47	2	additional	additional	ADJ
ct-10840	47	3	measurements	measurement	NOUN
ct-10840	47	4	nor	nor	CCONJ
ct-10840	47	5	follicular	follicular	ADJ
ct-10840	47	6	activity	activity	NOUN
ct-10840	47	7	of	of	ADP
ct-10840	47	8	the	the	DET
ct-10840	47	9	contralateral	contralateral	ADJ
ct-10840	47	10	ovary	ovary	NOUN
ct-10840	47	11	were	be	AUX
ct-10840	47	12	determined	determine	VERB
ct-10840	47	13	due	due	ADP
ct-10840	47	14	to	to	ADP
ct-10840	47	15	the	the	DET
ct-10840	47	16	critical	critical	ADJ
ct-10840	47	17	state	state	NOUN
ct-10840	47	18	of	of	ADP
ct-10840	47	19	the	the	DET
ct-10840	47	20	patient	patient	NOUN
ct-10840	47	21	(	(	PUNCT
ct-10840	47	22	bone	bone	NOUN
ct-10840	47	23	marrow	marrow	NOUN
ct-10840	47	24	suppression	suppression	NOUN
ct-10840	47	25	)	)	PUNCT
ct-10840	47	26	.	.	PUNCT
ct-10840	48	1	treatment	treatment	NOUN
ct-10840	48	2	before	before	ADP
ct-10840	48	3	surgery	surgery	NOUN
ct-10840	48	4	,	,	PUNCT
ct-10840	48	5	blood	blood	NOUN
ct-10840	48	6	crossmatching	crossmatching	NOUN
ct-10840	48	7	(	(	PUNCT
ct-10840	48	8	centrifuged	centrifuge	VERB
ct-10840	48	9	edta	edta	NOUN
ct-10840	48	10	blood	blood	NOUN
ct-10840	48	11	samples	sample	NOUN
ct-10840	48	12	of	of	ADP
ct-10840	48	13	donor	donor	NOUN
ct-10840	48	14	and	and	CCONJ
ct-10840	48	15	recipient	recipient	NOUN
ct-10840	48	16	)	)	PUNCT
ct-10840	48	17	was	be	AUX
ct-10840	48	18	carried	carry	VERB
ct-10840	48	19	out	out	ADP
ct-10840	48	20	,	,	PUNCT
ct-10840	48	21	and	and	CCONJ
ct-10840	48	22	a	a	DET
ct-10840	48	23	unit	unit	NOUN
ct-10840	48	24	of	of	ADP
ct-10840	48	25	dea	dea	PROPN
ct-10840	48	26	1.1	1.1	NUM
ct-10840	48	27	(	(	PUNCT
ct-10840	48	28	+	+	NOUN
ct-10840	48	29	)	)	PUNCT
ct-10840	48	30	blood	blood	NOUN
ct-10840	48	31	was	be	AUX
ct-10840	48	32	given	give	VERB
ct-10840	48	33	intraoperatively	intraoperatively	ADV
ct-10840	48	34	to	to	PART
ct-10840	48	35	improve	improve	VERB
ct-10840	48	36	low	low	ADJ
ct-10840	48	37	oxygen	oxygen	NOUN
ct-10840	48	38	-	-	PUNCT
ct-10840	48	39	carrying	carry	VERB
ct-10840	48	40	capacity	capacity	NOUN
ct-10840	48	41	caused	cause	VERB
ct-10840	48	42	by	by	ADP
ct-10840	48	43	bone	bone	NOUN
ct-10840	48	44	marrow	marrow	NOUN
ct-10840	48	45	suppression	suppression	NOUN
ct-10840	48	46	.	.	PUNCT
ct-10840	49	1	unilateral	unilateral	ADJ
ct-10840	49	2	ovariectomy	ovariectomy	NOUN
ct-10840	49	3	(	(	PUNCT
ct-10840	49	4	laparoscopic	laparoscopic	NOUN
ct-10840	49	5	laparotomy	laparotomy	NOUN
ct-10840	49	6	)	)	PUNCT
ct-10840	49	7	was	be	AUX
ct-10840	49	8	performed	perform	VERB
ct-10840	49	9	.	.	PUNCT
ct-10840	50	1	briefly	briefly	NOUN
ct-10840	50	2	,	,	PUNCT
ct-10840	50	3	a	a	DET
ct-10840	50	4	3	3	NUM
ct-10840	50	5	cm	cm	NOUN
ct-10840	50	6	incision	incision	NOUN
ct-10840	50	7	was	be	AUX
ct-10840	50	8	made	make	VERB
ct-10840	50	9	in	in	ADP
ct-10840	50	10	caudal	caudal	NOUN
ct-10840	50	11	abdomen	abdoman	NOUN
ct-10840	50	12	on	on	ADP
ct-10840	50	13	the	the	DET
ct-10840	50	14	ventral	ventral	ADJ
ct-10840	50	15	midline	midline	NOUN
ct-10840	50	16	to	to	PART
ct-10840	50	17	facilitate	facilitate	VERB
ct-10840	50	18	laparoscope	laparoscope	NOUN
ct-10840	50	19	introduction	introduction	NOUN
ct-10840	50	20	.	.	PUNCT
ct-10840	51	1	abdomen	abdomen	PROPN
ct-10840	51	2	was	be	AUX
ct-10840	51	3	insufflated	insufflate	VERB
ct-10840	51	4	to	to	ADP
ct-10840	51	5	11	11	NUM
ct-10840	51	6	mm	mm	NUM
ct-10840	51	7	hg	hg	NOUN
ct-10840	51	8	,	,	PUNCT
ct-10840	51	9	and	and	CCONJ
ct-10840	51	10	left	leave	VERB
ct-10840	51	11	ovary	ovary	NOUN
ct-10840	51	12	was	be	AUX
ct-10840	51	13	visualized	visualize	VERB
ct-10840	51	14	(	(	PUNCT
ct-10840	51	15	figure	figure	NOUN
ct-10840	51	16	4	4	NUM
ct-10840	51	17	)	)	PUNCT
ct-10840	51	18	and	and	CCONJ
ct-10840	51	19	transected	transect	VERB
ct-10840	51	20	using	use	VERB
ct-10840	51	21	a	a	DET
ct-10840	51	22	ligasure	ligasure	NOUN
ct-10840	51	23	™	™	ADJ
ct-10840	51	24	(	(	PUNCT
ct-10840	51	25	medtronic	medtronic	ADJ
ct-10840	51	26	)	)	PUNCT
ct-10840	51	27	.	.	PUNCT
ct-10840	52	1	incision	incision	NOUN
ct-10840	52	2	site	site	NOUN
ct-10840	52	3	was	be	AUX
ct-10840	52	4	widened	widen	VERB
ct-10840	52	5	to	to	PART
ct-10840	52	6	exteriorize	exteriorize	VERB
ct-10840	52	7	left	leave	VERB
ct-10840	52	8	ovary	ovary	NOUN
ct-10840	52	9	from	from	ADP
ct-10840	52	10	abdomen	abdomen	NOUN
ct-10840	52	11	(	(	PUNCT
ct-10840	52	12	figure	figure	NOUN
ct-10840	52	13	5	5	NUM
ct-10840	52	14	)	)	PUNCT
ct-10840	52	15	.	.	PUNCT
ct-10840	53	1	right	right	ADJ
ct-10840	53	2	ovary	ovary	NOUN
ct-10840	53	3	appeared	appear	VERB
ct-10840	53	4	small	small	ADJ
ct-10840	53	5	with	with	ADP
ct-10840	53	6	no	no	DET
ct-10840	53	7	grossly	grossly	ADV
ct-10840	53	8	evident	evident	ADJ
ct-10840	53	9	follicular	follicular	ADJ
ct-10840	53	10	activity	activity	NOUN
ct-10840	53	11	during	during	ADP
ct-10840	53	12	the	the	DET
ct-10840	53	13	procedure	procedure	NOUN
ct-10840	53	14	.	.	PUNCT
ct-10840	54	1	hemorrhage	hemorrhage	NOUN
ct-10840	54	2	was	be	AUX
ct-10840	54	3	minimal	minimal	ADJ
ct-10840	54	4	and	and	CCONJ
ct-10840	54	5	controlled	control	VERB
ct-10840	54	6	using	use	VERB
ct-10840	54	7	monopolar	monopolar	ADJ
ct-10840	54	8	electrocautery	electrocautery	NOUN
ct-10840	54	9	.	.	PUNCT
ct-10840	55	1	abdominal	abdominal	ADJ
ct-10840	55	2	wall	wall	NOUN
ct-10840	55	3	was	be	AUX
ct-10840	55	4	closed	close	VERB
ct-10840	55	5	,	,	PUNCT
ct-10840	55	6	and	and	CCONJ
ct-10840	55	7	a	a	DET
ct-10840	55	8	tegaderm	tegaderm	PROPN
ct-10840	55	9	™	™	PROPN
ct-10840	55	10	(	(	PUNCT
ct-10840	55	11	nexcare	nexcare	PROPN
ct-10840	55	12	™	™	PROPN
ct-10840	55	13	,	,	PUNCT
ct-10840	55	14	3	3	NUM
ct-10840	55	15	m	m	NOUN
ct-10840	55	16	)	)	PUNCT
ct-10840	55	17	bandage	bandage	NOUN
ct-10840	55	18	was	be	AUX
ct-10840	55	19	placed	place	VERB
ct-10840	55	20	over	over	ADP
ct-10840	55	21	the	the	DET
ct-10840	55	22	incision	incision	NOUN
ct-10840	55	23	site	site	NOUN
ct-10840	55	24	.	.	PUNCT
ct-10840	56	1	dog	dog	NOUN
ct-10840	56	2	recovered	recover	VERB
ct-10840	56	3	uneventfully	uneventfully	ADV
ct-10840	56	4	and	and	CCONJ
ct-10840	56	5	was	be	AUX
ct-10840	56	6	discharged	discharge	VERB
ct-10840	56	7	the	the	DET
ct-10840	56	8	following	following	ADJ
ct-10840	56	9	day	day	NOUN
ct-10840	56	10	.	.	PUNCT
ct-10840	57	1	removed	remove	VERB
ct-10840	57	2	left	left	ADJ
ct-10840	57	3	ovary	ovary	NOUN
ct-10840	57	4	was	be	AUX
ct-10840	57	5	submitted	submit	VERB
ct-10840	57	6	for	for	ADP
ct-10840	57	7	histopathology	histopathology	NOUN
ct-10840	57	8	.	.	PUNCT
ct-10840	58	1	outcome	outcome	NOUN
ct-10840	58	2	left	leave	VERB
ct-10840	58	3	ovary	ovary	NOUN
ct-10840	58	4	(	(	PUNCT
ct-10840	58	5	~	~	SYM
ct-10840	58	6	8.5	8.5	NUM
ct-10840	58	7	x	x	SYM
ct-10840	58	8	4	4	NUM
ct-10840	58	9	cm	cm	NOUN
ct-10840	58	10	)	)	PUNCT
ct-10840	58	11	had	have	VERB
ct-10840	58	12	prominent	prominent	ADJ
ct-10840	58	13	multinodular	multinodular	ADJ
ct-10840	58	14	white	white	NOUN
ct-10840	58	15	to	to	ADP
ct-10840	58	16	tan	tan	VERB
ct-10840	58	17	ovarian	ovarian	ADJ
ct-10840	58	18	tissue	tissue	NOUN
ct-10840	58	19	with	with	ADP
ct-10840	58	20	well	well	ADV
ct-10840	58	21	-	-	PUNCT
ct-10840	58	22	demarcated	demarcate	VERB
ct-10840	58	23	white	white	ADJ
ct-10840	58	24	,	,	PUNCT
ct-10840	58	25	variably	variably	ADV
ct-10840	58	26	friable	friable	ADJ
ct-10840	58	27	,	,	PUNCT
ct-10840	58	28	and	and	CCONJ
ct-10840	58	29	partially	partially	ADV
ct-10840	58	30	caveated	caveate	VERB
ct-10840	58	31	mass	mass	NOUN
ct-10840	58	32	(	(	PUNCT
ct-10840	58	33	3	3	NUM
ct-10840	58	34	cm	cm	NOUN
ct-10840	58	35	)	)	PUNCT
ct-10840	58	36	;	;	PUNCT
ct-10840	58	37	expanding	expand	VERB
ct-10840	58	38	around	around	ADP
ct-10840	58	39	the	the	DET
ct-10840	58	40	mass	mass	NOUN
ct-10840	58	41	were	be	AUX
ct-10840	58	42	regions	region	NOUN
ct-10840	58	43	of	of	ADP
ct-10840	58	44	frank	frank	ADJ
ct-10840	58	45	blood	blood	NOUN
ct-10840	58	46	(	(	PUNCT
ct-10840	58	47	hemorrhage	hemorrhage	NOUN
ct-10840	58	48	)	)	PUNCT
ct-10840	58	49	.	.	PUNCT
ct-10840	59	1	circumscribing	circumscribe	VERB
ct-10840	59	2	the	the	DET
ct-10840	59	3	mass	mass	NOUN
ct-10840	59	4	was	be	AUX
ct-10840	59	5	white	white	ADJ
ct-10840	59	6	to	to	PART
ct-10840	59	7	yellow	yellow	VERB
ct-10840	59	8	thick	thick	ADJ
ct-10840	59	9	fibrous	fibrous	ADJ
ct-10840	59	10	capsule	capsule	NOUN
ct-10840	59	11	.	.	PUNCT
ct-10840	60	1	remainder	remainder	NOUN
ct-10840	60	2	of	of	ADP
ct-10840	60	3	the	the	DET
ct-10840	60	4	ovarian	ovarian	ADJ
ct-10840	60	5	tissue	tissue	NOUN
ct-10840	60	6	was	be	AUX
ct-10840	60	7	tan	tan	ADJ
ct-10840	60	8	with	with	ADP
ct-10840	60	9	variably	variably	ADV
ct-10840	60	10	sized	sized	ADJ
ct-10840	60	11	cystic	cystic	ADJ
ct-10840	60	12	structures	structure	NOUN
ct-10840	60	13	(	(	PUNCT
ct-10840	60	14	developing	develop	VERB
ct-10840	60	15	follicles	follicle	NOUN
ct-10840	60	16	;	;	PUNCT
ct-10840	60	17	figure	figure	NOUN
ct-10840	60	18	6	6	NUM
ct-10840	60	19	)	)	PUNCT
ct-10840	60	20	.	.	PUNCT
ct-10840	61	1	histopathology	histopathology	NOUN
ct-10840	61	2	confirmed	confirm	VERB
ct-10840	61	3	that	that	SCONJ
ct-10840	61	4	the	the	DET
ct-10840	61	5	tumor	tumor	NOUN
ct-10840	61	6	effaced	efface	VERB
ct-10840	61	7	over	over	ADP
ct-10840	61	8	60	60	NUM
ct-10840	61	9	%	%	NOUN
ct-10840	61	10	of	of	ADP
ct-10840	61	11	left	left	ADJ
ct-10840	61	12	ovary	ovary	NOUN
ct-10840	61	13	and	and	CCONJ
ct-10840	61	14	was	be	AUX
ct-10840	61	15	highly	highly	ADV
ct-10840	61	16	cellular	cellular	ADJ
ct-10840	61	17	,	,	PUNCT
ct-10840	61	18	encapsulated	encapsulate	VERB
ct-10840	61	19	and	and	CCONJ
ct-10840	61	20	well	well	ADV
ct-10840	61	21	-	-	PUNCT
ct-10840	61	22	demarcated	demarcate	VERB
ct-10840	61	23	sex	sex	NOUN
ct-10840	61	24	cord	cord	NOUN
ct-10840	61	25	neoplasm	neoplasm	NOUN
ct-10840	61	26	.	.	PUNCT
ct-10840	62	1	neoplastic	neoplastic	ADJ
ct-10840	62	2	cell	cell	NOUN
ct-10840	62	3	population	population	NOUN
ct-10840	62	4	was	be	AUX
ct-10840	62	5	arranged	arrange	VERB
ct-10840	62	6	in	in	ADP
ct-10840	62	7	a	a	DET
ct-10840	62	8	rare	rare	ADJ
ct-10840	62	9	glandular	glandular	ADJ
ct-10840	62	10	/	/	SYM
ct-10840	62	11	pseudo	pseudo	NOUN
ct-10840	62	12	-	-	ADJ
ct-10840	62	13	rosette	rosette	NOUN
ct-10840	62	14	structure	structure	NOUN
ct-10840	62	15	,	,	PUNCT
ct-10840	62	16	with	with	ADP
ct-10840	62	17	the	the	DET
ct-10840	62	18	remaining	remain	VERB
ct-10840	62	19	population	population	NOUN
ct-10840	62	20	located	locate	VERB
ct-10840	62	21	within	within	ADP
ct-10840	62	22	interlacing	interlace	VERB
ct-10840	62	23	streams	stream	NOUN
ct-10840	62	24	supported	support	VERB
ct-10840	62	25	by	by	ADP
ct-10840	62	26	collagenous	collagenous	ADJ
ct-10840	62	27	stroma	stroma	NOUN
ct-10840	62	28	.	.	PUNCT
ct-10840	63	1	anisocytosis	anisocytosis	NOUN
ct-10840	63	2	and	and	CCONJ
ct-10840	63	3	anisokaryosis	anisokaryosis	NOUN
ct-10840	63	4	was	be	AUX
ct-10840	63	5	moderate	moderate	ADJ
ct-10840	63	6	with	with	ADP
ct-10840	63	7	3	3	NUM
ct-10840	63	8	mitotic	mitotic	ADJ
ct-10840	63	9	figures	figure	NOUN
ct-10840	63	10	per	per	ADP
ct-10840	63	11	mitotic	mitotic	ADJ
ct-10840	63	12	area	area	NOUN
ct-10840	63	13	.	.	PUNCT
ct-10840	64	1	histopathology	histopathology	NOUN
ct-10840	64	2	findings	finding	NOUN
ct-10840	64	3	were	be	AUX
ct-10840	64	4	consistent	consistent	ADJ
ct-10840	64	5	with	with	ADP
ct-10840	64	6	a	a	DET
ct-10840	64	7	poorly	poorly	ADV
ct-10840	64	8	differentiated	differentiate	VERB
ct-10840	64	9	gct	gct	PROPN
ct-10840	64	10	.	.	PUNCT
ct-10840	65	1	remaining	remain	VERB
ct-10840	65	2	ovarian	ovarian	ADJ
ct-10840	65	3	tissue	tissue	NOUN
ct-10840	65	4	within	within	ADP
ct-10840	65	5	left	left	ADJ
ct-10840	65	6	ovary	ovary	NOUN
ct-10840	65	7	was	be	AUX
ct-10840	65	8	histologically	histologically	ADV
ct-10840	65	9	normal	normal	ADJ
ct-10840	65	10	,	,	PUNCT
ct-10840	65	11	with	with	SCONJ
ct-10840	65	12	ovarian	ovarian	ADJ
ct-10840	65	13	follicles	follicle	NOUN
ct-10840	65	14	observed	observe	VERB
ct-10840	65	15	in	in	ADP
ct-10840	65	16	varying	vary	VERB
ct-10840	65	17	stages	stage	NOUN
ct-10840	65	18	of	of	ADP
ct-10840	65	19	maturation	maturation	NOUN
ct-10840	65	20	(	(	PUNCT
ct-10840	65	21	figure	figure	NOUN
ct-10840	65	22	7	7	NUM
ct-10840	65	23	)	)	PUNCT
ct-10840	65	24	.	.	PUNCT
ct-10840	66	1	a	a	DET
ct-10840	66	2	portion	portion	NOUN
ct-10840	66	3	of	of	ADP
ct-10840	66	4	left	left	ADJ
ct-10840	66	5	uterine	uterine	ADJ
ct-10840	66	6	horn	horn	NOUN
ct-10840	66	7	was	be	AUX
ct-10840	66	8	also	also	ADV
ct-10840	66	9	submitted	submit	VERB
ct-10840	66	10	for	for	ADP
ct-10840	66	11	histologic	histologic	ADJ
ct-10840	66	12	evaluation	evaluation	NOUN
ct-10840	66	13	,	,	PUNCT
ct-10840	66	14	and	and	CCONJ
ct-10840	66	15	endometrium	endometrium	NOUN
ct-10840	66	16	was	be	AUX
ct-10840	66	17	described	describe	VERB
ct-10840	66	18	as	as	ADP
ct-10840	66	19	hyperplastic	hyperplastic	ADJ
ct-10840	66	20	,	,	PUNCT
ct-10840	66	21	measuring	measure	VERB
ct-10840	66	22	~	~	PUNCT
ct-10840	66	23	2	2	NUM
ct-10840	66	24	mm	mm	NOUN
ct-10840	66	25	in	in	ADP
ct-10840	66	26	thickness	thickness	NOUN
ct-10840	66	27	with	with	ADP
ct-10840	66	28	variably	variably	ADV
ct-10840	66	29	ectatic	ectatic	ADJ
ct-10840	66	30	endometrial	endometrial	ADJ
ct-10840	66	31	glands	gland	NOUN
ct-10840	66	32	containing	contain	VERB
ct-10840	66	33	scant	scant	ADJ
ct-10840	66	34	a	a	DET
ct-10840	66	35	b	b	NUM
ct-10840	66	36	figure	figure	NOUN
ct-10840	66	37	1	1	NUM
ct-10840	66	38	.	.	PUNCT
ct-10840	66	39	a.	a.	NOUN
ct-10840	66	40	ultrasonographic	ultrasonographic	PROPN
ct-10840	66	41	image	image	NOUN
ct-10840	66	42	of	of	ADP
ct-10840	66	43	‘	'	PUNCT
ct-10840	66	44	abnormal	abnormal	ADJ
ct-10840	66	45	’	'	PUNCT
ct-10840	66	46	left	leave	VERB
ct-10840	66	47	ovary	ovary	NOUN
ct-10840	66	48	(	(	PUNCT
ct-10840	66	49	note	note	NOUN
ct-10840	66	50	enlarged	enlarge	VERB
ct-10840	66	51	ovary	ovary	NOUN
ct-10840	66	52	with	with	ADP
ct-10840	66	53	a	a	DET
ct-10840	66	54	heterogeneously	heterogeneously	ADV
ct-10840	66	55	hypoechoic	hypoechoic	ADJ
ct-10840	66	56	region	region	NOUN
ct-10840	66	57	within	within	ADP
ct-10840	66	58	the	the	DET
ct-10840	66	59	caudal	caudal	NOUN
ct-10840	66	60	pole	pole	NOUN
ct-10840	66	61	)	)	PUNCT
ct-10840	66	62	on	on	ADP
ct-10840	66	63	day	day	NOUN
ct-10840	66	64	40	40	NUM
ct-10840	66	65	of	of	ADP
ct-10840	66	66	estrus	estrus	NOUN
ct-10840	66	67	;	;	PUNCT
ct-10840	66	68	distance	distance	NOUN
ct-10840	66	69	between	between	ADP
ct-10840	66	70	calipers	caliper	NOUN
ct-10840	66	71	:	:	PUNCT
ct-10840	66	72	20.8	20.8	NUM
ct-10840	66	73	mm	mm	NOUN
ct-10840	66	74	and	and	CCONJ
ct-10840	66	75	arrow	arrow	NOUN
ct-10840	66	76	pointing	pointing	NOUN
ct-10840	66	77	cranial	cranial	ADJ
ct-10840	66	78	side	side	NOUN
ct-10840	66	79	.	.	PUNCT
ct-10840	67	1	b.	b.	PROPN
ct-10840	67	2	ultrasonographic	ultrasonographic	PROPN
ct-10840	67	3	image	image	NOUN
ct-10840	67	4	of	of	ADP
ct-10840	67	5	‘	'	PUNCT
ct-10840	67	6	normal	normal	ADJ
ct-10840	67	7	’	'	PUNCT
ct-10840	67	8	right	right	ADJ
ct-10840	67	9	ovary	ovary	NOUN
ct-10840	67	10	on	on	ADP
ct-10840	67	11	day	day	NOUN
ct-10840	67	12	40	40	NUM
ct-10840	67	13	of	of	ADP
ct-10840	67	14	estrus	estrus	NOUN
ct-10840	67	15	and	and	CCONJ
ct-10840	67	16	arrow	arrow	NOUN
ct-10840	67	17	pointing	pointing	NOUN
ct-10840	67	18	cranial	cranial	ADJ
ct-10840	67	19	side	side	NOUN
ct-10840	67	20	.	.	PUNCT
ct-10840	68	1	figure	figure	NOUN
ct-10840	68	2	2	2	NUM
ct-10840	68	3	.	.	PUNCT
ct-10840	68	4	ultrasonographic	ultrasonographic	ADJ
ct-10840	68	5	image	image	NOUN
ct-10840	68	6	of	of	ADP
ct-10840	68	7	‘	'	PUNCT
ct-10840	68	8	abnormal	abnormal	ADJ
ct-10840	68	9	’	'	PUNCT
ct-10840	68	10	left	leave	VERB
ct-10840	68	11	ovary	ovary	NOUN
ct-10840	68	12	on	on	ADP
ct-10840	68	13	day	day	NOUN
ct-10840	68	14	57	57	NUM
ct-10840	68	15	of	of	ADP
ct-10840	68	16	estrus	estrus	NOUN
ct-10840	68	17	(	(	PUNCT
ct-10840	68	18	note	note	NOUN
ct-10840	68	19	:	:	PUNCT
ct-10840	68	20	honeycomb	honeycomb	NOUN
ct-10840	68	21	-	-	PUNCT
ct-10840	68	22	like	like	ADJ
ct-10840	68	23	appearance	appearance	NOUN
ct-10840	68	24	suggestive	suggestive	ADJ
ct-10840	68	25	of	of	ADP
ct-10840	68	26	early	early	ADJ
ct-10840	68	27	stages	stage	NOUN
ct-10840	68	28	of	of	ADP
ct-10840	68	29	differentiation	differentiation	NOUN
ct-10840	68	30	of	of	ADP
ct-10840	68	31	a	a	DET
ct-10840	68	32	gct	gct	PROPN
ct-10840	68	33	)	)	PUNCT
ct-10840	68	34	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	68	35	4	4	NUM
ct-10840	68	36	citation	citation	NOUN
ct-10840	68	37	:	:	PUNCT
ct-10840	68	38	clinical	clinical	ADJ
ct-10840	68	39	theriogenology	theriogenology	NOUN
ct-10840	68	40	2024	2024	NUM
ct-10840	68	41	,	,	PUNCT
ct-10840	68	42	16	16	NUM
ct-10840	68	43	,	,	PUNCT
ct-10840	68	44	10840	10840	NUM
ct-10840	68	45	,	,	PUNCT
ct-10840	68	46	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	68	47	flocculent	flocculent	NOUN
ct-10840	68	48	eosinophilic	eosinophilic	ADJ
ct-10840	68	49	material	material	NOUN
ct-10840	68	50	.	.	PUNCT
ct-10840	69	1	uterine	uterine	ADJ
ct-10840	69	2	findings	finding	NOUN
ct-10840	69	3	were	be	AUX
ct-10840	69	4	consistent	consistent	ADJ
ct-10840	69	5	with	with	ADP
ct-10840	69	6	ceh	ceh	PROPN
ct-10840	69	7	.	.	PUNCT
ct-10840	70	1	on	on	ADP
ct-10840	70	2	day	day	NOUN
ct-10840	70	3	14	14	NUM
ct-10840	70	4	after	after	ADP
ct-10840	70	5	surgery	surgery	NOUN
ct-10840	70	6	,	,	PUNCT
ct-10840	70	7	serum	serum	NOUN
ct-10840	70	8	was	be	AUX
ct-10840	70	9	collected	collect	VERB
ct-10840	70	10	and	and	CCONJ
ct-10840	70	11	submitted	submit	VERB
ct-10840	70	12	(	(	PUNCT
ct-10840	70	13	university	university	NOUN
ct-10840	70	14	of	of	ADP
ct-10840	70	15	california	california	PROPN
ct-10840	70	16	davis	davis	PROPN
ct-10840	70	17	)	)	PUNCT
ct-10840	70	18	for	for	ADP
ct-10840	70	19	measurement	measurement	NOUN
ct-10840	70	20	of	of	ADP
ct-10840	70	21	progesterone	progesterone	NOUN
ct-10840	70	22	,	,	PUNCT
ct-10840	70	23	inhibin	inhibin	PROPN
ct-10840	70	24	b	b	PROPN
ct-10840	70	25	,	,	PUNCT
ct-10840	70	26	and	and	CCONJ
ct-10840	70	27	amh	amh	PROPN
ct-10840	70	28	concentrations	concentration	NOUN
ct-10840	70	29	.	.	PUNCT
ct-10840	71	1	inhibin	inhibin	PROPN
ct-10840	71	2	b	b	PROPN
ct-10840	71	3	concentrations	concentration	NOUN
ct-10840	71	4	had	have	AUX
ct-10840	71	5	declined	decline	VERB
ct-10840	71	6	substantially	substantially	ADV
ct-10840	71	7	to	to	ADP
ct-10840	71	8	8.4	8.4	NUM
ct-10840	71	9	pg	pg	NOUN
ct-10840	71	10	/	/	SYM
ct-10840	71	11	ml	ml	NOUN
ct-10840	71	12	;	;	PUNCT
ct-10840	71	13	progesterone	progesterone	NOUN
ct-10840	71	14	was	be	AUX
ct-10840	71	15	baseline	baseline	ADJ
ct-10840	71	16	(	(	PUNCT
ct-10840	71	17	<	<	X
ct-10840	71	18	0.2	0.2	NUM
ct-10840	71	19	ng	ng	PROPN
ct-10840	71	20	/	/	SYM
ct-10840	71	21	ml	ml	NOUN
ct-10840	71	22	)	)	PUNCT
ct-10840	71	23	,	,	PUNCT
ct-10840	71	24	and	and	CCONJ
ct-10840	71	25	amh	amh	PROPN
ct-10840	71	26	concentrations	concentration	NOUN
ct-10840	71	27	remained	remain	VERB
ct-10840	71	28	within	within	ADP
ct-10840	71	29	normal	normal	ADJ
ct-10840	71	30	reference	reference	NOUN
ct-10840	71	31	range	range	NOUN
ct-10840	71	32	,	,	PUNCT
ct-10840	71	33	consistent	consistent	ADJ
ct-10840	71	34	with	with	ADP
ct-10840	71	35	declining	decline	VERB
ct-10840	71	36	concentrations	concentration	NOUN
ct-10840	71	37	of	of	ADP
ct-10840	71	38	inhibin	inhibin	ADJ
ct-10840	71	39	after	after	ADP
ct-10840	71	40	ovariectomy	ovariectomy	NOUN
ct-10840	71	41	as	as	SCONJ
ct-10840	71	42	observed	observe	VERB
ct-10840	71	43	in	in	ADP
ct-10840	71	44	mares.22	mares.22	PROPN
ct-10840	71	45	amh	amh	PROPN
ct-10840	71	46	and	and	CCONJ
ct-10840	71	47	inhibin	inhibin	ADJ
ct-10840	71	48	concentrations	concentration	NOUN
ct-10840	71	49	were	be	AUX
ct-10840	71	50	not	not	PART
ct-10840	71	51	measured	measure	VERB
ct-10840	71	52	during	during	ADP
ct-10840	71	53	the	the	DET
ct-10840	71	54	follow	follow	NOUN
ct-10840	71	55	-	-	PUNCT
ct-10840	71	56	up	up	NOUN
ct-10840	71	57	period	period	NOUN
ct-10840	71	58	prior	prior	ADV
ct-10840	71	59	to	to	ADP
ct-10840	71	60	returning	return	VERB
ct-10840	71	61	to	to	ADP
ct-10840	71	62	cyclicity	cyclicity	NOUN
ct-10840	71	63	.	.	PUNCT
ct-10840	72	1	dog	dog	NOUN
ct-10840	72	2	returned	return	VERB
ct-10840	72	3	to	to	ADP
ct-10840	72	4	proestrus	proestrus	NOUN
ct-10840	72	5	4	4	NUM
ct-10840	72	6	months	month	NOUN
ct-10840	72	7	after	after	ADP
ct-10840	72	8	unilateral	unilateral	ADJ
ct-10840	72	9	ovariectomy	ovariectomy	NOUN
ct-10840	72	10	.	.	PUNCT
ct-10840	73	1	blood	blood	NOUN
ct-10840	73	2	sample	sample	NOUN
ct-10840	73	3	was	be	AUX
ct-10840	73	4	submitted	submit	VERB
ct-10840	73	5	for	for	ADP
ct-10840	73	6	cbc	cbc	NOUN
ct-10840	73	7	and	and	CCONJ
ct-10840	73	8	chemistry	chemistry	NOUN
ct-10840	73	9	analyses	analysis	NOUN
ct-10840	73	10	;	;	PUNCT
ct-10840	73	11	nothing	nothing	PRON
ct-10840	73	12	was	be	AUX
ct-10840	73	13	remarkable	remarkable	ADJ
ct-10840	73	14	.	.	PUNCT
ct-10840	74	1	importantly	importantly	ADV
ct-10840	74	2	,	,	PUNCT
ct-10840	74	3	there	there	PRON
ct-10840	74	4	was	be	VERB
ct-10840	74	5	complete	complete	ADJ
ct-10840	74	6	resolution	resolution	NOUN
ct-10840	74	7	of	of	ADP
ct-10840	74	8	nonregenerative	nonregenerative	ADJ
ct-10840	74	9	anemia	anemia	NOUN
ct-10840	74	10	,	,	PUNCT
ct-10840	74	11	thrombocytopenia	thrombocytopenia	PROPN
ct-10840	74	12	,	,	PUNCT
ct-10840	74	13	and	and	CCONJ
ct-10840	74	14	inflammatory	inflammatory	ADJ
ct-10840	74	15	profile	profile	NOUN
ct-10840	74	16	.	.	PUNCT
ct-10840	75	1	ultrasonographic	ultrasonographic	ADJ
ct-10840	75	2	examination	examination	NOUN
ct-10840	75	3	of	of	ADP
ct-10840	75	4	uterus	uterus	NOUN
ct-10840	75	5	demonstrated	demonstrate	VERB
ct-10840	75	6	continued	continue	VERB
ct-10840	75	7	endometrial	endometrial	ADJ
ct-10840	75	8	changes	change	NOUN
ct-10840	75	9	associated	associate	VERB
ct-10840	75	10	with	with	ADP
ct-10840	75	11	ceh	ceh	PROPN
ct-10840	75	12	.	.	PUNCT
ct-10840	76	1	there	there	PRON
ct-10840	76	2	was	be	VERB
ct-10840	76	3	no	no	DET
ct-10840	76	4	intrauterine	intrauterine	ADJ
ct-10840	76	5	fluid	fluid	NOUN
ct-10840	76	6	.	.	PUNCT
ct-10840	77	1	to	to	PART
ct-10840	77	2	maximize	maximize	VERB
ct-10840	77	3	chances	chance	NOUN
ct-10840	77	4	of	of	ADP
ct-10840	77	5	pregnancy	pregnancy	NOUN
ct-10840	77	6	,	,	PUNCT
ct-10840	77	7	breeding	breeding	NOUN
ct-10840	77	8	management	management	NOUN
ct-10840	77	9	was	be	AUX
ct-10840	77	10	performed	perform	VERB
ct-10840	77	11	,	,	PUNCT
ct-10840	77	12	and	and	CCONJ
ct-10840	77	13	the	the	DET
ct-10840	77	14	dog	dog	NOUN
ct-10840	77	15	was	be	AUX
ct-10840	77	16	naturally	naturally	ADV
ct-10840	77	17	mated	mate	VERB
ct-10840	77	18	(	(	PUNCT
ct-10840	77	19	young	young	ADJ
ct-10840	77	20	proven	prove	VERB
ct-10840	77	21	stud	stud	NOUN
ct-10840	77	22	dog	dog	NOUN
ct-10840	77	23	)	)	PUNCT
ct-10840	77	24	on	on	ADP
ct-10840	77	25	days	day	NOUN
ct-10840	77	26	4	4	NUM
ct-10840	77	27	and	and	CCONJ
ct-10840	77	28	6	6	NUM
ct-10840	77	29	after	after	ADP
ct-10840	77	30	lh0	lh0	ADV
ct-10840	77	31	.	.	PUNCT
ct-10840	78	1	transabdominal	transabdominal	ADJ
ct-10840	78	2	ultrasonography	ultrasonography	NOUN
ct-10840	78	3	was	be	AUX
ct-10840	78	4	performed	perform	VERB
ct-10840	78	5	on	on	ADP
ct-10840	78	6	day	day	NOUN
ct-10840	78	7	30	30	NUM
ct-10840	78	8	after	after	ADP
ct-10840	78	9	lh0	lh0	ADV
ct-10840	78	10	;	;	PUNCT
ct-10840	78	11	4	4	NUM
ct-10840	78	12	viable	viable	ADJ
ct-10840	78	13	amniotic	amniotic	ADJ
ct-10840	78	14	sacs	sac	NOUN
ct-10840	78	15	and	and	CCONJ
ct-10840	78	16	1	1	NUM
ct-10840	78	17	resorption	resorption	NOUN
ct-10840	78	18	site	site	NOUN
ct-10840	78	19	(	(	PUNCT
ct-10840	78	20	figure	figure	NOUN
ct-10840	78	21	  	  	SPACE
ct-10840	78	22	8)	8)	NUM
ct-10840	78	23	were	be	AUX
ct-10840	78	24	observed	observe	VERB
ct-10840	78	25	.	.	PUNCT
ct-10840	79	1	a	a	DET
ct-10840	79	2	single	single	ADJ
ct-10840	79	3	lateral	lateral	ADJ
ct-10840	79	4	abdominal	abdominal	ADJ
ct-10840	79	5	radiograph	radiograph	NOUN
ct-10840	79	6	was	be	AUX
ct-10840	79	7	obtained	obtain	VERB
ct-10840	79	8	1	1	NUM
ct-10840	79	9	week	week	NOUN
ct-10840	79	10	before	before	ADP
ct-10840	79	11	calculated	calculate	VERB
ct-10840	79	12	whelping	whelping	NOUN
ct-10840	79	13	date	date	NOUN
ct-10840	79	14	,	,	PUNCT
ct-10840	79	15	and	and	CCONJ
ct-10840	79	16	3	3	NUM
ct-10840	79	17	fetal	fetal	ADJ
ct-10840	79	18	skeletons	skeleton	NOUN
ct-10840	79	19	were	be	AUX
ct-10840	79	20	identified	identify	VERB
ct-10840	79	21	(	(	PUNCT
ct-10840	79	22	figure	figure	NOUN
ct-10840	79	23	9	9	NUM
ct-10840	79	24	)	)	PUNCT
ct-10840	79	25	.	.	PUNCT
ct-10840	80	1	due	due	ADP
ct-10840	80	2	to	to	ADP
ct-10840	80	3	unexpected	unexpected	ADJ
ct-10840	80	4	complications	complication	NOUN
ct-10840	80	5	,	,	PUNCT
ct-10840	80	6	cesarian	cesarian	ADJ
ct-10840	80	7	surgery	surgery	NOUN
ct-10840	80	8	was	be	AUX
ct-10840	80	9	performed	perform	VERB
ct-10840	80	10	at	at	ADP
ct-10840	80	11	a	a	DET
ct-10840	80	12	local	local	ADJ
ct-10840	80	13	veterinary	veterinary	ADJ
ct-10840	80	14	clinic	clinic	NOUN
ct-10840	80	15	and	and	CCONJ
ct-10840	80	16	deceased	deceased	ADJ
ct-10840	80	17	pups	pup	NOUN
ct-10840	80	18	were	be	AUX
ct-10840	80	19	removed	remove	VERB
ct-10840	80	20	.	.	PUNCT
ct-10840	81	1	information	information	NOUN
ct-10840	81	2	on	on	ADP
ct-10840	81	3	presurgical	presurgical	ADJ
ct-10840	81	4	fetal	fetal	ADJ
ct-10840	81	5	viability	viability	NOUN
ct-10840	81	6	(	(	PUNCT
ct-10840	81	7	transabdominal	transabdominal	NOUN
ct-10840	81	8	ultrasonography	ultrasonography	NOUN
ct-10840	81	9	)	)	PUNCT
ct-10840	81	10	nor	nor	CCONJ
ct-10840	81	11	gross	gross	ADJ
ct-10840	81	12	findings	finding	NOUN
ct-10840	81	13	of	of	ADP
ct-10840	81	14	pups	pup	NOUN
ct-10840	81	15	were	be	AUX
ct-10840	81	16	not	not	PART
ct-10840	81	17	provided	provide	VERB
ct-10840	81	18	and	and	CCONJ
ct-10840	81	19	necropsy	necropsy	NOUN
ct-10840	81	20	was	be	AUX
ct-10840	81	21	not	not	PART
ct-10840	81	22	performed	perform	VERB
ct-10840	81	23	.	.	PUNCT
ct-10840	82	1	discussion	discussion	NOUN
ct-10840	82	2	granulosa	granulosa	PROPN
ct-10840	82	3	cell	cell	NOUN
ct-10840	82	4	tumors	tumor	NOUN
ct-10840	82	5	are	be	AUX
ct-10840	82	6	among	among	ADP
ct-10840	82	7	the	the	DET
ct-10840	82	8	most	most	ADV
ct-10840	82	9	common	common	ADJ
ct-10840	82	10	ovarian	ovarian	ADJ
ct-10840	82	11	neoplasia	neoplasia	NOUN
ct-10840	82	12	identified	identify	VERB
ct-10840	82	13	in	in	ADP
ct-10840	82	14	female	female	ADJ
ct-10840	82	15	dogs.42	dogs.42	NOUN
ct-10840	82	16	however	however	ADV
ct-10840	82	17	,	,	PUNCT
ct-10840	82	18	literature	literature	NOUN
ct-10840	82	19	regarding	regard	VERB
ct-10840	82	20	diagnosis	diagnosis	NOUN
ct-10840	82	21	and	and	CCONJ
ct-10840	82	22	treatment	treatment	NOUN
ct-10840	82	23	options	option	NOUN
ct-10840	82	24	in	in	ADP
ct-10840	82	25	dogs	dog	NOUN
ct-10840	82	26	is	be	AUX
ct-10840	82	27	limited	limited	ADJ
ct-10840	82	28	.	.	PUNCT
ct-10840	83	1	this	this	PRON
ct-10840	83	2	is	be	AUX
ct-10840	83	3	attributed	attribute	VERB
ct-10840	83	4	to	to	ADP
ct-10840	83	5	most	most	ADJ
ct-10840	83	6	female	female	ADJ
ct-10840	83	7	dogs	dog	NOUN
ct-10840	83	8	,	,	PUNCT
ct-10840	83	9	especially	especially	ADV
ct-10840	83	10	in	in	ADP
ct-10840	83	11	north	north	PROPN
ct-10840	83	12	america	america	PROPN
ct-10840	83	13	(	(	PUNCT
ct-10840	83	14	gonadectomized	gonadectomize	VERB
ct-10840	83	15	early	early	ADV
ct-10840	83	16	in	in	ADP
ct-10840	83	17	life	life	NOUN
ct-10840	83	18	)	)	PUNCT
ct-10840	83	19	,	,	PUNCT
ct-10840	83	20	apparently	apparently	ADV
ct-10840	83	21	resulting	result	VERB
ct-10840	83	22	in	in	ADP
ct-10840	83	23	a	a	DET
ct-10840	83	24	low	low	ADJ
ct-10840	83	25	incidence	incidence	NOUN
ct-10840	83	26	rate	rate	NOUN
ct-10840	83	27	of	of	ADP
ct-10840	83	28	this	this	DET
ct-10840	83	29	disease.15	disease.15	NOUN
ct-10840	83	30	however	however	ADV
ct-10840	83	31	,	,	PUNCT
ct-10840	83	32	as	as	SCONJ
ct-10840	83	33	more	more	ADJ
ct-10840	83	34	female	female	ADJ
ct-10840	83	35	dogs	dog	NOUN
ct-10840	83	36	remain	remain	VERB
ct-10840	83	37	intact	intact	ADJ
ct-10840	83	38	for	for	ADP
ct-10840	83	39	extended	extended	ADJ
ct-10840	83	40	periods	period	NOUN
ct-10840	83	41	,	,	PUNCT
ct-10840	83	42	either	either	CCONJ
ct-10840	83	43	for	for	ADP
ct-10840	83	44	figure	figure	NOUN
ct-10840	83	45	3	3	NUM
ct-10840	83	46	.	.	PUNCT
ct-10840	83	47	ultrasonographic	ultrasonographic	ADJ
ct-10840	83	48	images	image	NOUN
ct-10840	83	49	of	of	ADP
ct-10840	83	50	uterus	uterus	NOUN
ct-10840	83	51	on	on	ADP
ct-10840	83	52	day	day	NOUN
ct-10840	83	53	30	30	NUM
ct-10840	83	54	:	:	PUNCT
ct-10840	83	55	a.	a.	NOUN
ct-10840	83	56	transverse	transverse	NOUN
ct-10840	83	57	view	view	NOUN
ct-10840	83	58	of	of	ADP
ct-10840	83	59	uterine	uterine	ADJ
ct-10840	83	60	body	body	NOUN
ct-10840	83	61	and	and	CCONJ
ct-10840	83	62	b.	b.	PROPN
ct-10840	83	63	uterine	uterine	PROPN
ct-10840	83	64	horn	horn	PROPN
ct-10840	83	65	bifurcation	bifurcation	NOUN
ct-10840	83	66	(	(	PUNCT
ct-10840	83	67	characteristic	characteristic	ADJ
ct-10840	83	68	of	of	ADP
ct-10840	83	69	cystic	cystic	ADJ
ct-10840	83	70	endometrial	endometrial	ADJ
ct-10840	83	71	hyperplasia	hyperplasia	NOUN
ct-10840	83	72	)	)	PUNCT
ct-10840	83	73	cysts	cyst	NOUN
ct-10840	83	74	;	;	PUNCT
ct-10840	83	75	note	note	VERB
ct-10840	83	76	cysts	cyst	NOUN
ct-10840	83	77	(	(	PUNCT
ct-10840	83	78	arrows	arrow	NOUN
ct-10840	83	79	)	)	PUNCT
ct-10840	83	80	within	within	ADP
ct-10840	83	81	uterine	uterine	ADJ
ct-10840	83	82	endometrial	endometrial	ADJ
ct-10840	83	83	lining	lining	NOUN
ct-10840	83	84	.	.	PUNCT
ct-10840	84	1	a	a	DET
ct-10840	84	2	b	b	NUM
ct-10840	84	3	figure	figure	NOUN
ct-10840	84	4	4	4	NUM
ct-10840	84	5	.	.	PUNCT
ct-10840	84	6	intraoperative	intraoperative	ADJ
ct-10840	84	7	image	image	NOUN
ct-10840	84	8	of	of	ADP
ct-10840	84	9	left	left	ADJ
ct-10840	84	10	ovary	ovary	NOUN
ct-10840	84	11	(	(	PUNCT
ct-10840	84	12	black	black	ADJ
ct-10840	84	13	arrow	arrow	NOUN
ct-10840	84	14	)	)	PUNCT
ct-10840	84	15	before	before	ADP
ct-10840	84	16	surgical	surgical	ADJ
ct-10840	84	17	resection	resection	NOUN
ct-10840	84	18	(	(	PUNCT
ct-10840	84	19	note	note	VERB
ct-10840	84	20	abnormal	abnormal	ADJ
ct-10840	84	21	gross	gross	ADJ
ct-10840	84	22	appearance	appearance	NOUN
ct-10840	84	23	ovarian	ovarian	ADJ
ct-10840	84	24	serosal	serosal	PROPN
ct-10840	84	25	surface	surface	PROPN
ct-10840	84	26	with	with	ADP
ct-10840	84	27	multilobulated	multilobulate	VERB
ct-10840	84	28	darkened	darken	VERB
ct-10840	84	29	parenchyma	parenchyma	NOUN
ct-10840	84	30	)	)	PUNCT
ct-10840	84	31	.	.	PUNCT
ct-10840	85	1	figure	figure	NOUN
ct-10840	85	2	5	5	NUM
ct-10840	85	3	.	.	PUNCT
ct-10840	85	4	gross	gross	ADJ
ct-10840	85	5	image	image	NOUN
ct-10840	85	6	of	of	ADP
ct-10840	85	7	left	left	ADJ
ct-10840	85	8	ovary	ovary	NOUN
ct-10840	85	9	immediately	immediately	ADV
ct-10840	85	10	after	after	ADP
ct-10840	85	11	surgical	surgical	ADJ
ct-10840	85	12	removal	removal	NOUN
ct-10840	85	13	(	(	PUNCT
ct-10840	85	14	note	note	VERB
ct-10840	85	15	irregular	irregular	ADJ
ct-10840	85	16	nodular	nodular	ADJ
ct-10840	85	17	mass	mass	NOUN
ct-10840	86	1	[	[	X
ct-10840	86	2	black	black	ADJ
ct-10840	86	3	arrow	arrow	NOUN
ct-10840	86	4	]	]	PUNCT
ct-10840	86	5	representing	represent	VERB
ct-10840	86	6	gct	gct	PROPN
ct-10840	86	7	that	that	PRON
ct-10840	86	8	is	be	AUX
ct-10840	86	9	clearly	clearly	ADV
ct-10840	86	10	visible	visible	ADJ
ct-10840	86	11	through	through	ADP
ct-10840	86	12	ovarian	ovarian	ADJ
ct-10840	86	13	bursa	bursa	NOUN
ct-10840	86	14	)	)	PUNCT
ct-10840	86	15	.	.	PUNCT
ct-10840	87	1	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	87	2	citation	citation	NOUN
ct-10840	87	3	:	:	PUNCT
ct-10840	87	4	clinical	clinical	ADJ
ct-10840	87	5	theriogenology	theriogenology	NOUN
ct-10840	87	6	2024	2024	NUM
ct-10840	87	7	,	,	PUNCT
ct-10840	87	8	16	16	NUM
ct-10840	87	9	,	,	PUNCT
ct-10840	87	10	10840	10840	NUM
ct-10840	87	11	,	,	PUNCT
ct-10840	87	12	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	87	13	5	5	NUM
ct-10840	87	14	a	a	DET
ct-10840	87	15	b	b	NOUN
ct-10840	87	16	b	b	X
ct-10840	87	17	figure	figure	NOUN
ct-10840	87	18	6	6	NUM
ct-10840	87	19	.	.	PUNCT
ct-10840	87	20	left	leave	VERB
ct-10840	87	21	ovary	ovary	NOUN
ct-10840	87	22	after	after	ADP
ct-10840	87	23	surgical	surgical	ADJ
ct-10840	87	24	removal	removal	NOUN
ct-10840	87	25	;	;	PUNCT
ct-10840	87	26	a.	a.	PROPN
ct-10840	87	27	gct	gct	PROPN
ct-10840	87	28	along	along	ADP
ct-10840	87	29	with	with	ADP
ct-10840	87	30	intact	intact	ADJ
ct-10840	87	31	oviduct	oviduct	NOUN
ct-10840	87	32	and	and	CCONJ
ct-10840	87	33	uterine	uterine	ADJ
ct-10840	87	34	horn	horn	NOUN
ct-10840	87	35	tip	tip	NOUN
ct-10840	87	36	(	(	PUNCT
ct-10840	87	37	note	note	NOUN
ct-10840	87	38	cut	cut	VERB
ct-10840	87	39	surface	surface	NOUN
ct-10840	87	40	of	of	ADP
ct-10840	87	41	gct	gct	PROPN
ct-10840	87	42	has	have	VERB
ct-10840	87	43	well	well	ADV
ct-10840	87	44	-	-	PUNCT
ct-10840	87	45	demarcated	demarcate	VERB
ct-10840	87	46	white	white	ADJ
ct-10840	87	47	,	,	PUNCT
ct-10840	87	48	variably	variably	ADV
ct-10840	87	49	friable	friable	ADJ
ct-10840	87	50	,	,	PUNCT
ct-10840	87	51	and	and	CCONJ
ct-10840	87	52	partially	partially	ADV
ct-10840	87	53	cavitated	cavitate	VERB
ct-10840	87	54	mass	mass	NOUN
ct-10840	87	55	[	[	X
ct-10840	87	56	arrow	arrow	NOUN
ct-10840	87	57	]	]	PUNCT
ct-10840	87	58	)	)	PUNCT
ct-10840	87	59	and	and	CCONJ
ct-10840	87	60	b.	b.	PROPN
ct-10840	87	61	diameter	diameter	NOUN
ct-10840	87	62	of	of	ADP
ct-10840	87	63	gct	gct	PROPN
ct-10840	87	64	(	(	PUNCT
ct-10840	87	65	~	~	PUNCT
ct-10840	87	66	3	3	NUM
ct-10840	87	67	cm	cm	NOUN
ct-10840	87	68	)	)	PUNCT
ct-10840	87	69	mass	mass	PROPN
ct-10840	87	70	.	.	PUNCT
ct-10840	88	1	figure	figure	NOUN
ct-10840	88	2	7	7	NUM
ct-10840	88	3	.	.	PUNCT
ct-10840	88	4	histopathology	histopathology	NOUN
ct-10840	88	5	of	of	ADP
ct-10840	88	6	left	left	ADJ
ct-10840	88	7	ovary	ovary	NOUN
ct-10840	88	8	:	:	PUNCT
ct-10840	88	9	a.	a.	PROPN
ct-10840	88	10	subgross	subgross	PROPN
ct-10840	88	11	(	(	PUNCT
ct-10840	88	12	10	10	NUM
ct-10840	88	13	x	x	NOUN
ct-10840	88	14	magnification	magnification	NOUN
ct-10840	88	15	)	)	PUNCT
ct-10840	88	16	;	;	PUNCT
ct-10840	88	17	b.	b.	NOUN
ct-10840	88	18	tissue	tissue	NOUN
ct-10840	88	19	margin	margin	NOUN
ct-10840	88	20	(	(	PUNCT
ct-10840	88	21	20	20	NUM
ct-10840	88	22	x	x	NOUN
ct-10840	88	23	magnification	magnification	NOUN
ct-10840	88	24	)	)	PUNCT
ct-10840	88	25	;	;	PUNCT
ct-10840	88	26	c.	c.	PROPN
ct-10840	88	27	neoplastic	neoplastic	ADJ
ct-10840	88	28	cells	cell	NOUN
ct-10840	88	29	arranged	arrange	VERB
ct-10840	88	30	in	in	ADP
ct-10840	88	31	variably	variably	ADV
ct-10840	88	32	formed	form	VERB
ct-10840	88	33	glandular	glandular	ADJ
ct-10840	88	34	structures	structure	NOUN
ct-10840	88	35	that	that	PRON
ct-10840	88	36	contain	contain	VERB
ct-10840	88	37	mucinous	mucinous	ADJ
ct-10840	88	38	eosinophilic	eosinophilic	ADJ
ct-10840	88	39	material	material	NOUN
ct-10840	88	40	(	(	PUNCT
ct-10840	88	41	100	100	NUM
ct-10840	88	42	x	x	NOUN
ct-10840	88	43	magnification	magnification	NOUN
ct-10840	88	44	)	)	PUNCT
ct-10840	88	45	,	,	PUNCT
ct-10840	88	46	and	and	CCONJ
ct-10840	88	47	d.	d.	PROPN
ct-10840	88	48	neoplastic	neoplastic	ADJ
ct-10840	88	49	cells	cell	NOUN
ct-10840	88	50	are	be	AUX
ct-10840	88	51	polygonal	polygonal	ADJ
ct-10840	88	52	to	to	PART
ct-10840	88	53	rarely	rarely	ADV
ct-10840	88	54	spindled	spindle	VERB
ct-10840	88	55	with	with	ADP
ct-10840	88	56	variably	variably	ADV
ct-10840	88	57	discrete	discrete	ADJ
ct-10840	88	58	cell	cell	NOUN
ct-10840	88	59	borders	border	NOUN
ct-10840	88	60	and	and	CCONJ
ct-10840	88	61	foamy	foamy	ADJ
ct-10840	88	62	eosinophilic	eosinophilic	ADJ
ct-10840	88	63	cytoplasm	cytoplasm	NOUN
ct-10840	88	64	,	,	PUNCT
ct-10840	88	65	mild	mild	ADJ
ct-10840	88	66	to	to	ADP
ct-10840	88	67	moderate	moderate	ADJ
ct-10840	88	68	anisokaryosis	anisokaryosis	NOUN
ct-10840	88	69	and	and	CCONJ
ct-10840	88	70	anisocytosis	anisocytosis	NOUN
ct-10840	88	71	(	(	PUNCT
ct-10840	88	72	di	di	NOUN
ct-10840	88	73	200	200	NUM
ct-10840	88	74	x	x	NOUN
ct-10840	88	75	magnification	magnification	NOUN
ct-10840	88	76	and	and	CCONJ
ct-10840	88	77	dii	dii	NOUN
ct-10840	88	78	400	400	NUM
ct-10840	88	79	x	x	NOUN
ct-10840	88	80	magnification	magnification	NOUN
ct-10840	88	81	)	)	PUNCT
ct-10840	88	82	.	.	PUNCT
ct-10840	89	1	ba	ba	PROPN
ct-10840	89	2	figure	figure	NOUN
ct-10840	89	3	8	8	NUM
ct-10840	89	4	.	.	PUNCT
ct-10840	90	1	ultrasonographic	ultrasonographic	ADJ
ct-10840	90	2	image	image	NOUN
ct-10840	90	3	of	of	ADP
ct-10840	90	4	amniotic	amniotic	ADJ
ct-10840	90	5	sacs	sac	NOUN
ct-10840	90	6	(	(	PUNCT
ct-10840	90	7	a	a	NOUN
ct-10840	90	8	)	)	PUNCT
ct-10840	90	9	and	and	CCONJ
ct-10840	90	10	reabsorption	reabsorption	NOUN
ct-10840	90	11	site	site	NOUN
ct-10840	90	12	(	(	PUNCT
ct-10840	90	13	b	b	NOUN
ct-10840	90	14	)	)	PUNCT
ct-10840	90	15	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	90	16	6	6	NUM
ct-10840	90	17	citation	citation	NOUN
ct-10840	90	18	:	:	PUNCT
ct-10840	90	19	clinical	clinical	ADJ
ct-10840	90	20	theriogenology	theriogenology	NOUN
ct-10840	90	21	2024	2024	NUM
ct-10840	90	22	,	,	PUNCT
ct-10840	90	23	16	16	NUM
ct-10840	90	24	,	,	PUNCT
ct-10840	90	25	10840	10840	NUM
ct-10840	90	26	,	,	PUNCT
ct-10840	90	27	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	90	28	breeding	breed	VERB
ct-10840	90	29	purposes	purpose	NOUN
ct-10840	90	30	or	or	CCONJ
ct-10840	90	31	for	for	ADP
ct-10840	90	32	potential	potential	ADJ
ct-10840	90	33	health	health	NOUN
ct-10840	90	34	benefits	benefit	NOUN
ct-10840	90	35	,	,	PUNCT
ct-10840	90	36	the	the	DET
ct-10840	90	37	likelihood	likelihood	NOUN
ct-10840	90	38	of	of	ADP
ct-10840	90	39	diagnosing	diagnose	VERB
ct-10840	90	40	an	an	DET
ct-10840	90	41	ovarian	ovarian	ADJ
ct-10840	90	42	tumor	tumor	NOUN
ct-10840	90	43	will	will	AUX
ct-10840	90	44	become	become	VERB
ct-10840	90	45	more	more	ADV
ct-10840	90	46	common.43,44	common.43,44	ADJ
ct-10840	90	47	therefore	therefore	ADV
ct-10840	90	48	,	,	PUNCT
ct-10840	90	49	understanding	understand	VERB
ct-10840	90	50	the	the	DET
ct-10840	90	51	current	current	ADJ
ct-10840	90	52	diagnostic	diagnostic	ADJ
ct-10840	90	53	tools	tool	NOUN
ct-10840	90	54	available	available	ADJ
ct-10840	90	55	and	and	CCONJ
ct-10840	90	56	the	the	DET
ct-10840	90	57	potential	potential	ADJ
ct-10840	90	58	limitations	limitation	NOUN
ct-10840	90	59	of	of	ADP
ct-10840	90	60	each	each	DET
ct-10840	90	61	method	method	NOUN
ct-10840	90	62	is	be	AUX
ct-10840	90	63	important	important	ADJ
ct-10840	90	64	for	for	ADP
ct-10840	90	65	clinicians	clinician	NOUN
ct-10840	90	66	to	to	PART
ct-10840	90	67	recognize	recognize	VERB
ct-10840	90	68	when	when	SCONJ
ct-10840	90	69	pursuing	pursue	VERB
ct-10840	90	70	gct	gct	PROPN
ct-10840	90	71	diagnosis	diagnosis	NOUN
ct-10840	90	72	.	.	PUNCT
ct-10840	91	1	in	in	ADP
ct-10840	91	2	mares	mare	NOUN
ct-10840	91	3	,	,	PUNCT
ct-10840	91	4	tests	test	NOUN
ct-10840	91	5	available	available	ADJ
ct-10840	91	6	for	for	ADP
ct-10840	91	7	the	the	DET
ct-10840	91	8	diagnosis	diagnosis	NOUN
ct-10840	91	9	of	of	ADP
ct-10840	91	10	a	a	DET
ct-10840	91	11	gct	gct	PROPN
ct-10840	91	12	include	include	VERB
ct-10840	91	13	hormonal	hormonal	ADJ
ct-10840	91	14	bioassays	bioassay	NOUN
ct-10840	91	15	or	or	CCONJ
ct-10840	91	16	‘	'	PUNCT
ct-10840	91	17	gct	gct	PROPN
ct-10840	91	18	panels	panel	NOUN
ct-10840	91	19	’	'	PUNCT
ct-10840	91	20	(	(	PUNCT
ct-10840	91	21	amh	amh	PROPN
ct-10840	91	22	,	,	PUNCT
ct-10840	91	23	inhibin	inhibin	PROPN
ct-10840	91	24	,	,	PUNCT
ct-10840	91	25	progesterone	progesterone	NOUN
ct-10840	91	26	,	,	PUNCT
ct-10840	91	27	and	and	CCONJ
ct-10840	91	28	testosterone	testosterone	NOUN
ct-10840	91	29	)	)	PUNCT
ct-10840	91	30	,	,	PUNCT
ct-10840	91	31	ovarian	ovarian	ADJ
ct-10840	91	32	ultrasonography	ultrasonography	NOUN
ct-10840	91	33	,	,	PUNCT
ct-10840	91	34	transrectal	transrectal	ADJ
ct-10840	91	35	ovarian	ovarian	ADJ
ct-10840	91	36	palpation	palpation	NOUN
ct-10840	91	37	and	and	CCONJ
ct-10840	91	38	overt	overt	ADJ
ct-10840	91	39	behavioral	behavioral	ADJ
ct-10840	91	40	changes	change	NOUN
ct-10840	91	41	associated	associate	VERB
ct-10840	91	42	with	with	ADP
ct-10840	91	43	increased	increase	VERB
ct-10840	91	44	concentrations	concentration	NOUN
ct-10840	91	45	of	of	ADP
ct-10840	91	46	estrogen	estrogen	NOUN
ct-10840	91	47	and/or	and/or	CCONJ
ct-10840	91	48	testosterone	testosterone	NOUN
ct-10840	91	49	through	through	ADP
ct-10840	91	50	stallion	stallion	NOUN
ct-10840	91	51	-	-	PUNCT
ct-10840	91	52	like	like	ADJ
ct-10840	91	53	or	or	CCONJ
ct-10840	91	54	aggressive	aggressive	ADJ
ct-10840	91	55	behavior.20	behavior.20	NOUN
ct-10840	91	56	in	in	ADP
ct-10840	91	57	dogs	dog	NOUN
ct-10840	91	58	,	,	PUNCT
ct-10840	91	59	a	a	DET
ct-10840	91	60	distinctive	distinctive	ADJ
ct-10840	91	61	behavioral	behavioral	ADJ
ct-10840	91	62	change	change	NOUN
ct-10840	91	63	,	,	PUNCT
ct-10840	91	64	similar	similar	ADJ
ct-10840	91	65	to	to	ADP
ct-10840	91	66	stallion	stallion	NOUN
ct-10840	91	67	-	-	PUNCT
ct-10840	91	68	like	like	ADJ
ct-10840	91	69	behavior	behavior	NOUN
ct-10840	91	70	observed	observe	VERB
ct-10840	91	71	in	in	ADP
ct-10840	91	72	mares	mare	NOUN
ct-10840	91	73	,	,	PUNCT
ct-10840	91	74	has	have	AUX
ct-10840	91	75	not	not	PART
ct-10840	91	76	been	be	AUX
ct-10840	91	77	documented	document	VERB
ct-10840	91	78	,	,	PUNCT
ct-10840	91	79	and	and	CCONJ
ct-10840	91	80	diagnosis	diagnosis	NOUN
ct-10840	91	81	can	can	AUX
ct-10840	91	82	be	be	AUX
ct-10840	91	83	more	more	ADV
ct-10840	91	84	challenging	challenging	ADJ
ct-10840	91	85	because	because	SCONJ
ct-10840	91	86	there	there	PRON
ct-10840	91	87	is	be	VERB
ct-10840	91	88	no	no	DET
ct-10840	91	89	pathognomonic	pathognomonic	ADJ
ct-10840	91	90	finding	finding	NOUN
ct-10840	91	91	,	,	PUNCT
ct-10840	91	92	no	no	DET
ct-10840	91	93	consistent	consistent	ADJ
ct-10840	91	94	ultrasonographic	ultrasonographic	ADJ
ct-10840	91	95	appearance	appearance	NOUN
ct-10840	91	96	and	and	CCONJ
ct-10840	91	97	no	no	DET
ct-10840	91	98	standardized	standardized	ADJ
ct-10840	91	99	hormone	hormone	NOUN
ct-10840	91	100	panel	panel	NOUN
ct-10840	91	101	with	with	ADP
ct-10840	91	102	reference	reference	NOUN
ct-10840	91	103	ranges	range	VERB
ct-10840	91	104	specific	specific	ADJ
ct-10840	91	105	to	to	ADP
ct-10840	91	106	dogs	dog	NOUN
ct-10840	91	107	.	.	PUNCT
ct-10840	92	1	hormonal	hormonal	ADJ
ct-10840	92	2	findings	finding	NOUN
ct-10840	92	3	associated	associate	VERB
ct-10840	92	4	with	with	ADP
ct-10840	92	5	canine	canine	NOUN
ct-10840	92	6	gcts	gct	NOUN
ct-10840	92	7	can	can	AUX
ct-10840	92	8	be	be	AUX
ct-10840	92	9	unpredictable	unpredictable	ADJ
ct-10840	92	10	,	,	PUNCT
ct-10840	92	11	especially	especially	ADV
ct-10840	92	12	when	when	SCONJ
ct-10840	92	13	other	other	ADJ
ct-10840	92	14	physiological	physiological	ADJ
ct-10840	92	15	processes	process	NOUN
ct-10840	92	16	may	may	AUX
ct-10840	92	17	present	present	VERB
ct-10840	92	18	concurrently	concurrently	ADV
ct-10840	92	19	in	in	ADP
ct-10840	92	20	the	the	DET
ct-10840	92	21	early	early	ADJ
ct-10840	92	22	stages	stage	NOUN
ct-10840	92	23	of	of	ADP
ct-10840	92	24	pathology.20	pathology.20	NOUN
ct-10840	92	25	ovarian	ovarian	ADJ
ct-10840	92	26	tumors	tumor	NOUN
ct-10840	92	27	,	,	PUNCT
ct-10840	92	28	particularly	particularly	ADV
ct-10840	92	29	gcts	gct	NOUN
ct-10840	92	30	,	,	PUNCT
ct-10840	92	31	alter	alter	VERB
ct-10840	92	32	normal	normal	ADJ
ct-10840	92	33	ovarian	ovarian	ADJ
ct-10840	92	34	echotexture	echotexture	NOUN
ct-10840	92	35	and	and	CCONJ
ct-10840	92	36	have	have	VERB
ct-10840	92	37	an	an	DET
ct-10840	92	38	irregular	irregular	ADJ
ct-10840	92	39	shape	shape	NOUN
ct-10840	92	40	in	in	ADP
ct-10840	92	41	69	69	NUM
ct-10840	92	42	%	%	NOUN
ct-10840	92	43	of	of	ADP
ct-10840	92	44	reported	report	VERB
ct-10840	92	45	cases	case	NOUN
ct-10840	92	46	in	in	ADP
ct-10840	92	47	dogs.6	dogs.6	PROPN
ct-10840	92	48	however	however	ADV
ct-10840	92	49	,	,	PUNCT
ct-10840	92	50	there	there	PRON
ct-10840	92	51	can	can	AUX
ct-10840	92	52	be	be	AUX
ct-10840	92	53	many	many	ADJ
ct-10840	92	54	variations	variation	NOUN
ct-10840	92	55	in	in	ADP
ct-10840	92	56	appearance	appearance	NOUN
ct-10840	92	57	;	;	PUNCT
ct-10840	92	58	as	as	SCONJ
ct-10840	92	59	in	in	ADP
ct-10840	92	60	our	our	PRON
ct-10840	92	61	case	case	NOUN
ct-10840	92	62	,	,	PUNCT
ct-10840	92	63	only	only	ADV
ct-10840	92	64	a	a	DET
ct-10840	92	65	change	change	NOUN
ct-10840	92	66	in	in	ADP
ct-10840	92	67	echotexture	echotexture	NOUN
ct-10840	92	68	of	of	ADP
ct-10840	92	69	the	the	DET
ct-10840	92	70	ovarian	ovarian	ADJ
ct-10840	92	71	parenchyma	parenchyma	NOUN
ct-10840	92	72	and	and	CCONJ
ct-10840	92	73	a	a	DET
ct-10840	92	74	slight	slight	ADJ
ct-10840	92	75	increase	increase	NOUN
ct-10840	92	76	in	in	ADP
ct-10840	92	77	ovarian	ovarian	ADJ
ct-10840	92	78	size	size	NOUN
ct-10840	92	79	but	but	CCONJ
ct-10840	92	80	normal	normal	ADJ
ct-10840	92	81	shape	shape	NOUN
ct-10840	92	82	was	be	AUX
ct-10840	92	83	initially	initially	ADV
ct-10840	92	84	detected	detect	VERB
ct-10840	92	85	on	on	ADP
ct-10840	92	86	ultrasonography	ultrasonography	NOUN
ct-10840	92	87	.	.	PUNCT
ct-10840	93	1	this	this	PRON
ct-10840	93	2	is	be	AUX
ct-10840	93	3	most	most	ADV
ct-10840	93	4	likely	likely	ADV
ct-10840	93	5	attributed	attribute	VERB
ct-10840	93	6	to	to	ADP
ct-10840	93	7	the	the	DET
ct-10840	93	8	very	very	ADV
ct-10840	93	9	early	early	ADJ
ct-10840	93	10	diagnosis	diagnosis	NOUN
ct-10840	93	11	of	of	ADP
ct-10840	93	12	gct	gct	PROPN
ct-10840	93	13	in	in	ADP
ct-10840	93	14	our	our	PRON
ct-10840	93	15	case	case	NOUN
ct-10840	93	16	.	.	PUNCT
ct-10840	94	1	human	human	ADJ
ct-10840	94	2	medicine	medicine	NOUN
ct-10840	94	3	utilizes	utilize	VERB
ct-10840	94	4	color	color	NOUN
ct-10840	94	5	doppler	doppler	NOUN
ct-10840	94	6	to	to	PART
ct-10840	94	7	differentiate	differentiate	VERB
ct-10840	94	8	between	between	ADP
ct-10840	94	9	malignant	malignant	ADJ
ct-10840	94	10	and	and	CCONJ
ct-10840	94	11	benign	benign	ADJ
ct-10840	94	12	ovarian	ovarian	ADJ
ct-10840	94	13	neoplasms	neoplasm	NOUN
ct-10840	94	14	by	by	ADP
ct-10840	94	15	detecting	detect	VERB
ct-10840	94	16	abnormal	abnormal	ADJ
ct-10840	94	17	changes	change	NOUN
ct-10840	94	18	to	to	ADP
ct-10840	94	19	the	the	DET
ct-10840	94	20	intraovarian	intraovarian	ADJ
ct-10840	94	21	vasculature.45,46	vasculature.45,46	NOUN
ct-10840	94	22	we	we	PRON
ct-10840	94	23	utilized	utilize	VERB
ct-10840	94	24	this	this	DET
ct-10840	94	25	technique	technique	NOUN
ct-10840	94	26	in	in	ADP
ct-10840	94	27	our	our	PRON
ct-10840	94	28	case	case	NOUN
ct-10840	94	29	to	to	PART
ct-10840	94	30	demonstrate	demonstrate	VERB
ct-10840	94	31	an	an	DET
ct-10840	94	32	increase	increase	NOUN
ct-10840	94	33	in	in	ADP
ct-10840	94	34	the	the	DET
ct-10840	94	35	vasculature	vasculature	NOUN
ct-10840	94	36	to	to	ADP
ct-10840	94	37	and	and	CCONJ
ct-10840	94	38	within	within	ADP
ct-10840	94	39	the	the	DET
ct-10840	94	40	abnormal	abnormal	ADJ
ct-10840	94	41	region	region	NOUN
ct-10840	94	42	that	that	SCONJ
ct-10840	94	43	when	when	SCONJ
ct-10840	94	44	combined	combine	VERB
ct-10840	94	45	with	with	ADP
ct-10840	94	46	initial	initial	ADJ
ct-10840	94	47	changes	change	NOUN
ct-10840	94	48	to	to	ADP
ct-10840	94	49	a	a	DET
ct-10840	94	50	honeycomb	honeycomb	NOUN
ct-10840	94	51	-	-	PUNCT
ct-10840	94	52	like	like	ADJ
ct-10840	94	53	appearance	appearance	NOUN
ct-10840	94	54	,	,	PUNCT
ct-10840	94	55	aided	aid	VERB
ct-10840	94	56	in	in	ADP
ct-10840	94	57	the	the	DET
ct-10840	94	58	presumptive	presumptive	ADJ
ct-10840	94	59	diagnosis	diagnosis	NOUN
ct-10840	94	60	of	of	ADP
ct-10840	94	61	gct	gct	PROPN
ct-10840	94	62	.	.	PROPN
ct-10840	94	63	in	in	ADP
ct-10840	94	64	mares	mare	NOUN
ct-10840	94	65	,	,	PUNCT
ct-10840	94	66	peripheral	peripheral	ADJ
ct-10840	94	67	amh	amh	PROPN
ct-10840	94	68	and	and	CCONJ
ct-10840	94	69	inhibin	inhibin	PROPN
ct-10840	94	70	b	b	PROPN
ct-10840	94	71	concentrations	concentration	NOUN
ct-10840	94	72	are	be	AUX
ct-10840	94	73	routinely	routinely	ADV
ct-10840	94	74	measured	measure	VERB
ct-10840	94	75	to	to	PART
ct-10840	94	76	diagnose	diagnose	VERB
ct-10840	94	77	gct.20	gct.20	PROPN
ct-10840	94	78	elevated	elevated	PROPN
ct-10840	94	79	amh	amh	PROPN
ct-10840	94	80	concentrations	concentration	NOUN
ct-10840	94	81	ranging	range	VERB
ct-10840	94	82	from	from	ADP
ct-10840	94	83	1.12	1.12	NUM
ct-10840	94	84	to	to	ADP
ct-10840	94	85	≥	≥	PROPN
ct-10840	94	86	23	23	NUM
ct-10840	94	87	ng	ng	NOUN
ct-10840	94	88	/	/	SYM
ct-10840	94	89	ml	ml	PROPN
ct-10840	94	90	have	have	AUX
ct-10840	94	91	been	be	AUX
ct-10840	94	92	reported	report	VERB
ct-10840	94	93	in	in	ADP
ct-10840	94	94	dogs	dog	NOUN
ct-10840	94	95	diagnosed	diagnose	VERB
ct-10840	94	96	with	with	ADP
ct-10840	94	97	gct.21	gct.21	PROPN
ct-10840	94	98	however	however	ADV
ct-10840	94	99	,	,	PUNCT
ct-10840	94	100	reference	reference	NOUN
ct-10840	94	101	ranges	range	VERB
ct-10840	94	102	can	can	AUX
ct-10840	94	103	be	be	AUX
ct-10840	94	104	>	>	X
ct-10840	94	105	12	12	NUM
ct-10840	94	106	ng	ng	PROPN
ct-10840	94	107	/	/	SYM
ct-10840	94	108	ml	ml	X
ct-10840	94	109	in	in	ADP
ct-10840	94	110	clinically	clinically	ADV
ct-10840	94	111	normal	normal	ADJ
ct-10840	94	112	intact	intact	ADJ
ct-10840	94	113	dogs.47	dogs.47	NOUN
ct-10840	94	114	therefore	therefore	ADV
ct-10840	94	115	,	,	PUNCT
ct-10840	94	116	supportive	supportive	ADJ
ct-10840	94	117	clinical	clinical	ADJ
ct-10840	94	118	signs	sign	NOUN
ct-10840	94	119	,	,	PUNCT
ct-10840	94	120	vaginal	vaginal	ADJ
ct-10840	94	121	cytological	cytological	ADJ
ct-10840	94	122	findings	finding	NOUN
ct-10840	94	123	(	(	PUNCT
ct-10840	94	124	indicative	indicative	ADJ
ct-10840	94	125	of	of	ADP
ct-10840	94	126	estrogen	estrogen	NOUN
ct-10840	94	127	)	)	PUNCT
ct-10840	94	128	,	,	PUNCT
ct-10840	94	129	ultrasonography	ultrasonography	NOUN
ct-10840	94	130	findings	finding	NOUN
ct-10840	94	131	and	and	CCONJ
ct-10840	94	132	ultimately	ultimately	ADV
ct-10840	94	133	,	,	PUNCT
ct-10840	94	134	histopathology	histopathology	NOUN
ct-10840	94	135	are	be	AUX
ct-10840	94	136	required	require	VERB
ct-10840	94	137	for	for	ADP
ct-10840	94	138	the	the	DET
ct-10840	94	139	diagnosis	diagnosis	NOUN
ct-10840	94	140	of	of	ADP
ct-10840	94	141	a	a	DET
ct-10840	94	142	gct	gct	PROPN
ct-10840	94	143	in	in	ADP
ct-10840	94	144	dogs	dog	NOUN
ct-10840	94	145	.	.	PUNCT
ct-10840	95	1	in	in	ADP
ct-10840	95	2	this	this	DET
ct-10840	95	3	case	case	NOUN
ct-10840	95	4	,	,	PUNCT
ct-10840	95	5	circulating	circulate	VERB
ct-10840	95	6	amh	amh	PROPN
ct-10840	95	7	concentrations	concentration	NOUN
ct-10840	95	8	were	be	AUX
ct-10840	95	9	not	not	PART
ct-10840	95	10	high	high	ADJ
ct-10840	95	11	(	(	PUNCT
ct-10840	95	12	possibly	possibly	ADV
ct-10840	95	13	due	due	ADP
ct-10840	95	14	to	to	ADP
ct-10840	95	15	the	the	DET
ct-10840	95	16	early	early	ADJ
ct-10840	95	17	diagnosis	diagnosis	NOUN
ct-10840	95	18	of	of	ADP
ct-10840	95	19	a	a	DET
ct-10840	95	20	gct	gct	PROPN
ct-10840	95	21	)	)	PUNCT
ct-10840	95	22	.	.	PUNCT
ct-10840	96	1	another	another	DET
ct-10840	96	2	endocrine	endocrine	NOUN
ct-10840	96	3	marker	marker	NOUN
ct-10840	96	4	used	use	VERB
ct-10840	96	5	in	in	ADP
ct-10840	96	6	large	large	ADJ
ct-10840	96	7	animals	animal	NOUN
ct-10840	96	8	to	to	PART
ct-10840	96	9	diagnose	diagnose	VERB
ct-10840	96	10	gcts	gct	NOUN
ct-10840	96	11	is	be	AUX
ct-10840	96	12	inhibin	inhibin	PROPN
ct-10840	96	13	b	b	PROPN
ct-10840	96	14	that	that	PRON
ct-10840	96	15	was	be	AUX
ct-10840	96	16	elevated	elevate	VERB
ct-10840	96	17	in	in	ADP
ct-10840	96	18	this	this	DET
ct-10840	96	19	case	case	NOUN
ct-10840	96	20	compared	compare	VERB
ct-10840	96	21	to	to	ADP
ct-10840	96	22	mare	mare	PROPN
ct-10840	96	23	’s	’s	PART
ct-10840	96	24	reference	reference	NOUN
ct-10840	96	25	range	range	NOUN
ct-10840	96	26	of	of	ADP
ct-10840	96	27	2	2	NUM
ct-10840	96	28	to	to	PART
ct-10840	96	29	100	100	NUM
ct-10840	96	30	pg	pg	NOUN
ct-10840	96	31	/	/	SYM
ct-10840	96	32	ml.20	ml.20	PROPN
ct-10840	96	33	however	however	ADV
ct-10840	96	34	,	,	PUNCT
ct-10840	96	35	there	there	PRON
ct-10840	96	36	is	be	VERB
ct-10840	96	37	currently	currently	ADV
ct-10840	96	38	no	no	DET
ct-10840	96	39	reference	reference	NOUN
ct-10840	96	40	range	range	NOUN
ct-10840	96	41	for	for	ADP
ct-10840	96	42	inhibin	inhibin	ADJ
ct-10840	96	43	in	in	ADP
ct-10840	96	44	dogs	dog	NOUN
ct-10840	96	45	,	,	PUNCT
ct-10840	96	46	though	though	SCONJ
ct-10840	96	47	high	high	ADJ
ct-10840	96	48	concentrations	concentration	NOUN
ct-10840	96	49	of	of	ADP
ct-10840	96	50	inhibin	inhibin	ADJ
ct-10840	96	51	,	,	PUNCT
ct-10840	96	52	in	in	ADP
ct-10840	96	53	this	this	DET
ct-10840	96	54	case	case	NOUN
ct-10840	96	55	,	,	PUNCT
ct-10840	96	56	followed	follow	VERB
ct-10840	96	57	by	by	ADP
ct-10840	96	58	substantial	substantial	ADJ
ct-10840	96	59	decline	decline	NOUN
ct-10840	96	60	after	after	ADP
ct-10840	96	61	removal	removal	NOUN
ct-10840	96	62	of	of	ADP
ct-10840	96	63	the	the	DET
ct-10840	96	64	ovary	ovary	NOUN
ct-10840	96	65	containing	contain	VERB
ct-10840	96	66	gct	gct	PROPN
ct-10840	96	67	,	,	PUNCT
ct-10840	96	68	helped	help	VERB
ct-10840	96	69	support	support	VERB
ct-10840	96	70	our	our	PRON
ct-10840	96	71	other	other	ADJ
ct-10840	96	72	initial	initial	ADJ
ct-10840	96	73	clinical	clinical	ADJ
ct-10840	96	74	findings	finding	NOUN
ct-10840	96	75	suggestive	suggestive	ADJ
ct-10840	96	76	of	of	ADP
ct-10840	96	77	gct	gct	PROPN
ct-10840	96	78	and	and	CCONJ
ct-10840	96	79	confirm	confirm	VERB
ct-10840	96	80	that	that	SCONJ
ct-10840	96	81	a	a	DET
ct-10840	96	82	hormonally	hormonally	ADV
ct-10840	96	83	active	active	ADJ
ct-10840	96	84	tumor	tumor	NOUN
ct-10840	96	85	had	have	AUX
ct-10840	96	86	successfully	successfully	ADV
ct-10840	96	87	been	be	AUX
ct-10840	96	88	resected	resect	VERB
ct-10840	96	89	.	.	PUNCT
ct-10840	97	1	appearance	appearance	NOUN
ct-10840	97	2	of	of	ADP
ct-10840	97	3	ovary	ovary	NOUN
ct-10840	97	4	on	on	ADP
ct-10840	97	5	ultrasonography	ultrasonography	NOUN
ct-10840	97	6	with	with	ADP
ct-10840	97	7	the	the	DET
ct-10840	97	8	coinciding	coincide	VERB
ct-10840	97	9	lack	lack	NOUN
ct-10840	97	10	of	of	ADP
ct-10840	97	11	contralateral	contralateral	ADJ
ct-10840	97	12	ovarian	ovarian	ADJ
ct-10840	97	13	follicular	follicular	ADJ
ct-10840	97	14	activity	activity	NOUN
ct-10840	97	15	(	(	PUNCT
ct-10840	97	16	acquired	acquire	VERB
ct-10840	97	17	hypoplasia	hypoplasia	NOUN
ct-10840	97	18	and	and	CCONJ
ct-10840	97	19	suppression	suppression	NOUN
ct-10840	97	20	of	of	ADP
ct-10840	97	21	normal	normal	ADJ
ct-10840	97	22	positive	positive	ADJ
ct-10840	97	23	and	and	CCONJ
ct-10840	97	24	negative	negative	ADJ
ct-10840	97	25	feedback	feedback	NOUN
ct-10840	97	26	mechanism	mechanism	NOUN
ct-10840	97	27	of	of	ADP
ct-10840	97	28	cyclicity	cyclicity	NOUN
ct-10840	97	29	)	)	PUNCT
ct-10840	97	30	suggested	suggest	VERB
ct-10840	97	31	gct	gct	PROPN
ct-10840	97	32	;	;	PUNCT
ct-10840	97	33	typical	typical	ADJ
ct-10840	97	34	findings	finding	NOUN
ct-10840	97	35	in	in	ADP
ct-10840	97	36	other	other	ADJ
ct-10840	97	37	species	specie	NOUN
ct-10840	97	38	with	with	ADP
ct-10840	97	39	hormonally	hormonally	ADV
ct-10840	97	40	active	active	ADJ
ct-10840	97	41	gcts	gct	NOUN
ct-10840	97	42	as	as	ADP
ct-10840	97	43	in	in	ADP
ct-10840	97	44	mares.17,48	mares.17,48	NOUN
ct-10840	97	45	lack	lack	NOUN
ct-10840	97	46	of	of	ADP
ct-10840	97	47	follicular	follicular	ADJ
ct-10840	97	48	activity	activity	NOUN
ct-10840	97	49	by	by	ADP
ct-10840	97	50	the	the	DET
ct-10840	97	51	unaffected	unaffected	ADJ
ct-10840	97	52	ovary	ovary	NOUN
ct-10840	97	53	was	be	AUX
ct-10840	97	54	hypothesized	hypothesize	VERB
ct-10840	97	55	to	to	PART
ct-10840	97	56	be	be	AUX
ct-10840	97	57	the	the	DET
ct-10840	97	58	result	result	NOUN
ct-10840	97	59	of	of	ADP
ct-10840	97	60	negative	negative	ADJ
ct-10840	97	61	feedback	feedback	NOUN
ct-10840	97	62	due	due	ADP
ct-10840	97	63	to	to	ADP
ct-10840	97	64	elevated	elevate	VERB
ct-10840	97	65	inhibin	inhibin	ADJ
ct-10840	97	66	secretion	secretion	NOUN
ct-10840	97	67	by	by	ADP
ct-10840	97	68	the	the	DET
ct-10840	97	69	tumor	tumor	NOUN
ct-10840	97	70	,	,	PUNCT
ct-10840	97	71	causing	cause	VERB
ct-10840	97	72	suppression	suppression	NOUN
ct-10840	97	73	of	of	ADP
ct-10840	97	74	follicle	follicle	NOUN
ct-10840	97	75	-	-	PUNCT
ct-10840	97	76	stimulating	stimulate	VERB
ct-10840	97	77	hormone	hormone	NOUN
ct-10840	97	78	(	(	PUNCT
ct-10840	97	79	fsh).23,49	fsh).23,49	VERB
ct-10840	97	80	thus	thus	ADV
ct-10840	97	81	,	,	PUNCT
ct-10840	97	82	it	it	PRON
ct-10840	97	83	affects	affect	VERB
ct-10840	97	84	normal	normal	ADJ
ct-10840	97	85	follicle	follicle	NOUN
ct-10840	97	86	recruitment	recruitment	NOUN
ct-10840	97	87	,	,	PUNCT
ct-10840	97	88	deviation	deviation	NOUN
ct-10840	97	89	,	,	PUNCT
ct-10840	97	90	growth	growth	NOUN
ct-10840	97	91	,	,	PUNCT
ct-10840	97	92	and	and	CCONJ
ct-10840	97	93	ovulation	ovulation	NOUN
ct-10840	97	94	.	.	PUNCT
ct-10840	98	1	ongoing	ongoing	ADJ
ct-10840	98	2	suppression	suppression	NOUN
ct-10840	98	3	is	be	AUX
ct-10840	98	4	likely	likely	ADV
ct-10840	98	5	caused	cause	VERB
ct-10840	98	6	by	by	ADP
ct-10840	98	7	normal	normal	ADJ
ct-10840	98	8	ovary	ovary	NOUN
ct-10840	98	9	’s	’s	PART
ct-10840	98	10	acquired	acquire	VERB
ct-10840	98	11	hypoplasia	hypoplasia	NOUN
ct-10840	98	12	.	.	PUNCT
ct-10840	99	1	we	we	PRON
ct-10840	99	2	suspect	suspect	VERB
ct-10840	99	3	a	a	DET
ct-10840	99	4	similar	similar	ADJ
ct-10840	99	5	process	process	NOUN
ct-10840	99	6	was	be	AUX
ct-10840	99	7	occurring	occur	VERB
ct-10840	99	8	in	in	ADP
ct-10840	99	9	the	the	DET
ct-10840	99	10	present	present	ADJ
ct-10840	99	11	case	case	NOUN
ct-10840	99	12	,	,	PUNCT
ct-10840	99	13	though	though	SCONJ
ct-10840	99	14	data	datum	NOUN
ct-10840	99	15	collection	collection	NOUN
ct-10840	99	16	at	at	ADP
ct-10840	99	17	that	that	DET
ct-10840	99	18	stage	stage	NOUN
ct-10840	99	19	of	of	ADP
ct-10840	99	20	the	the	DET
ct-10840	99	21	investigation	investigation	NOUN
ct-10840	99	22	was	be	AUX
ct-10840	99	23	not	not	PART
ct-10840	99	24	a	a	DET
ct-10840	99	25	priority	priority	NOUN
ct-10840	99	26	due	due	ADP
ct-10840	99	27	to	to	ADP
ct-10840	99	28	dog	dog	NOUN
ct-10840	99	29	’s	’s	PART
ct-10840	99	30	clinical	clinical	ADJ
ct-10840	99	31	well	well	ADV
ct-10840	99	32	-	-	PUNCT
ct-10840	99	33	being	being	NOUN
ct-10840	99	34	.	.	PUNCT
ct-10840	100	1	however	however	ADV
ct-10840	100	2	,	,	PUNCT
ct-10840	100	3	further	further	ADJ
ct-10840	100	4	research	research	NOUN
ct-10840	100	5	is	be	AUX
ct-10840	100	6	still	still	ADV
ct-10840	100	7	required	require	VERB
ct-10840	100	8	to	to	PART
ct-10840	100	9	fully	fully	ADV
ct-10840	100	10	understand	understand	VERB
ct-10840	100	11	the	the	DET
ct-10840	100	12	pathogenesis	pathogenesis	NOUN
ct-10840	100	13	of	of	ADP
ct-10840	100	14	unaffected	unaffected	ADJ
ct-10840	100	15	ovary	ovary	NOUN
ct-10840	100	16	as	as	SCONJ
ct-10840	100	17	there	there	PRON
ct-10840	100	18	are	be	VERB
ct-10840	100	19	discrepancies	discrepancy	NOUN
ct-10840	100	20	in	in	ADP
ct-10840	100	21	literature	literature	NOUN
ct-10840	100	22	,	,	PUNCT
ct-10840	100	23	especially	especially	ADV
ct-10840	100	24	in	in	ADP
ct-10840	100	25	mares.17	mares.17	ADJ
ct-10840	100	26	reports	report	NOUN
ct-10840	100	27	confirmed	confirm	VERB
ct-10840	100	28	low	low	ADJ
ct-10840	100	29	and	and	CCONJ
ct-10840	100	30	no	no	DET
ct-10840	100	31	differences	difference	NOUN
ct-10840	100	32	in	in	ADP
ct-10840	100	33	fsh	fsh	ADJ
ct-10840	100	34	concentrations	concentration	NOUN
ct-10840	100	35	in	in	ADP
ct-10840	100	36	mares	mare	NOUN
ct-10840	100	37	with	with	ADP
ct-10840	100	38	gcts.49,50	gcts.49,50	NOUN
ct-10840	100	39	definitive	definitive	ADJ
ct-10840	100	40	diagnosis	diagnosis	NOUN
ct-10840	100	41	of	of	ADP
ct-10840	100	42	a	a	DET
ct-10840	100	43	gct	gct	PROPN
ct-10840	100	44	was	be	AUX
ct-10840	100	45	confirmed	confirm	VERB
ct-10840	100	46	by	by	ADP
ct-10840	100	47	histopathology	histopathology	NOUN
ct-10840	100	48	.	.	PUNCT
ct-10840	101	1	resection	resection	NOUN
ct-10840	101	2	of	of	ADP
ct-10840	101	3	part	part	NOUN
ct-10840	101	4	of	of	ADP
ct-10840	101	5	uterine	uterine	ADJ
ct-10840	101	6	horn	horn	NOUN
ct-10840	101	7	with	with	ADP
ct-10840	101	8	laparoscopic	laparoscopic	NOUN
ct-10840	101	9	laparotomy	laparotomy	NOUN
ct-10840	101	10	also	also	ADV
ct-10840	101	11	allowed	allow	VERB
ct-10840	101	12	confirmation	confirmation	NOUN
ct-10840	101	13	of	of	ADP
ct-10840	101	14	ceh	ceh	PROPN
ct-10840	101	15	.	.	PUNCT
ct-10840	102	1	this	this	DET
ct-10840	102	2	information	information	NOUN
ct-10840	102	3	allowed	allow	VERB
ct-10840	102	4	us	we	PRON
ct-10840	102	5	to	to	PART
ct-10840	102	6	give	give	VERB
ct-10840	102	7	the	the	DET
ct-10840	102	8	owner	owner	NOUN
ct-10840	102	9	a	a	DET
ct-10840	102	10	more	more	ADV
ct-10840	102	11	informed	informed	ADJ
ct-10840	102	12	prognosis	prognosis	NOUN
ct-10840	102	13	of	of	ADP
ct-10840	102	14	future	future	ADJ
ct-10840	102	15	fertility	fertility	NOUN
ct-10840	102	16	.	.	PUNCT
ct-10840	103	1	although	although	SCONJ
ct-10840	103	2	gct	gct	PROPN
ct-10840	103	3	,	,	PUNCT
ct-10840	103	4	in	in	ADP
ct-10840	103	5	this	this	DET
ct-10840	103	6	case	case	NOUN
ct-10840	103	7	,	,	PUNCT
ct-10840	103	8	was	be	AUX
ct-10840	103	9	easily	easily	ADV
ct-10840	103	10	identified	identify	VERB
ct-10840	103	11	by	by	ADP
ct-10840	103	12	our	our	PRON
ct-10840	103	13	pathologist	pathologist	NOUN
ct-10840	103	14	through	through	ADP
ct-10840	103	15	gross	gross	ADJ
ct-10840	103	16	and	and	CCONJ
ct-10840	103	17	histologic	histologic	ADJ
ct-10840	103	18	assessment	assessment	NOUN
ct-10840	103	19	,	,	PUNCT
ct-10840	103	20	it	it	PRON
ct-10840	103	21	is	be	AUX
ct-10840	103	22	important	important	ADJ
ct-10840	103	23	to	to	PART
ct-10840	103	24	note	note	VERB
ct-10840	103	25	that	that	SCONJ
ct-10840	103	26	cytological	cytological	ADJ
ct-10840	103	27	features	feature	NOUN
ct-10840	103	28	can	can	AUX
ct-10840	103	29	be	be	AUX
ct-10840	103	30	variable	variable	ADJ
ct-10840	103	31	regarding	regard	VERB
ct-10840	103	32	cellularity	cellularity	NOUN
ct-10840	103	33	and	and	CCONJ
ct-10840	103	34	mitotic	mitotic	ADJ
ct-10840	103	35	indices	index	NOUN
ct-10840	103	36	that	that	PRON
ct-10840	103	37	ultimately	ultimately	ADV
ct-10840	103	38	reflects	reflect	VERB
ct-10840	103	39	the	the	DET
ct-10840	103	40	wide	wide	ADJ
ct-10840	103	41	variability	variability	NOUN
ct-10840	103	42	in	in	ADP
ct-10840	103	43	the	the	DET
ct-10840	103	44	functionality	functionality	NOUN
ct-10840	103	45	of	of	ADP
ct-10840	103	46	gcts	gct	NOUN
ct-10840	103	47	across	across	ADP
ct-10840	103	48	species.20,51	species.20,51	NOUN
ct-10840	103	49	unilateral	unilateral	ADJ
ct-10840	103	50	ovariectomy	ovariectomy	NOUN
ct-10840	103	51	is	be	AUX
ct-10840	103	52	a	a	DET
ct-10840	103	53	standard	standard	ADJ
ct-10840	103	54	treatment	treatment	NOUN
ct-10840	103	55	option	option	NOUN
ct-10840	103	56	for	for	ADP
ct-10840	103	57	gcts	gct	NOUN
ct-10840	103	58	in	in	ADP
ct-10840	103	59	mares.52–54	mares.52–54	NOUN
ct-10840	103	60	however	however	ADV
ct-10840	103	61	,	,	PUNCT
ct-10840	103	62	to	to	ADP
ct-10840	103	63	authors	author	NOUN
ct-10840	103	64	’	'	PUNCT
ct-10840	103	65	knowledge	knowledge	NOUN
ct-10840	103	66	,	,	PUNCT
ct-10840	103	67	there	there	PRON
ct-10840	103	68	was	be	VERB
ct-10840	103	69	no	no	DET
ct-10840	103	70	reported	report	VERB
ct-10840	103	71	cases	case	NOUN
ct-10840	103	72	of	of	ADP
ct-10840	103	73	pregnancy	pregnancy	NOUN
ct-10840	103	74	after	after	ADP
ct-10840	103	75	unilateral	unilateral	ADJ
ct-10840	103	76	ovariectomy	ovariectomy	NOUN
ct-10840	103	77	via	via	ADP
ct-10840	103	78	laparoscopy	laparoscopy	NOUN
ct-10840	103	79	for	for	ADP
ct-10840	103	80	gct	gct	PROPN
ct-10840	103	81	treatment	treatment	NOUN
ct-10840	103	82	in	in	ADP
ct-10840	103	83	dogs	dog	NOUN
ct-10840	103	84	.	.	PUNCT
ct-10840	104	1	laparoscopic	laparoscopic	NOUN
ct-10840	104	2	approach	approach	NOUN
ct-10840	104	3	is	be	AUX
ct-10840	104	4	minimally	minimally	ADV
ct-10840	104	5	invasive	invasive	ADJ
ct-10840	104	6	and	and	CCONJ
ct-10840	104	7	has	have	VERB
ct-10840	104	8	a	a	DET
ct-10840	104	9	lower	low	ADJ
ct-10840	104	10	postoperative	postoperative	ADJ
ct-10840	104	11	complication	complication	NOUN
ct-10840	104	12	rate	rate	NOUN
ct-10840	104	13	and	and	CCONJ
ct-10840	104	14	a	a	DET
ct-10840	104	15	shorter	short	ADJ
ct-10840	104	16	recovery	recovery	NOUN
ct-10840	104	17	time	time	NOUN
ct-10840	104	18	than	than	SCONJ
ct-10840	104	19	traditional	traditional	ADJ
ct-10840	104	20	laparotomy	laparotomy	NOUN
ct-10840	104	21	methods.55	methods.55	VERB
ct-10840	104	22	a	a	DET
ct-10840	104	23	minimally	minimally	ADV
ct-10840	104	24	invasive	invasive	ADJ
ct-10840	104	25	surgery	surgery	NOUN
ct-10840	104	26	was	be	AUX
ct-10840	104	27	particularly	particularly	ADV
ct-10840	104	28	important	important	ADJ
ct-10840	104	29	in	in	ADP
ct-10840	104	30	this	this	DET
ct-10840	104	31	case	case	NOUN
ct-10840	104	32	,	,	PUNCT
ct-10840	104	33	as	as	SCONJ
ct-10840	104	34	the	the	DET
ct-10840	104	35	patient	patient	NOUN
ct-10840	104	36	had	have	VERB
ct-10840	104	37	hematological	hematological	ADJ
ct-10840	104	38	clinical	clinical	ADJ
ct-10840	104	39	signs	sign	NOUN
ct-10840	104	40	associated	associate	VERB
ct-10840	104	41	with	with	ADP
ct-10840	104	42	bone	bone	NOUN
ct-10840	104	43	marrow	marrow	NOUN
ct-10840	104	44	suppression	suppression	NOUN
ct-10840	104	45	due	due	ADP
ct-10840	104	46	to	to	ADP
ct-10840	104	47	prolonged	prolonged	ADJ
ct-10840	104	48	endogenous	endogenous	ADJ
ct-10840	104	49	estrogen	estrogen	NOUN
ct-10840	104	50	exposure	exposure	NOUN
ct-10840	104	51	caused	cause	VERB
ct-10840	104	52	by	by	ADP
ct-10840	104	53	gct	gct	PROPN
ct-10840	104	54	secretions	secretion	NOUN
ct-10840	104	55	.	.	PUNCT
ct-10840	105	1	although	although	SCONJ
ct-10840	105	2	the	the	DET
ct-10840	105	3	objective	objective	NOUN
ct-10840	105	4	of	of	ADP
ct-10840	105	5	our	our	PRON
ct-10840	105	6	treatment	treatment	NOUN
ct-10840	105	7	methodology	methodology	NOUN
ct-10840	105	8	was	be	AUX
ct-10840	105	9	aimed	aim	VERB
ct-10840	105	10	to	to	PART
ct-10840	105	11	preserve	preserve	VERB
ct-10840	105	12	dog	dog	NOUN
ct-10840	105	13	’s	’s	PART
ct-10840	105	14	reproductive	reproductive	ADJ
ct-10840	105	15	potential	potential	NOUN
ct-10840	105	16	,	,	PUNCT
ct-10840	105	17	there	there	PRON
ct-10840	105	18	were	be	VERB
ct-10840	105	19	several	several	ADJ
ct-10840	105	20	concerns	concern	NOUN
ct-10840	105	21	regarding	regard	VERB
ct-10840	105	22	reproductive	reproductive	ADJ
ct-10840	105	23	performance	performance	NOUN
ct-10840	105	24	after	after	ADP
ct-10840	105	25	surgery	surgery	NOUN
ct-10840	105	26	that	that	PRON
ct-10840	105	27	included	include	VERB
ct-10840	105	28	:	:	PUNCT
ct-10840	105	29	a	a	X
ct-10840	105	30	)	)	PUNCT
ct-10840	105	31	fewer	few	ADJ
ct-10840	105	32	oocytes	oocyte	NOUN
ct-10840	105	33	would	would	AUX
ct-10840	105	34	be	be	AUX
ct-10840	105	35	ovulated	ovulate	VERB
ct-10840	105	36	with	with	ADP
ct-10840	105	37	only	only	ADV
ct-10840	105	38	1	1	NUM
ct-10840	105	39	remaining	remain	VERB
ct-10840	105	40	ovary	ovary	NOUN
ct-10840	105	41	;	;	PUNCT
ct-10840	105	42	and	and	CCONJ
ct-10840	105	43	b	b	X
ct-10840	105	44	)	)	PUNCT
ct-10840	105	45	uterine	uterine	NOUN
ct-10840	105	46	ceh	ceh	PROPN
ct-10840	105	47	changes	change	NOUN
ct-10840	105	48	.	.	PUNCT
ct-10840	106	1	however	however	ADV
ct-10840	106	2	,	,	PUNCT
ct-10840	106	3	remaining	remaining	ADJ
ct-10840	106	4	ovary	ovary	NOUN
ct-10840	106	5	reported	report	VERB
ct-10840	106	6	to	to	PART
ct-10840	106	7	have	have	AUX
ct-10840	106	8	compensated	compensate	VERB
ct-10840	106	9	by	by	ADP
ct-10840	106	10	undergoing	undergo	VERB
ct-10840	106	11	hypertrophy	hypertrophy	NOUN
ct-10840	106	12	and	and	CCONJ
ct-10840	106	13	ovulated	ovulate	VERB
ct-10840	106	14	similar	similar	ADJ
ct-10840	106	15	number	number	NOUN
ct-10840	106	16	of	of	ADP
ct-10840	106	17	oocytes	oocyte	NOUN
ct-10840	106	18	despite	despite	SCONJ
ct-10840	106	19	contralateral	contralateral	ADJ
ct-10840	106	20	ovary	ovary	ADJ
ct-10840	106	21	removal.56	removal.56	NOUN
ct-10840	106	22	in	in	ADP
ct-10840	106	23	this	this	DET
ct-10840	106	24	case	case	NOUN
ct-10840	106	25	,	,	PUNCT
ct-10840	106	26	a	a	DET
ct-10840	106	27	possible	possible	ADJ
ct-10840	106	28	slight	slight	ADJ
ct-10840	106	29	figure	figure	NOUN
ct-10840	106	30	9	9	NUM
ct-10840	106	31	.	.	PUNCT
ct-10840	106	32	left	leave	VERB
ct-10840	106	33	lateral	lateral	ADJ
ct-10840	106	34	radiograph	radiograph	NOUN
ct-10840	106	35	(	(	PUNCT
ct-10840	106	36	note	note	NOUN
ct-10840	106	37	:	:	PUNCT
ct-10840	106	38	3	3	NUM
ct-10840	106	39	fetal	fetal	ADJ
ct-10840	106	40	skeletons	skeleton	NOUN
ct-10840	106	41	)	)	PUNCT
ct-10840	106	42	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	106	43	citation	citation	NOUN
ct-10840	106	44	:	:	PUNCT
ct-10840	106	45	clinical	clinical	ADJ
ct-10840	106	46	theriogenology	theriogenology	NOUN
ct-10840	106	47	2024	2024	NUM
ct-10840	106	48	,	,	PUNCT
ct-10840	106	49	16	16	NUM
ct-10840	106	50	,	,	PUNCT
ct-10840	106	51	10840	10840	NUM
ct-10840	106	52	,	,	PUNCT
ct-10840	106	53	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	106	54	7	7	NUM
ct-10840	106	55	compensatory	compensatory	ADJ
ct-10840	106	56	effect	effect	NOUN
ct-10840	106	57	was	be	AUX
ct-10840	106	58	appreciated	appreciate	VERB
ct-10840	106	59	with	with	ADP
ct-10840	106	60	5	5	NUM
ct-10840	106	61	amniotic	amniotic	ADJ
ct-10840	106	62	sacs	sac	NOUN
ct-10840	106	63	detected	detect	VERB
ct-10840	106	64	via	via	ADP
ct-10840	106	65	ultrasonography	ultrasonography	NOUN
ct-10840	106	66	on	on	ADP
ct-10840	106	67	day	day	NOUN
ct-10840	106	68	35	35	NUM
ct-10840	106	69	after	after	ADP
ct-10840	106	70	lh0	lh0	ADV
ct-10840	106	71	.	.	PUNCT
ct-10840	107	1	many	many	ADJ
ct-10840	107	2	ovarian	ovarian	ADJ
ct-10840	107	3	pathologies	pathology	NOUN
ct-10840	107	4	such	such	ADJ
ct-10840	107	5	as	as	ADP
ct-10840	107	6	gcts	gct	NOUN
ct-10840	107	7	and	and	CCONJ
ct-10840	107	8	ovarian	ovarian	ADJ
ct-10840	107	9	cysts	cyst	NOUN
ct-10840	107	10	,	,	PUNCT
ct-10840	107	11	especially	especially	ADV
ct-10840	107	12	those	those	DET
ct-10840	107	13	processes	process	NOUN
ct-10840	107	14	that	that	PRON
ct-10840	107	15	are	be	AUX
ct-10840	107	16	hormonally	hormonally	ADV
ct-10840	107	17	active	active	ADJ
ct-10840	107	18	,	,	PUNCT
ct-10840	107	19	are	be	AUX
ct-10840	107	20	associated	associate	VERB
ct-10840	107	21	with	with	ADP
ct-10840	107	22	concurrent	concurrent	ADJ
ct-10840	107	23	uterine	uterine	ADJ
ct-10840	107	24	changes	change	NOUN
ct-10840	107	25	,	,	PUNCT
ct-10840	107	26	specifically	specifically	ADV
ct-10840	107	27	,	,	PUNCT
ct-10840	107	28	ceh.9,36	ceh.9,36	NOUN
ct-10840	107	29	repeated	repeat	VERB
ct-10840	107	30	exposure	exposure	NOUN
ct-10840	107	31	of	of	ADP
ct-10840	107	32	the	the	DET
ct-10840	107	33	endometrium	endometrium	NOUN
ct-10840	107	34	to	to	ADP
ct-10840	107	35	cycles	cycle	NOUN
ct-10840	107	36	of	of	ADP
ct-10840	107	37	estrogen	estrogen	NOUN
ct-10840	107	38	priming	priming	NOUN
ct-10840	107	39	followed	follow	VERB
ct-10840	107	40	by	by	ADP
ct-10840	107	41	2	2	NUM
ct-10840	107	42	months	month	NOUN
ct-10840	107	43	of	of	ADP
ct-10840	107	44	luteal	luteal	ADJ
ct-10840	107	45	/	/	SYM
ct-10840	107	46	nonpregnant	nonpregnant	NOUN
ct-10840	107	47	progesterone	progesterone	NOUN
ct-10840	107	48	is	be	AUX
ct-10840	107	49	a	a	DET
ct-10840	107	50	prominent	prominent	ADJ
ct-10840	107	51	contributing	contribute	VERB
ct-10840	107	52	factor	factor	NOUN
ct-10840	107	53	to	to	ADP
ct-10840	107	54	the	the	DET
ct-10840	107	55	development	development	NOUN
ct-10840	107	56	of	of	ADP
ct-10840	107	57	ceh	ceh	PROPN
ct-10840	107	58	especially	especially	ADV
ct-10840	107	59	in	in	ADP
ct-10840	107	60	older	old	ADJ
ct-10840	107	61	,	,	PUNCT
ct-10840	107	62	maiden	maiden	ADJ
ct-10840	107	63	dogs.6,57–59	dogs.6,57–59	PROPN
ct-10840	107	64	ceh	ceh	PROPN
ct-10840	107	65	is	be	AUX
ct-10840	107	66	associated	associate	VERB
ct-10840	107	67	with	with	ADP
ct-10840	107	68	infertility	infertility	NOUN
ct-10840	107	69	in	in	ADP
ct-10840	107	70	dogs	dog	NOUN
ct-10840	107	71	as	as	SCONJ
ct-10840	107	72	the	the	DET
ct-10840	107	73	changes	change	NOUN
ct-10840	107	74	induced	induce	VERB
ct-10840	107	75	can	can	AUX
ct-10840	107	76	result	result	VERB
ct-10840	107	77	in	in	ADP
ct-10840	107	78	interference	interference	NOUN
ct-10840	107	79	with	with	ADP
ct-10840	107	80	embryonic	embryonic	ADJ
ct-10840	107	81	attachment	attachment	NOUN
ct-10840	107	82	and	and	CCONJ
ct-10840	107	83	increase	increase	VERB
ct-10840	107	84	the	the	DET
ct-10840	107	85	risk	risk	NOUN
ct-10840	107	86	of	of	ADP
ct-10840	107	87	pyometra.54–58	pyometra.54–58	ADJ
ct-10840	107	88	endometrial	endometrial	ADJ
ct-10840	107	89	changes	change	NOUN
ct-10840	107	90	associated	associate	VERB
ct-10840	107	91	with	with	ADP
ct-10840	107	92	ceh	ceh	PROPN
ct-10840	107	93	include	include	VERB
ct-10840	107	94	hyperplasia	hyperplasia	NOUN
ct-10840	107	95	of	of	ADP
ct-10840	107	96	endometrial	endometrial	ADJ
ct-10840	107	97	glands	gland	NOUN
ct-10840	107	98	that	that	PRON
ct-10840	107	99	become	become	VERB
ct-10840	107	100	enlarged	enlarged	ADJ
ct-10840	107	101	and	and	CCONJ
ct-10840	107	102	cystic	cystic	ADJ
ct-10840	107	103	in	in	ADP
ct-10840	107	104	appearance	appearance	NOUN
ct-10840	107	105	and	and	CCONJ
ct-10840	107	106	result	result	NOUN
ct-10840	107	107	in	in	ADP
ct-10840	107	108	delayed	delay	VERB
ct-10840	107	109	uterine	uterine	ADJ
ct-10840	107	110	clearance	clearance	NOUN
ct-10840	107	111	of	of	ADP
ct-10840	107	112	ascending	ascend	VERB
ct-10840	107	113	bacteria	bacteria	NOUN
ct-10840	107	114	during	during	ADP
ct-10840	107	115	estrus	estrus	NOUN
ct-10840	107	116	and	and	CCONJ
ct-10840	107	117	dead	dead	ADJ
ct-10840	107	118	sperm	sperm	NOUN
ct-10840	107	119	and	and	CCONJ
ct-10840	107	120	extenders	extender	NOUN
ct-10840	107	121	after	after	ADP
ct-10840	107	122	intrauterine	intrauterine	ADJ
ct-10840	107	123	insemination	insemination	NOUN
ct-10840	107	124	.	.	PUNCT
ct-10840	108	1	furthermore	furthermore	ADV
ct-10840	108	2	,	,	PUNCT
ct-10840	108	3	the	the	DET
ct-10840	108	4	cystic	cystic	ADJ
ct-10840	108	5	endometrial	endometrial	ADJ
ct-10840	108	6	environment	environment	NOUN
ct-10840	108	7	is	be	AUX
ct-10840	108	8	not	not	PART
ct-10840	108	9	conducive	conducive	ADJ
ct-10840	108	10	to	to	ADP
ct-10840	108	11	implantation	implantation	NOUN
ct-10840	108	12	and	and	CCONJ
ct-10840	108	13	normal	normal	ADJ
ct-10840	108	14	placentation	placentation	NOUN
ct-10840	108	15	required	require	VERB
ct-10840	108	16	for	for	ADP
ct-10840	108	17	embryonic	embryonic	ADJ
ct-10840	108	18	development.18,59	development.18,59	NOUN
ct-10840	108	19	in	in	ADP
ct-10840	108	20	mares	mare	NOUN
ct-10840	108	21	,	,	PUNCT
ct-10840	108	22	endometrial	endometrial	ADJ
ct-10840	108	23	biopsies	biopsy	NOUN
ct-10840	108	24	are	be	AUX
ct-10840	108	25	graded	grade	VERB
ct-10840	108	26	using	use	VERB
ct-10840	108	27	the	the	DET
ct-10840	108	28	kenny	kenny	PROPN
ct-10840	108	29	-	-	PUNCT
ct-10840	108	30	doig	doig	PROPN
ct-10840	108	31	system	system	NOUN
ct-10840	108	32	.	.	PUNCT
ct-10840	109	1	this	this	PRON
ct-10840	109	2	helps	help	VERB
ct-10840	109	3	predict	predict	VERB
ct-10840	109	4	the	the	DET
ct-10840	109	5	potential	potential	ADJ
ct-10840	109	6	likelihood	likelihood	NOUN
ct-10840	109	7	of	of	ADP
ct-10840	109	8	pregnancy	pregnancy	NOUN
ct-10840	109	9	,	,	PUNCT
ct-10840	109	10	maintenance	maintenance	NOUN
ct-10840	109	11	of	of	ADP
ct-10840	109	12	pregnancy	pregnancy	NOUN
ct-10840	109	13	and	and	CCONJ
ct-10840	109	14	ultimately	ultimately	ADV
ct-10840	109	15	,	,	PUNCT
ct-10840	109	16	delivery	delivery	NOUN
ct-10840	109	17	of	of	ADP
ct-10840	109	18	a	a	DET
ct-10840	109	19	live	live	ADJ
ct-10840	109	20	foal	foal	NOUN
ct-10840	109	21	based	base	VERB
ct-10840	109	22	on	on	ADP
ct-10840	109	23	microscopic	microscopic	ADJ
ct-10840	109	24	features	feature	NOUN
ct-10840	109	25	of	of	ADP
ct-10840	109	26	luminal	luminal	ADJ
ct-10840	109	27	and	and	CCONJ
ct-10840	109	28	glandular	glandular	ADJ
ct-10840	109	29	epithelium	epithelium	NOUN
ct-10840	109	30	,	,	PUNCT
ct-10840	109	31	stratum	stratum	NOUN
ct-10840	109	32	compactum	compactum	NOUN
ct-10840	109	33	and	and	CCONJ
ct-10840	109	34	spongiosum.60	spongiosum.60	NOUN
ct-10840	109	35	unfortunately	unfortunately	ADV
ct-10840	109	36	,	,	PUNCT
ct-10840	109	37	we	we	PRON
ct-10840	109	38	currently	currently	ADV
ct-10840	109	39	do	do	AUX
ct-10840	109	40	not	not	PART
ct-10840	109	41	have	have	VERB
ct-10840	109	42	biopsy	biopsy	NOUN
ct-10840	109	43	‘	'	PUNCT
ct-10840	109	44	grades	grade	NOUN
ct-10840	109	45	’	'	PUNCT
ct-10840	109	46	for	for	ADP
ct-10840	109	47	dogs	dog	NOUN
ct-10840	109	48	;	;	PUNCT
ct-10840	109	49	furthermore	furthermore	ADV
ct-10840	109	50	,	,	PUNCT
ct-10840	109	51	biopsies	biopsy	NOUN
ct-10840	109	52	are	be	AUX
ct-10840	109	53	obtained	obtain	VERB
ct-10840	109	54	in	in	ADP
ct-10840	109	55	diestrus	diestrus	NOUN
ct-10840	109	56	(	(	PUNCT
ct-10840	109	57	time	time	NOUN
ct-10840	109	58	for	for	SCONJ
ct-10840	109	59	it	it	PRON
ct-10840	109	60	to	to	PART
ct-10840	109	61	be	be	AUX
ct-10840	109	62	diagnostic	diagnostic	ADJ
ct-10840	109	63	)	)	PUNCT
ct-10840	109	64	can	can	AUX
ct-10840	109	65	result	result	VERB
ct-10840	109	66	in	in	ADP
ct-10840	109	67	pyometra	pyometra	NOUN
ct-10840	109	68	and	and	CCONJ
ct-10840	109	69	loss	loss	NOUN
ct-10840	109	70	of	of	ADP
ct-10840	109	71	an	an	DET
ct-10840	109	72	estrous	estrous	ADJ
ct-10840	109	73	cycle	cycle	NOUN
ct-10840	109	74	due	due	ADP
ct-10840	109	75	to	to	ADP
ct-10840	109	76	the	the	DET
ct-10840	109	77	unique	unique	ADJ
ct-10840	109	78	feature	feature	NOUN
ct-10840	109	79	in	in	ADP
ct-10840	109	80	dogs	dog	NOUN
ct-10840	109	81	(	(	PUNCT
ct-10840	109	82	no	no	DET
ct-10840	109	83	luteolytic	luteolytic	ADJ
ct-10840	109	84	mechanism	mechanism	NOUN
ct-10840	109	85	if	if	SCONJ
ct-10840	109	86	not	not	PART
ct-10840	109	87	pregnant	pregnant	ADJ
ct-10840	109	88	)	)	PUNCT
ct-10840	109	89	.	.	PUNCT
ct-10840	110	1	larger	large	ADJ
ct-10840	110	2	studies	study	NOUN
ct-10840	110	3	are	be	AUX
ct-10840	110	4	required	require	VERB
ct-10840	110	5	in	in	ADP
ct-10840	110	6	dogs	dog	NOUN
ct-10840	110	7	for	for	ADP
ct-10840	110	8	the	the	DET
ct-10840	110	9	development	development	NOUN
ct-10840	110	10	of	of	ADP
ct-10840	110	11	cytological	cytological	ADJ
ct-10840	110	12	and	and	CCONJ
ct-10840	110	13	endometrial	endometrial	ADJ
ct-10840	110	14	ultrasonographic	ultrasonographic	NOUN
ct-10840	110	15	grading	grade	VERB
ct-10840	110	16	parameters	parameter	NOUN
ct-10840	110	17	of	of	ADP
ct-10840	110	18	ceh	ceh	PROPN
ct-10840	110	19	that	that	PRON
ct-10840	110	20	are	be	AUX
ct-10840	110	21	correlated	correlate	VERB
ct-10840	110	22	to	to	ADP
ct-10840	110	23	reproductive	reproductive	ADJ
ct-10840	110	24	performance	performance	NOUN
ct-10840	110	25	and	and	CCONJ
ct-10840	110	26	allow	allow	VERB
ct-10840	110	27	prediction	prediction	NOUN
ct-10840	110	28	of	of	ADP
ct-10840	110	29	the	the	DET
ct-10840	110	30	likelihood	likelihood	NOUN
ct-10840	110	31	of	of	ADP
ct-10840	110	32	fertility	fertility	NOUN
ct-10840	110	33	/	/	SYM
ct-10840	110	34	pregnancy	pregnancy	NOUN
ct-10840	110	35	success	success	NOUN
ct-10840	110	36	after	after	ADP
ct-10840	110	37	breeding	breed	VERB
ct-10840	110	38	,	,	PUNCT
ct-10840	110	39	as	as	ADP
ct-10840	110	40	in	in	ADP
ct-10840	110	41	mares	mare	NOUN
ct-10840	110	42	.	.	PUNCT
ct-10840	111	1	in	in	ADP
ct-10840	111	2	this	this	DET
ct-10840	111	3	case	case	NOUN
ct-10840	111	4	,	,	PUNCT
ct-10840	111	5	despite	despite	SCONJ
ct-10840	111	6	dog	dog	NOUN
ct-10840	111	7	’s	’s	PART
ct-10840	111	8	young	young	ADJ
ct-10840	111	9	age	age	NOUN
ct-10840	111	10	,	,	PUNCT
ct-10840	111	11	excessive	excessive	ADJ
ct-10840	111	12	exposure	exposure	NOUN
ct-10840	111	13	of	of	ADP
ct-10840	111	14	endometrium	endometrium	NOUN
ct-10840	111	15	to	to	ADP
ct-10840	111	16	estrogen	estrogen	NOUN
ct-10840	111	17	and	and	CCONJ
ct-10840	111	18	progesterone	progesterone	NOUN
ct-10840	111	19	produced	produce	VERB
ct-10840	111	20	by	by	ADP
ct-10840	111	21	gct	gct	PROPN
ct-10840	111	22	resulted	result	VERB
ct-10840	111	23	in	in	ADP
ct-10840	111	24	ceh	ceh	PROPN
ct-10840	111	25	development	development	NOUN
ct-10840	111	26	and	and	CCONJ
ct-10840	111	27	was	be	AUX
ct-10840	111	28	most	most	ADV
ct-10840	111	29	likely	likely	ADJ
ct-10840	111	30	the	the	DET
ct-10840	111	31	underlying	underlying	ADJ
ct-10840	111	32	cause	cause	NOUN
ct-10840	111	33	of	of	ADP
ct-10840	111	34	embryonic	embryonic	ADJ
ct-10840	111	35	and	and	CCONJ
ct-10840	111	36	fetal	fetal	ADJ
ct-10840	111	37	loss	loss	NOUN
ct-10840	111	38	(	(	PUNCT
ct-10840	111	39	detected	detect	VERB
ct-10840	111	40	via	via	ADP
ct-10840	111	41	ultrasonography	ultrasonography	NOUN
ct-10840	111	42	and	and	CCONJ
ct-10840	111	43	radiography	radiography	NOUN
ct-10840	111	44	)	)	PUNCT
ct-10840	111	45	.	.	PUNCT
ct-10840	112	1	ultrasonography	ultrasonography	NOUN
ct-10840	112	2	is	be	AUX
ct-10840	112	3	valuable	valuable	ADJ
ct-10840	112	4	not	not	PART
ct-10840	112	5	only	only	ADV
ct-10840	112	6	to	to	PART
ct-10840	112	7	assist	assist	VERB
ct-10840	112	8	in	in	ADP
ct-10840	112	9	gct	gct	PROPN
ct-10840	112	10	diagnosis	diagnosis	NOUN
ct-10840	112	11	but	but	CCONJ
ct-10840	112	12	also	also	ADV
ct-10840	112	13	to	to	PART
ct-10840	112	14	assess	assess	VERB
ct-10840	112	15	any	any	DET
ct-10840	112	16	damage	damage	NOUN
ct-10840	112	17	to	to	ADP
ct-10840	112	18	uterus	uterus	NOUN
ct-10840	112	19	caused	cause	VERB
ct-10840	112	20	by	by	ADP
ct-10840	112	21	chronic	chronic	ADJ
ct-10840	112	22	sex	sex	NOUN
ct-10840	112	23	steroid	steroid	NOUN
ct-10840	112	24	hormone	hormone	NOUN
ct-10840	112	25	exposure	exposure	NOUN
ct-10840	112	26	.	.	PUNCT
ct-10840	113	1	it	it	PRON
ct-10840	113	2	is	be	AUX
ct-10840	113	3	important	important	ADJ
ct-10840	113	4	to	to	PART
ct-10840	113	5	take	take	VERB
ct-10840	113	6	into	into	ADP
ct-10840	113	7	consideration	consideration	NOUN
ct-10840	113	8	uterine	uterine	ADJ
ct-10840	113	9	‘	'	PUNCT
ct-10840	113	10	health	health	NOUN
ct-10840	113	11	’	'	PUNCT
ct-10840	113	12	when	when	SCONJ
ct-10840	113	13	offering	offer	VERB
ct-10840	113	14	treatment	treatment	NOUN
ct-10840	113	15	that	that	PRON
ct-10840	113	16	also	also	ADV
ct-10840	113	17	preserves	preserve	VERB
ct-10840	113	18	fertility	fertility	NOUN
ct-10840	113	19	.	.	PUNCT
ct-10840	114	1	loss	loss	NOUN
ct-10840	114	2	of	of	ADP
ct-10840	114	3	at	at	ADP
ct-10840	114	4	-	-	PUNCT
ct-10840	114	5	term	term	NOUN
ct-10840	114	6	fetuses	fetus	NOUN
ct-10840	114	7	in	in	ADP
ct-10840	114	8	this	this	DET
ct-10840	114	9	case	case	NOUN
ct-10840	114	10	is	be	AUX
ct-10840	114	11	unknown	unknown	ADJ
ct-10840	114	12	.	.	PUNCT
ct-10840	115	1	despite	despite	SCONJ
ct-10840	115	2	loss	loss	NOUN
ct-10840	115	3	of	of	ADP
ct-10840	115	4	pups	pup	NOUN
ct-10840	115	5	during	during	ADP
ct-10840	115	6	whelping	whelp	VERB
ct-10840	115	7	,	,	PUNCT
ct-10840	115	8	this	this	DET
ct-10840	115	9	case	case	NOUN
ct-10840	115	10	had	have	VERB
ct-10840	115	11	positive	positive	ADJ
ct-10840	115	12	outcomes	outcome	NOUN
ct-10840	115	13	(	(	PUNCT
ct-10840	115	14	successful	successful	ADJ
ct-10840	115	15	treatment	treatment	NOUN
ct-10840	115	16	of	of	ADP
ct-10840	115	17	gct	gct	PROPN
ct-10840	115	18	and	and	CCONJ
ct-10840	115	19	maintenance	maintenance	NOUN
ct-10840	115	20	of	of	ADP
ct-10840	115	21	breeding	breed	VERB
ct-10840	115	22	potential	potential	NOUN
ct-10840	115	23	on	on	ADP
ct-10840	115	24	a	a	DET
ct-10840	115	25	young	young	ADJ
ct-10840	115	26	and	and	CCONJ
ct-10840	115	27	genetically	genetically	ADV
ct-10840	115	28	valuable	valuable	ADJ
ct-10840	115	29	female	female	ADJ
ct-10840	115	30	dog	dog	NOUN
ct-10840	115	31	)	)	PUNCT
ct-10840	115	32	.	.	PUNCT
ct-10840	116	1	we	we	PRON
ct-10840	116	2	discussed	discuss	VERB
ct-10840	116	3	diagnostic	diagnostic	ADJ
ct-10840	116	4	tools	tool	NOUN
ct-10840	116	5	and	and	CCONJ
ct-10840	116	6	surgical	surgical	ADJ
ct-10840	116	7	techniques	technique	NOUN
ct-10840	116	8	that	that	PRON
ct-10840	116	9	are	be	AUX
ct-10840	116	10	available	available	ADJ
ct-10840	116	11	to	to	PART
ct-10840	116	12	facilitate	facilitate	VERB
ct-10840	116	13	the	the	DET
ct-10840	116	14	diagnosis	diagnosis	NOUN
ct-10840	116	15	and	and	CCONJ
ct-10840	116	16	treatment	treatment	NOUN
ct-10840	116	17	of	of	ADP
ct-10840	116	18	gcts	gct	NOUN
ct-10840	116	19	to	to	PART
ct-10840	116	20	allow	allow	VERB
ct-10840	116	21	a	a	DET
ct-10840	116	22	genetically	genetically	ADV
ct-10840	116	23	valuable	valuable	ADJ
ct-10840	116	24	young	young	ADJ
ct-10840	116	25	dog	dog	NOUN
ct-10840	116	26	to	to	PART
ct-10840	116	27	maintain	maintain	VERB
ct-10840	116	28	fertility	fertility	NOUN
ct-10840	116	29	potential	potential	NOUN
ct-10840	116	30	.	.	PUNCT
ct-10840	117	1	we	we	PRON
ct-10840	117	2	also	also	ADV
ct-10840	117	3	highlighted	highlight	VERB
ct-10840	117	4	the	the	DET
ct-10840	117	5	importance	importance	NOUN
ct-10840	117	6	of	of	ADP
ct-10840	117	7	assessing	assess	VERB
ct-10840	117	8	secondary	secondary	ADJ
ct-10840	117	9	uterine	uterine	ADJ
ct-10840	117	10	changes	change	NOUN
ct-10840	117	11	caused	cause	VERB
ct-10840	117	12	by	by	ADP
ct-10840	117	13	excessive	excessive	ADJ
ct-10840	117	14	and	and	CCONJ
ct-10840	117	15	constant	constant	ADJ
ct-10840	117	16	hormone	hormone	NOUN
ct-10840	117	17	stimulation	stimulation	NOUN
ct-10840	117	18	to	to	PART
ct-10840	117	19	predict	predict	VERB
ct-10840	117	20	future	future	ADJ
ct-10840	117	21	fertility	fertility	NOUN
ct-10840	117	22	after	after	ADP
ct-10840	117	23	removal	removal	NOUN
ct-10840	117	24	of	of	ADP
ct-10840	117	25	gct	gct	PROPN
ct-10840	117	26	.	.	PUNCT
ct-10840	118	1	learning	learn	VERB
ct-10840	118	2	points	point	NOUN
ct-10840	118	3	•	•	NUM
ct-10840	118	4	gct	gct	PROPN
ct-10840	118	5	in	in	ADP
ct-10840	118	6	dogs	dog	NOUN
ct-10840	118	7	(	(	PUNCT
ct-10840	118	8	unlike	unlike	ADP
ct-10840	118	9	mares	mare	NOUN
ct-10840	118	10	)	)	PUNCT
ct-10840	118	11	have	have	VERB
ct-10840	118	12	a	a	DET
ct-10840	118	13	wide	wide	ADJ
ct-10840	118	14	range	range	NOUN
ct-10840	118	15	of	of	ADP
ct-10840	118	16	undefined	undefined	ADJ
ct-10840	118	17	ultrasonographic	ultrasonographic	NOUN
ct-10840	118	18	appearances	appearance	VERB
ct-10840	118	19	•	•	NUM
ct-10840	118	20	measurement	measurement	NOUN
ct-10840	118	21	of	of	ADP
ct-10840	118	22	serum	serum	NOUN
ct-10840	118	23	concentrations	concentration	NOUN
ct-10840	118	24	of	of	ADP
ct-10840	118	25	inhibin	inhibin	PROPN
ct-10840	118	26	b	b	PROPN
ct-10840	118	27	and	and	CCONJ
ct-10840	118	28	amh	amh	PROPN
ct-10840	118	29	are	be	AUX
ct-10840	118	30	a	a	DET
ct-10840	118	31	beneficial	beneficial	ADJ
ct-10840	118	32	additional	additional	ADJ
ct-10840	118	33	diagnostic	diagnostic	ADJ
ct-10840	118	34	tool	tool	NOUN
ct-10840	118	35	to	to	PART
ct-10840	118	36	diagnose	diagnose	VERB
ct-10840	118	37	canine	canine	PROPN
ct-10840	118	38	gct	gct	PROPN
ct-10840	118	39	cases	case	NOUN
ct-10840	118	40	before	before	ADP
ct-10840	118	41	surgical	surgical	ADJ
ct-10840	118	42	intervention	intervention	NOUN
ct-10840	118	43	•	•	SCONJ
ct-10840	118	44	unilateral	unilateral	ADJ
ct-10840	118	45	ovariectomy	ovariectomy	NOUN
ct-10840	118	46	is	be	AUX
ct-10840	118	47	an	an	DET
ct-10840	118	48	effective	effective	ADJ
ct-10840	118	49	treatment	treatment	NOUN
ct-10840	118	50	for	for	ADP
ct-10840	118	51	young	young	ADJ
ct-10840	118	52	,	,	PUNCT
ct-10840	118	53	genetically	genetically	ADV
ct-10840	118	54	valuable	valuable	ADJ
ct-10840	118	55	dogs	dog	NOUN
ct-10840	118	56	,	,	PUNCT
ct-10840	118	57	to	to	PART
ct-10840	118	58	maintain	maintain	VERB
ct-10840	118	59	their	their	PRON
ct-10840	118	60	potential	potential	ADJ
ct-10840	118	61	fertility	fertility	NOUN
ct-10840	118	62	•	•	NOUN
ct-10840	118	63	uterine	uterine	ADJ
ct-10840	118	64	changes	change	NOUN
ct-10840	118	65	(	(	PUNCT
ct-10840	118	66	e.g.	e.g.	ADV
ct-10840	118	67	ceh	ceh	NOUN
ct-10840	118	68	)	)	PUNCT
ct-10840	118	69	caused	cause	VERB
ct-10840	118	70	by	by	ADP
ct-10840	118	71	prolonged	prolonged	ADJ
ct-10840	118	72	exposure	exposure	NOUN
ct-10840	118	73	to	to	ADP
ct-10840	118	74	estrogen	estrogen	NOUN
ct-10840	118	75	and	and	CCONJ
ct-10840	118	76	progesterone	progesterone	NOUN
ct-10840	118	77	exposure	exposure	NOUN
ct-10840	118	78	in	in	ADP
ct-10840	118	79	gcts	gct	NOUN
ct-10840	118	80	,	,	PUNCT
ct-10840	118	81	should	should	AUX
ct-10840	118	82	be	be	AUX
ct-10840	118	83	considered	consider	VERB
ct-10840	118	84	when	when	SCONJ
ct-10840	118	85	selecting	select	VERB
ct-10840	118	86	dogs	dog	NOUN
ct-10840	118	87	for	for	ADP
ct-10840	118	88	future	future	ADJ
ct-10840	118	89	breeding	breeding	NOUN
ct-10840	118	90	acknowledgement	acknowledgement	NOUN
ct-10840	118	91	authors	author	NOUN
ct-10840	118	92	thank	thank	VERB
ct-10840	118	93	kelsey	kelsey	PROPN
ct-10840	118	94	tofany	tofany	PROPN
ct-10840	118	95	for	for	ADP
ct-10840	118	96	help	help	NOUN
ct-10840	118	97	in	in	ADP
ct-10840	118	98	sample	sample	NOUN
ct-10840	118	99	collection	collection	NOUN
ct-10840	118	100	and	and	CCONJ
ct-10840	118	101	submission	submission	NOUN
ct-10840	118	102	to	to	ADP
ct-10840	118	103	laboratories	laboratory	NOUN
ct-10840	118	104	and	and	CCONJ
ct-10840	118	105	the	the	DET
ct-10840	118	106	colorado	colorado	PROPN
ct-10840	118	107	state	state	PROPN
ct-10840	118	108	university	university	PROPN
ct-10840	118	109	surgery	surgery	NOUN
ct-10840	118	110	department	department	NOUN
ct-10840	118	111	for	for	ADP
ct-10840	118	112	their	their	PRON
ct-10840	118	113	assistance	assistance	NOUN
ct-10840	118	114	in	in	ADP
ct-10840	118	115	this	this	DET
ct-10840	118	116	case	case	NOUN
ct-10840	118	117	.	.	PUNCT
ct-10840	119	1	conflict	conflict	NOUN
ct-10840	119	2	of	of	ADP
ct-10840	119	3	interest	interest	NOUN
ct-10840	119	4	and	and	CCONJ
ct-10840	119	5	funding	funding	PROPN
ct-10840	119	6	alexandria	alexandria	PROPN
ct-10840	119	7	horner	horner	PROPN
ct-10840	119	8	’s	’s	PART
ct-10840	119	9	residency	residency	NOUN
ct-10840	119	10	program	program	NOUN
ct-10840	119	11	is	be	AUX
ct-10840	119	12	funded	fund	VERB
ct-10840	119	13	by	by	ADP
ct-10840	119	14	the	the	DET
ct-10840	119	15	american	american	ADJ
ct-10840	119	16	kennel	kennel	PROPN
ct-10840	119	17	club	club	NOUN
ct-10840	119	18	and	and	CCONJ
ct-10840	119	19	the	the	DET
ct-10840	119	20	canine	canine	PROPN
ct-10840	119	21	health	health	PROPN
ct-10840	119	22	foundation	foundation	PROPN
ct-10840	119	23	.	.	PUNCT
ct-10840	120	1	authors	author	NOUN
ct-10840	120	2	report	report	VERB
ct-10840	120	3	no	no	DET
ct-10840	120	4	conflict	conflict	NOUN
ct-10840	120	5	of	of	ADP
ct-10840	120	6	interest	interest	NOUN
ct-10840	120	7	.	.	PUNCT
ct-10840	121	1	author	author	NOUN
ct-10840	121	2	contributions	contribution	NOUN
ct-10840	121	3	ah	ah	INTJ
ct-10840	121	4	wrote	write	VERB
ct-10840	121	5	most	most	ADJ
ct-10840	121	6	of	of	ADP
ct-10840	121	7	the	the	DET
ct-10840	121	8	manuscript	manuscript	NOUN
ct-10840	121	9	,	,	PUNCT
ct-10840	121	10	and	and	CCONJ
ct-10840	121	11	mh	mh	PROPN
ct-10840	121	12	performed	perform	VERB
ct-10840	121	13	and	and	CCONJ
ct-10840	121	14	wrote	write	VERB
ct-10840	121	15	pathology	pathology	NOUN
ct-10840	121	16	and	and	CCONJ
ct-10840	121	17	histopathology	histopathology	NOUN
ct-10840	121	18	analysis	analysis	NOUN
ct-10840	121	19	/	/	SYM
ct-10840	121	20	descriptions	description	NOUN
ct-10840	121	21	.	.	PUNCT
ct-10840	122	1	fh	fh	PROPN
ct-10840	122	2	,	,	PUNCT
ct-10840	122	3	js	js	ADJ
ct-10840	122	4	,	,	PUNCT
ct-10840	122	5	and	and	CCONJ
ct-10840	122	6	gb	gb	PRON
ct-10840	122	7	reviewed	review	VERB
ct-10840	122	8	it	it	PRON
ct-10840	122	9	,	,	PUNCT
ct-10840	122	10	and	and	CCONJ
ct-10840	122	11	all	all	DET
ct-10840	122	12	authors	author	NOUN
ct-10840	122	13	approved	approve	VERB
ct-10840	122	14	the	the	DET
ct-10840	122	15	submission	submission	NOUN
ct-10840	122	16	.	.	PUNCT
ct-10840	123	1	references	reference	NOUN
ct-10840	123	2	1	1	NUM
ct-10840	123	3	.	.	PUNCT
ct-10840	124	1	marchant	marchant	PROPN
ct-10840	124	2	j	j	PROPN
ct-10840	124	3	:	:	PUNCT
ct-10840	124	4	animal	animal	NOUN
ct-10840	124	5	models	model	NOUN
ct-10840	124	6	for	for	ADP
ct-10840	124	7	tumours	tumour	NOUN
ct-10840	124	8	of	of	ADP
ct-10840	124	9	the	the	DET
ct-10840	124	10	ovary	ovary	NOUN
ct-10840	124	11	and	and	CCONJ
ct-10840	124	12	uterus	uterus	NOUN
ct-10840	124	13	.	.	PUNCT
ct-10840	125	1	in	in	ADP
ct-10840	125	2	:	:	PUNCT
ct-10840	125	3	cotchin	cotchin	PROPN
ct-10840	125	4	e	e	PROPN
ct-10840	125	5	,	,	PUNCT
ct-10840	125	6	marchant	marchant	PROPN
ct-10840	125	7	j	j	PROPN
ct-10840	125	8	:	:	PUNCT
ct-10840	125	9	editors	editor	NOUN
ct-10840	125	10	.	.	PUNCT
ct-10840	126	1	animal	animal	NOUN
ct-10840	126	2	tumours	tumour	NOUN
ct-10840	126	3	of	of	ADP
ct-10840	126	4	the	the	DET
ct-10840	126	5	female	female	ADJ
ct-10840	126	6	reproductive	reproductive	ADJ
ct-10840	126	7	tract	tract	NOUN
ct-10840	126	8	spontaneous	spontaneous	ADJ
ct-10840	126	9	and	and	CCONJ
ct-10840	126	10	experimental	experimental	ADJ
ct-10840	126	11	.	.	PUNCT
ct-10840	127	1	1st	1st	PROPN
ct-10840	127	2	edition	edition	PROPN
ct-10840	127	3	,	,	PUNCT
ct-10840	127	4	new	new	PROPN
ct-10840	127	5	york	york	PROPN
ct-10840	127	6	;	;	PUNCT
ct-10840	127	7	springer	springer	NOUN
ct-10840	127	8	-	-	PUNCT
ct-10840	127	9	verlag	verlag	PROPN
ct-10840	127	10	:	:	PUNCT
ct-10840	127	11	1977	1977	NUM
ct-10840	127	12	.	.	PUNCT
ct-10840	128	1	p.	p.	NOUN
ct-10840	128	2	1	1	NUM
ct-10840	128	3	-	-	SYM
ct-10840	128	4	10	10	NUM
ct-10840	128	5	.	.	PUNCT
ct-10840	129	1	2	2	X
ct-10840	129	2	.	.	X
ct-10840	129	3	dow	dow	PROPN
ct-10840	129	4	c	c	PROPN
ct-10840	129	5	:	:	PUNCT
ct-10840	129	6	ovarian	ovarian	ADJ
ct-10840	129	7	abnormalities	abnormality	NOUN
ct-10840	129	8	in	in	ADP
ct-10840	129	9	the	the	DET
ct-10840	129	10	bitch	bitch	NOUN
ct-10840	129	11	.	.	PUNCT
ct-10840	130	1	j	j	PROPN
ct-10840	130	2	comp	comp	PROPN
ct-10840	130	3	path	path	NOUN
ct-10840	130	4	1960;70:59	1960;70:59	PROPN
ct-10840	130	5	-	-	SYM
ct-10840	130	6	69	69	NUM
ct-10840	130	7	.	.	PUNCT
ct-10840	131	1	https://doi.org/10.1016/s0368-1742(60)80005-7	https://doi.org/10.1016/s0368-1742(60)80005-7	NOUN
ct-10840	132	1	3	3	X
ct-10840	132	2	.	.	PUNCT
ct-10840	132	3	hayes	hayes	PROPN
ct-10840	132	4	a	a	PROPN
ct-10840	132	5	,	,	PUNCT
ct-10840	132	6	harvey	harvey	NOUN
ct-10840	132	7	h	h	NOUN
ct-10840	132	8	:	:	PUNCT
ct-10840	132	9	treatment	treatment	NOUN
ct-10840	132	10	of	of	ADP
ct-10840	132	11	metastatic	metastatic	ADJ
ct-10840	132	12	granulosa	granulosa	NOUN
ct-10840	132	13	cell	cell	NOUN
ct-10840	132	14	tumour	tumour	NOUN
ct-10840	132	15	in	in	ADP
ct-10840	132	16	a	a	DET
ct-10840	132	17	dog	dog	NOUN
ct-10840	132	18	.	.	PUNCT
ct-10840	133	1	j	j	PROPN
ct-10840	133	2	am	be	AUX
ct-10840	133	3	vet	vet	NOUN
ct-10840	133	4	med	med	ADJ
ct-10840	133	5	assoc	assoc	PROPN
ct-10840	133	6	1979;174:1304	1979;174:1304	PROPN
ct-10840	133	7	-	-	PUNCT
ct-10840	133	8	1306	1306	NUM
ct-10840	133	9	.	.	PUNCT
ct-10840	134	1	4	4	X
ct-10840	134	2	.	.	X
ct-10840	134	3	jergens	jergen	NOUN
ct-10840	134	4	a	a	PRON
ct-10840	134	5	,	,	PUNCT
ct-10840	134	6	shaw	shaw	PROPN
ct-10840	134	7	d	d	PROPN
ct-10840	134	8	:	:	PUNCT
ct-10840	134	9	tumours	tumour	NOUN
ct-10840	134	10	of	of	ADP
ct-10840	134	11	the	the	DET
ct-10840	134	12	canine	canine	NOUN
ct-10840	134	13	ovary	ovary	NOUN
ct-10840	134	14	.	.	PUNCT
ct-10840	135	1	compend	compend	VERB
ct-10840	135	2	contin	contin	PROPN
ct-10840	135	3	educ	educ	PROPN
ct-10840	135	4	vet	vet	NOUN
ct-10840	135	5	1987;9:489	1987;9:489	NOUN
ct-10840	135	6	-	-	PUNCT
ct-10840	135	7	495	495	NUM
ct-10840	135	8	.	.	PUNCT
ct-10840	136	1	5	5	X
ct-10840	136	2	.	.	X
ct-10840	136	3	mcentee	mcentee	NOUN
ct-10840	136	4	k.	k.	PROPN
ct-10840	137	1	ovarian	ovarian	ADJ
ct-10840	137	2	neoplasms	neoplasm	NOUN
ct-10840	137	3	.	.	PUNCT
ct-10840	138	1	in	in	ADP
ct-10840	138	2	:	:	PUNCT
ct-10840	138	3	mcentee	mcentee	NOUN
ct-10840	138	4	k	k	NOUN
ct-10840	138	5	:	:	PUNCT
ct-10840	138	6	editor	editor	NOUN
ct-10840	138	7	.	.	PUNCT
ct-10840	139	1	reproductive	reproductive	ADJ
ct-10840	139	2	pathology	pathology	NOUN
ct-10840	139	3	of	of	ADP
ct-10840	139	4	domestic	domestic	ADJ
ct-10840	139	5	mammals	mammal	NOUN
ct-10840	139	6	.	.	PUNCT
ct-10840	140	1	1st	1st	PROPN
ct-10840	140	2	edition	edition	PROPN
ct-10840	140	3	,	,	PUNCT
ct-10840	140	4	san	san	PROPN
ct-10840	140	5	diego	diego	PROPN
ct-10840	140	6	;	;	PUNCT
ct-10840	140	7	academic	academic	ADJ
ct-10840	140	8	press	press	NOUN
ct-10840	140	9	:	:	PUNCT
ct-10840	140	10	1990	1990	NUM
ct-10840	140	11	.	.	PUNCT
ct-10840	141	1	p.	p.	NOUN
ct-10840	141	2	69	69	NUM
ct-10840	141	3	-	-	SYM
ct-10840	141	4	93	93	NUM
ct-10840	141	5	.	.	PUNCT
ct-10840	142	1	6	6	NUM
ct-10840	142	2	.	.	X
ct-10840	142	3	troisi	troisi	NOUN
ct-10840	142	4	a	a	X
ct-10840	142	5	,	,	PUNCT
ct-10840	142	6	orlandi	orlandi	PROPN
ct-10840	142	7	r	r	NOUN
ct-10840	142	8	,	,	PUNCT
ct-10840	142	9	vallesi	vallesi	NOUN
ct-10840	142	10	e	e	PROPN
ct-10840	142	11	,	,	PUNCT
ct-10840	142	12	et	et	PROPN
ct-10840	142	13	al	al	PROPN
ct-10840	142	14	:	:	PUNCT
ct-10840	142	15	clinical	clinical	ADJ
ct-10840	142	16	and	and	CCONJ
ct-10840	142	17	ultrasonographic	ultrasonographic	ADJ
ct-10840	142	18	findings	finding	NOUN
ct-10840	142	19	of	of	ADP
ct-10840	142	20	ovarian	ovarian	ADJ
ct-10840	142	21	tumours	tumour	NOUN
ct-10840	142	22	in	in	ADP
ct-10840	142	23	bitches	bitch	NOUN
ct-10840	142	24	:	:	PUNCT
ct-10840	142	25	a	a	DET
ct-10840	142	26	retrospective	retrospective	ADJ
ct-10840	142	27	study	study	NOUN
ct-10840	142	28	.	.	PUNCT
ct-10840	143	1	theriogenology	theriogenology	NOUN
ct-10840	143	2	2023;210:227	2023;210:227	PROPN
ct-10840	143	3	-	-	SYM
ct-10840	143	4	233	233	NUM
ct-10840	143	5	.	.	PUNCT
ct-10840	144	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ct-10840	144	2	.	.	PUNCT
ct-10840	145	1	theriogenology.2023.07.020	theriogenology.2023.07.020	ADP
ct-10840	145	2	7	7	NUM
ct-10840	145	3	.	.	PUNCT
ct-10840	145	4	jeffcoate	jeffcoate	PROPN
ct-10840	146	1	i	i	PRON
ct-10840	146	2	:	:	PUNCT
ct-10840	146	3	identification	identification	NOUN
ct-10840	146	4	of	of	ADP
ct-10840	146	5	spayed	spay	VERB
ct-10840	146	6	bitches	bitch	NOUN
ct-10840	146	7	.	.	PUNCT
ct-10840	147	1	vet	vet	NOUN
ct-10840	147	2	rec	rec	NOUN
ct-10840	147	3	1991;12:58	1991;12:58	NUM
ct-10840	147	4	.	.	PUNCT
ct-10840	148	1	https://doi.org/10.1136/vr.129.3.58-b	https://doi.org/10.1136/vr.129.3.58-b	PROPN
ct-10840	148	2	8	8	X
ct-10840	148	3	.	.	PUNCT
ct-10840	149	1	feldman	feldman	PROPN
ct-10840	149	2	e	e	PROPN
ct-10840	149	3	,	,	PUNCT
ct-10840	149	4	nelson	nelson	PROPN
ct-10840	149	5	r	r	PROPN
ct-10840	149	6	:	:	PUNCT
ct-10840	149	7	ovarian	ovarian	ADJ
ct-10840	149	8	tumours	tumours	NOUN
ct-10840	149	9	.	.	PUNCT
ct-10840	150	1	in	in	ADP
ct-10840	150	2	:	:	PUNCT
ct-10840	150	3	feldman	feldman	PROPN
ct-10840	150	4	e	e	PROPN
ct-10840	150	5	,	,	PUNCT
ct-10840	150	6	nelson	nelson	PROPN
ct-10840	150	7	r	r	NOUN
ct-10840	150	8	:	:	PUNCT
ct-10840	150	9	editors	editor	NOUN
ct-10840	150	10	.	.	PUNCT
ct-10840	151	1	canine	canine	NOUN
ct-10840	151	2	and	and	CCONJ
ct-10840	151	3	feline	feline	ADJ
ct-10840	151	4	endocrinology	endocrinology	NOUN
ct-10840	151	5	and	and	CCONJ
ct-10840	151	6	reproduction	reproduction	NOUN
ct-10840	151	7	.	.	PUNCT
ct-10840	152	1	3rd	3rd	ADJ
ct-10840	152	2	edition	edition	NOUN
ct-10840	152	3	,	,	PUNCT
ct-10840	152	4	philadelphia	philadelphia	PROPN
ct-10840	152	5	;	;	PUNCT
ct-10840	152	6	saunders	saunder	NOUN
ct-10840	152	7	:	:	PUNCT
ct-10840	152	8	2004	2004	NUM
ct-10840	152	9	.	.	PUNCT
ct-10840	153	1	p.	p.	NOUN
ct-10840	153	2	892	892	NUM
ct-10840	153	3	.	.	PUNCT
ct-10840	154	1	9	9	X
ct-10840	154	2	.	.	X
ct-10840	155	1	schaefers	schaefer	NOUN
ct-10840	155	2	-	-	PUNCT
ct-10840	155	3	okkens	okken	NOUN
ct-10840	155	4	a	a	DET
ct-10840	155	5	,	,	PUNCT
ct-10840	155	6	kooistra	kooistra	ADJ
ct-10840	155	7	h	h	NOUN
ct-10840	155	8	:	:	PUNCT
ct-10840	155	9	ovaries	ovary	NOUN
ct-10840	155	10	.	.	PUNCT
ct-10840	156	1	in	in	ADP
ct-10840	156	2	:	:	PUNCT
ct-10840	156	3	rijnberk	rijnberk	VERB
ct-10840	156	4	a	a	DET
ct-10840	156	5	,	,	PUNCT
ct-10840	156	6	kooistra	kooistra	PROPN
ct-10840	156	7	h	h	NOUN
ct-10840	156	8	:	:	PUNCT
ct-10840	156	9	editors	editor	NOUN
ct-10840	156	10	.	.	PUNCT
ct-10840	157	1	clinical	clinical	ADJ
ct-10840	157	2	endocrinology	endocrinology	NOUN
ct-10840	157	3	of	of	ADP
ct-10840	157	4	dogs	dog	NOUN
ct-10840	157	5	and	and	CCONJ
ct-10840	157	6	cats	cat	NOUN
ct-10840	157	7	,	,	PUNCT
ct-10840	157	8	2nd	2nd	PROPN
ct-10840	157	9	edition	edition	NOUN
ct-10840	157	10	,	,	PUNCT
ct-10840	157	11	hannover	hannover	PROPN
ct-10840	157	12	;	;	PUNCT
ct-10840	157	13	schlutersche	schlutersche	NOUN
ct-10840	157	14	verlagsgesellschaft	verlagsgesellschaft	NOUN
ct-10840	157	15	:	:	PUNCT
ct-10840	157	16	2010	2010	NUM
ct-10840	157	17	.	.	PUNCT
ct-10840	158	1	p.	p.	NOUN
ct-10840	158	2	203	203	NUM
ct-10840	158	3	-	-	SYM
ct-10840	158	4	234	234	NUM
ct-10840	158	5	.	.	PUNCT
ct-10840	158	6	10	10	NUM
ct-10840	158	7	.	.	PUNCT
ct-10840	159	1	malm	malm	PROPN
ct-10840	159	2	c	c	PROPN
ct-10840	159	3	,	,	PUNCT
ct-10840	159	4	ferreira	ferreira	PROPN
ct-10840	159	5	h	h	PROPN
ct-10840	159	6	,	,	PUNCT
ct-10840	159	7	nascimento	nascimento	PROPN
ct-10840	159	8	e	e	PROPN
ct-10840	159	9	,	,	PUNCT
ct-10840	159	10	et	et	PROPN
ct-10840	159	11	al	al	PROPN
ct-10840	159	12	:	:	PUNCT
ct-10840	159	13	clinical	clinical	ADJ
ct-10840	159	14	and	and	CCONJ
ct-10840	159	15	histopathological	histopathological	ADJ
ct-10840	159	16	survey	survey	NOUN
ct-10840	159	17	of	of	ADP
ct-10840	159	18	ovarian	ovarian	ADJ
ct-10840	159	19	and	and	CCONJ
ct-10840	159	20	uterine	uterine	ADJ
ct-10840	159	21	disorders	disorder	NOUN
ct-10840	159	22	in	in	ADP
ct-10840	159	23	ovariohysterectomized	ovariohysterectomized	ADJ
ct-10840	159	24	bitches	bitch	NOUN
ct-10840	159	25	.	.	PUNCT
ct-10840	160	1	i	i	PRON
ct-10840	160	2	–	–	PUNCT
ct-10840	160	3	granulosa	granulosa	NOUN
ct-10840	160	4	cell	cell	NOUN
ct-10840	160	5	tumours	tumour	VERB
ct-10840	160	6	.	.	PUNCT
ct-10840	161	1	arq	arq	PROPN
ct-10840	161	2	bras	bras	PROPN
ct-10840	161	3	de	de	X
ct-10840	161	4	med	med	PROPN
ct-10840	161	5	vet	vet	NOUN
ct-10840	161	6	zoo	zoo	NOUN
ct-10840	161	7	1994;46:13	1994;46:13	NUM
ct-10840	161	8	-	-	SYM
ct-10840	161	9	18	18	NUM
ct-10840	161	10	.	.	NOUN
ct-10840	161	11	11	11	NUM
ct-10840	161	12	.	.	X
ct-10840	162	1	mccandlish	mccandlish	PROPN
ct-10840	162	2	i	i	PROPN
ct-10840	162	3	,	,	PUNCT
ct-10840	162	4	munro	munro	PROPN
ct-10840	162	5	c	c	PROPN
ct-10840	162	6	,	,	PUNCT
ct-10840	162	7	breeze	breeze	ADJ
ct-10840	162	8	r	r	NOUN
ct-10840	162	9	,	,	PUNCT
ct-10840	162	10	et	et	PROPN
ct-10840	162	11	al	al	PROPN
ct-10840	162	12	:	:	PUNCT
ct-10840	162	13	hormone	hormone	NOUN
ct-10840	162	14	producing	produce	VERB
ct-10840	162	15	ovarian	ovarian	ADJ
ct-10840	162	16	tumours	tumour	NOUN
ct-10840	162	17	in	in	ADP
ct-10840	162	18	the	the	DET
ct-10840	162	19	dog	dog	NOUN
ct-10840	162	20	.	.	PUNCT
ct-10840	163	1	vet	vet	NOUN
ct-10840	163	2	rec	rec	X
ct-10840	163	3	1979;105:9	1979;105:9	PROPN
ct-10840	163	4	-	-	SYM
ct-10840	163	5	11	11	NUM
ct-10840	163	6	.	.	PUNCT
ct-10840	164	1	https://doi	https://doi	PROPN
ct-10840	164	2	.	.	PUNCT
ct-10840	165	1	org/10.1136	org/10.1136	NOUN
ct-10840	165	2	/	/	SYM
ct-10840	165	3	vr.105.1.9	vr.105.1.9	PROPN
ct-10840	165	4	12	12	NUM
ct-10840	165	5	.	.	PUNCT
ct-10840	166	1	johnston	johnston	PROPN
ct-10840	166	2	s	s	PROPN
ct-10840	166	3	,	,	PUNCT
ct-10840	166	4	kustritz	kustritz	PROPN
ct-10840	166	5	m	m	PROPN
ct-10840	166	6	,	,	PUNCT
ct-10840	166	7	olson	olson	NOUN
ct-10840	166	8	p	p	NOUN
ct-10840	166	9	:	:	PUNCT
ct-10840	166	10	clinical	clinical	ADJ
ct-10840	166	11	approach	approach	NOUN
ct-10840	166	12	to	to	ADP
ct-10840	166	13	infertility	infertility	NOUN
ct-10840	166	14	in	in	ADP
ct-10840	166	15	the	the	DET
ct-10840	166	16	bitch	bitch	NOUN
ct-10840	166	17	.	.	PUNCT
ct-10840	167	1	in	in	ADP
ct-10840	167	2	:	:	PUNCT
ct-10840	167	3	johnston	johnston	PROPN
ct-10840	167	4	s	s	PROPN
ct-10840	167	5	,	,	PUNCT
ct-10840	167	6	kustritz	kustritz	PROPN
ct-10840	167	7	m	m	PROPN
ct-10840	167	8	,	,	PUNCT
ct-10840	167	9	olson	olson	NOUN
ct-10840	167	10	p	p	NOUN
ct-10840	167	11	:	:	PUNCT
ct-10840	167	12	editor	editor	NOUN
ct-10840	167	13	.	.	PUNCT
ct-10840	168	1	canine	canine	VERB
ct-10840	168	2	and	and	CCONJ
ct-10840	168	3	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	168	4	https://doi.org/10.1016/s0368-1742(60)80005-7	https://doi.org/10.1016/s0368-1742(60)80005-7	PROPN
ct-10840	168	5	https://doi.org/10.1016/j.theriogenology.2023.07.020	https://doi.org/10.1016/j.theriogenology.2023.07.020	VERB
ct-10840	168	6	https://doi.org/10.1016/j.theriogenology.2023.07.020	https://doi.org/10.1016/j.theriogenology.2023.07.020	VERB
ct-10840	168	7	https://doi.org/10.1136/vr.129.3.58-b	https://doi.org/10.1136/vr.129.3.58-b	PRON
ct-10840	169	1	https://doi.org/10.1136/vr.105.1.9	https://doi.org/10.1136/vr.105.1.9	VERB
ct-10840	169	2	https://doi.org/10.1136/vr.105.1.9	https://doi.org/10.1136/vr.105.1.9	ADJ
ct-10840	169	3	8	8	NUM
ct-10840	169	4	citation	citation	NOUN
ct-10840	169	5	:	:	PUNCT
ct-10840	169	6	clinical	clinical	ADJ
ct-10840	169	7	theriogenology	theriogenology	NOUN
ct-10840	169	8	2024	2024	NUM
ct-10840	169	9	,	,	PUNCT
ct-10840	169	10	16	16	NUM
ct-10840	169	11	,	,	PUNCT
ct-10840	169	12	10840	10840	NUM
ct-10840	169	13	,	,	PUNCT
ct-10840	169	14	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	169	15	feline	feline	PROPN
ct-10840	169	16	theriogenology	theriogenology	PROPN
ct-10840	169	17	.	.	PUNCT
ct-10840	170	1	1st	1st	PROPN
ct-10840	170	2	edition	edition	PROPN
ct-10840	170	3	,	,	PUNCT
ct-10840	170	4	philadelphia	philadelphia	PROPN
ct-10840	170	5	;	;	PUNCT
ct-10840	170	6	saunders	saunder	NOUN
ct-10840	170	7	:	:	PUNCT
ct-10840	170	8	2001	2001	NUM
ct-10840	170	9	.	.	PUNCT
ct-10840	171	1	p.	p.	NOUN
ct-10840	171	2	262	262	NUM
ct-10840	172	1	-	-	SYM
ct-10840	172	2	264	264	NUM
ct-10840	172	3	.	.	NOUN
ct-10840	172	4	13	13	NUM
ct-10840	172	5	.	.	X
ct-10840	173	1	pluhar	pluhar	VERB
ct-10840	173	2	g	g	PROPN
ct-10840	173	3	,	,	PUNCT
ct-10840	173	4	memon	memon	PROPN
ct-10840	173	5	m	m	PROPN
ct-10840	173	6	,	,	PUNCT
ct-10840	173	7	wheaton	wheaton	PROPN
ct-10840	173	8	l	l	PROPN
ct-10840	173	9	:	:	PUNCT
ct-10840	173	10	granulosa	granulosa	NOUN
ct-10840	173	11	cell	cell	NOUN
ct-10840	173	12	tumour	tumour	NOUN
ct-10840	173	13	in	in	ADP
ct-10840	173	14	an	an	DET
ct-10840	173	15	ovariohysterectomized	ovariohysterectomized	ADJ
ct-10840	173	16	dog	dog	NOUN
ct-10840	173	17	.	.	PUNCT
ct-10840	174	1	j	j	PROPN
ct-10840	174	2	am	be	AUX
ct-10840	174	3	vet	vet	NOUN
ct-10840	174	4	med	med	ADJ
ct-10840	174	5	assoc	assoc	NOUN
ct-10840	174	6	1995;207:10631065	1995;207:10631065	NUM
ct-10840	174	7	.	.	PUNCT
ct-10840	175	1	https://doi.org/10.2460/javma.1995.207.08.1063	https://doi.org/10.2460/javma.1995.207.08.1063	NUM
ct-10840	175	2	14	14	NUM
ct-10840	175	3	.	.	PUNCT
ct-10840	176	1	sivacolundhu	sivacolundhu	NOUN
ct-10840	176	2	r	r	NOUN
ct-10840	176	3	,	,	PUNCT
ct-10840	176	4	o’hara	o’hara	PROPN
ct-10840	176	5	a	a	PRON
ct-10840	176	6	,	,	PUNCT
ct-10840	176	7	read	read	VERB
ct-10840	176	8	r	r	NOUN
ct-10840	176	9	:	:	PUNCT
ct-10840	176	10	granulosa	granulosa	NOUN
ct-10840	176	11	cell	cell	NOUN
ct-10840	176	12	tumour	tumour	NOUN
ct-10840	176	13	in	in	ADP
ct-10840	176	14	two	two	NUM
ct-10840	176	15	spayed	spay	VERB
ct-10840	176	16	bitches	bitch	NOUN
ct-10840	176	17	.	.	PUNCT
ct-10840	177	1	aust	aust	PROPN
ct-10840	177	2	vet	vet	PROPN
ct-10840	177	3	j	j	PROPN
ct-10840	177	4	2001;79:173	2001;79:173	NUM
ct-10840	177	5	-	-	PROPN
ct-10840	177	6	176	176	NUM
ct-10840	177	7	.	.	PUNCT
ct-10840	178	1	https://doi	https://doi	PROPN
ct-10840	178	2	.	.	PUNCT
ct-10840	178	3	org/10.1111	org/10.1111	PROPN
ct-10840	178	4	/	/	SYM
ct-10840	178	5	j.1751	j.1751	NOUN
ct-10840	178	6	-	-	PUNCT
ct-10840	178	7	0813.2001.tb14571.x	0813.2001.tb14571.x	NOUN
ct-10840	178	8	15	15	NUM
ct-10840	178	9	.	.	PUNCT
ct-10840	179	1	mcentee	mcentee	NOUN
ct-10840	179	2	m	m	PROPN
ct-10840	179	3	:	:	PUNCT
ct-10840	179	4	reproductive	reproductive	ADJ
ct-10840	179	5	oncology	oncology	NOUN
ct-10840	179	6	.	.	PUNCT
ct-10840	180	1	clin	clin	PROPN
ct-10840	180	2	tech	tech	PROPN
ct-10840	180	3	small	small	ADJ
ct-10840	180	4	anim	anim	NOUN
ct-10840	180	5	pract	pract	NOUN
ct-10840	180	6	2002;17:133	2002;17:133	PROPN
ct-10840	180	7	-	-	SYM
ct-10840	180	8	149	149	NUM
ct-10840	180	9	.	.	PUNCT
ct-10840	181	1	https://doi.org/10.1053/svms.2002.34642	https://doi.org/10.1053/svms.2002.34642	PROPN
ct-10840	181	2	16	16	NUM
ct-10840	181	3	.	.	PUNCT
ct-10840	182	1	sontas	sontas	PROPN
ct-10840	182	2	h	h	PROPN
ct-10840	182	3	,	,	PUNCT
ct-10840	182	4	dokuzeylu	dokuzeylu	PROPN
ct-10840	182	5	b	b	PROPN
ct-10840	182	6	,	,	PUNCT
ct-10840	182	7	turna	turna	ADJ
ct-10840	182	8	o	o	NOUN
ct-10840	182	9	,	,	PUNCT
ct-10840	182	10	et	et	PROPN
ct-10840	182	11	al	al	PROPN
ct-10840	182	12	:	:	PUNCT
ct-10840	182	13	estrogen	estrogen	NOUN
ct-10840	182	14	-	-	PUNCT
ct-10840	182	15	induced	induce	VERB
ct-10840	182	16	myelotoxicity	myelotoxicity	NOUN
ct-10840	182	17	in	in	ADP
ct-10840	182	18	dogs	dog	NOUN
ct-10840	182	19	:	:	PUNCT
ct-10840	182	20	a	a	DET
ct-10840	182	21	review	review	NOUN
ct-10840	182	22	.	.	PUNCT
ct-10840	183	1	can	can	AUX
ct-10840	183	2	vet	vet	VERB
ct-10840	183	3	j	j	PROPN
ct-10840	183	4	2009;50	2009;50	NUM
ct-10840	183	5	:	:	PUNCT
ct-10840	183	6	1054	1054	NUM
ct-10840	183	7	-	-	SYM
ct-10840	183	8	1058	1058	NUM
ct-10840	183	9	.	.	PUNCT
ct-10840	184	1	17	17	NUM
ct-10840	184	2	.	.	PUNCT
ct-10840	185	1	ball	ball	PROPN
ct-10840	185	2	b	b	PROPN
ct-10840	185	3	,	,	PUNCT
ct-10840	185	4	conley	conley	PROPN
ct-10840	185	5	a	a	PROPN
ct-10840	185	6	,	,	PUNCT
ct-10840	185	7	maclaughlin	maclaughlin	PROPN
ct-10840	185	8	d	d	PROPN
ct-10840	185	9	,	,	PUNCT
ct-10840	185	10	et	et	PROPN
ct-10840	185	11	al	al	PROPN
ct-10840	185	12	:	:	PUNCT
ct-10840	185	13	expression	expression	NOUN
ct-10840	185	14	of	of	ADP
ct-10840	185	15	anti	anti	ADJ
ct-10840	185	16	-	-	ADJ
ct-10840	185	17	mullerian	mullerian	ADJ
ct-10840	185	18	hormone	hormone	NOUN
ct-10840	185	19	(	(	PUNCT
ct-10840	185	20	amh	amh	PROPN
ct-10840	185	21	)	)	PUNCT
ct-10840	185	22	in	in	ADP
ct-10840	185	23	equine	equine	NOUN
ct-10840	185	24	granulosa	granulosa	NOUN
ct-10840	185	25	-	-	PUNCT
ct-10840	185	26	cell	cell	NOUN
ct-10840	185	27	tumours	tumour	NOUN
ct-10840	185	28	and	and	CCONJ
ct-10840	185	29	in	in	ADP
ct-10840	185	30	normal	normal	ADJ
ct-10840	185	31	equine	equine	NOUN
ct-10840	185	32	ovaries	ovary	NOUN
ct-10840	185	33	.	.	PUNCT
ct-10840	186	1	theriogenology	theriogenology	NOUN
ct-10840	186	2	2008;70:968	2008;70:968	PROPN
ct-10840	186	3	-	-	SYM
ct-10840	186	4	977	977	NUM
ct-10840	186	5	.	.	PUNCT
ct-10840	186	6	https://doi.org/10.1016/j.theriogenology.2008.05.059	https://doi.org/10.1016/j.theriogenology.2008.05.059	PROPN
ct-10840	186	7	18	18	NUM
ct-10840	186	8	.	.	PUNCT
ct-10840	187	1	fontbonne	fontbonne	PROPN
ct-10840	187	2	a	a	DET
ct-10840	187	3	:	:	PUNCT
ct-10840	187	4	causes	cause	NOUN
ct-10840	187	5	of	of	ADP
ct-10840	187	6	pregnancy	pregnancy	NOUN
ct-10840	187	7	arrest	arrest	NOUN
ct-10840	187	8	in	in	ADP
ct-10840	187	9	the	the	DET
ct-10840	187	10	canine	canine	NOUN
ct-10840	187	11	species	specie	NOUN
ct-10840	187	12	.	.	PUNCT
ct-10840	188	1	reprod	reprod	PROPN
ct-10840	188	2	domest	domest	PROPN
ct-10840	188	3	anim	anim	PROPN
ct-10840	188	4	2023;58:72	2023;58:72	PROPN
ct-10840	188	5	-	-	SYM
ct-10840	188	6	83	83	NUM
ct-10840	188	7	.	.	PUNCT
ct-10840	189	1	https://doi.org/10.1111/	https://doi.org/10.1111/	PROPN
ct-10840	189	2	rda.14407	rda.14407	SYM
ct-10840	189	3	19	19	NUM
ct-10840	189	4	.	.	PUNCT
ct-10840	190	1	verstegen	verstegen	PROPN
ct-10840	190	2	j	j	PROPN
ct-10840	190	3	,	,	PUNCT
ct-10840	190	4	dhaliwal	dhaliwal	PROPN
ct-10840	190	5	g	g	PROPN
ct-10840	190	6	,	,	PUNCT
ct-10840	190	7	verstegen	verstegen	NOUN
ct-10840	190	8	-	-	PUNCT
ct-10840	190	9	onclin	onclin	NOUN
ct-10840	190	10	k	k	NOUN
ct-10840	190	11	:	:	PUNCT
ct-10840	190	12	canine	canine	NOUN
ct-10840	190	13	and	and	CCONJ
ct-10840	190	14	feline	feline	ADJ
ct-10840	190	15	pregnancy	pregnancy	NOUN
ct-10840	190	16	loss	loss	NOUN
ct-10840	190	17	due	due	ADP
ct-10840	190	18	to	to	ADP
ct-10840	190	19	viral	viral	ADJ
ct-10840	190	20	and	and	CCONJ
ct-10840	190	21	non	non	ADJ
ct-10840	190	22	-	-	ADJ
ct-10840	190	23	infectious	infectious	ADJ
ct-10840	190	24	causes	cause	NOUN
ct-10840	190	25	:	:	PUNCT
ct-10840	190	26	a	a	DET
ct-10840	190	27	review	review	NOUN
ct-10840	190	28	.	.	PUNCT
ct-10840	191	1	theriogenology	theriogenology	NOUN
ct-10840	191	2	2008;70:304	2008;70:304	PROPN
ct-10840	191	3	-	-	SYM
ct-10840	191	4	319	319	NUM
ct-10840	191	5	.	.	PUNCT
ct-10840	192	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ct-10840	192	2	.	.	PUNCT
ct-10840	193	1	theriogenology.2008.05.035	theriogenology.2008.05.035	VERB
ct-10840	194	1	20	20	NUM
ct-10840	194	2	.	.	PUNCT
ct-10840	195	1	renaudin	renaudin	VERB
ct-10840	195	2	c	c	PROPN
ct-10840	195	3	,	,	PUNCT
ct-10840	195	4	kelleman	kelleman	NOUN
ct-10840	195	5	a	a	PRON
ct-10840	195	6	,	,	PUNCT
ct-10840	195	7	keel	keel	PROPN
ct-10840	195	8	k	k	PROPN
ct-10840	195	9	,	,	PUNCT
ct-10840	195	10	et	et	PROPN
ct-10840	195	11	al	al	PROPN
ct-10840	195	12	:	:	PUNCT
ct-10840	195	13	equine	equine	NOUN
ct-10840	195	14	granulosa	granulosa	NOUN
ct-10840	195	15	cell	cell	NOUN
ct-10840	195	16	tumours	tumour	NOUN
ct-10840	195	17	among	among	ADP
ct-10840	195	18	other	other	ADJ
ct-10840	195	19	ovarian	ovarian	ADJ
ct-10840	195	20	conditions	condition	NOUN
ct-10840	195	21	:	:	PUNCT
ct-10840	195	22	diagnostic	diagnostic	ADJ
ct-10840	195	23	challenges	challenge	NOUN
ct-10840	195	24	.	.	PUNCT
ct-10840	196	1	equine	equine	NOUN
ct-10840	196	2	vet	vet	NOUN
ct-10840	196	3	j	j	PROPN
ct-10840	196	4	2021;53:60	2021;53:60	NUM
ct-10840	196	5	-	-	SYM
ct-10840	196	6	70	70	NUM
ct-10840	196	7	.	.	PUNCT
ct-10840	197	1	https://doi.org/10.1111/evj.13279	https://doi.org/10.1111/evj.13279	PROPN
ct-10840	197	2	21	21	NUM
ct-10840	197	3	.	.	PUNCT
ct-10840	198	1	walter	walter	PROPN
ct-10840	198	2	b	b	PROPN
ct-10840	198	3	,	,	PUNCT
ct-10840	198	4	coelfen	coelfen	NOUN
ct-10840	198	5	a	a	PRON
ct-10840	198	6	,	,	PUNCT
ct-10840	198	7	jäger	jäger	PROPN
ct-10840	198	8	k	k	PROPN
ct-10840	198	9	,	,	PUNCT
ct-10840	198	10	et	et	PROPN
ct-10840	198	11	al	al	PROPN
ct-10840	198	12	:	:	PUNCT
ct-10840	198	13	anti	anti	ADJ
ct-10840	198	14	-	-	ADJ
ct-10840	198	15	mullerian	mullerian	ADJ
ct-10840	198	16	hormone	hormone	NOUN
ct-10840	198	17	concentration	concentration	NOUN
ct-10840	198	18	in	in	ADP
ct-10840	198	19	bitches	bitch	NOUN
ct-10840	198	20	with	with	ADP
ct-10840	198	21	histopathologically	histopathologically	ADV
ct-10840	198	22	diagnosed	diagnose	VERB
ct-10840	198	23	ovarian	ovarian	ADJ
ct-10840	198	24	tumours	tumour	NOUN
ct-10840	198	25	and	and	CCONJ
ct-10840	198	26	cysts	cyst	NOUN
ct-10840	198	27	.	.	PUNCT
ct-10840	199	1	reprod	reprod	PROPN
ct-10840	199	2	domest	domest	PROPN
ct-10840	199	3	anim	anim	NOUN
ct-10840	199	4	2018;53:784	2018;53:784	PROPN
ct-10840	199	5	-	-	SYM
ct-10840	199	6	792	792	NUM
ct-10840	199	7	.	.	PUNCT
ct-10840	200	1	https://doi.org/10.1111/rda.13171	https://doi.org/10.1111/rda.13171	PROPN
ct-10840	200	2	22	22	NUM
ct-10840	200	3	.	.	PUNCT
ct-10840	201	1	conley	conley	PROPN
ct-10840	201	2	a	a	DET
ct-10840	201	3	,	,	PUNCT
ct-10840	201	4	scholtz	scholtz	ADJ
ct-10840	201	5	e	e	NOUN
ct-10840	201	6	,	,	PUNCT
ct-10840	201	7	dujovne	dujovne	ADV
ct-10840	201	8	g	g	NOUN
ct-10840	201	9	,	,	PUNCT
ct-10840	201	10	et	et	PROPN
ct-10840	201	11	al	al	PROPN
ct-10840	201	12	:	:	PUNCT
ct-10840	201	13	inhibin	inhibin	VERB
ct-10840	201	14	-	-	PUNCT
ct-10840	201	15	a	a	NOUN
ct-10840	201	16	and	and	CCONJ
ct-10840	201	17	inhibin	inhibin	NOUN
ct-10840	201	18	-	-	PUNCT
ct-10840	201	19	b	b	NOUN
ct-10840	201	20	in	in	ADP
ct-10840	201	21	cyclic	cyclic	ADJ
ct-10840	201	22	and	and	CCONJ
ct-10840	201	23	pregnant	pregnant	ADJ
ct-10840	201	24	mares	mare	NOUN
ct-10840	201	25	,	,	PUNCT
ct-10840	201	26	and	and	CCONJ
ct-10840	201	27	mares	mare	NOUN
ct-10840	201	28	with	with	ADP
ct-10840	201	29	granulosa	granulosa	NOUN
ct-10840	201	30	-	-	PUNCT
ct-10840	201	31	theca	theca	NOUN
ct-10840	201	32	cell	cell	NOUN
ct-10840	201	33	tumours	tumour	VERB
ct-10840	201	34	:	:	PUNCT
ct-10840	201	35	physiological	physiological	ADJ
ct-10840	201	36	and	and	CCONJ
ct-10840	201	37	diagnostic	diagnostic	ADJ
ct-10840	201	38	implications	implication	NOUN
ct-10840	201	39	.	.	PUNCT
ct-10840	202	1	theriogenology	theriogenology	NOUN
ct-10840	202	2	2018;108:192	2018;108:192	NOUN
ct-10840	202	3	-	-	SYM
ct-10840	202	4	200	200	NUM
ct-10840	202	5	.	.	PUNCT
ct-10840	203	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ct-10840	203	2	.	.	PUNCT
ct-10840	204	1	theriogenology.2017.12.003	theriogenology.2017.12.003	X
ct-10840	205	1	23	23	NUM
ct-10840	205	2	.	.	PUNCT
ct-10840	206	1	mccue	mccue	PROPN
ct-10840	206	2	p	p	PROPN
ct-10840	206	3	,	,	PUNCT
ct-10840	206	4	roser	roser	PROPN
ct-10840	206	5	j	j	PROPN
ct-10840	206	6	,	,	PUNCT
ct-10840	206	7	munro	munro	PROPN
ct-10840	206	8	c	c	PROPN
ct-10840	206	9	,	,	PUNCT
ct-10840	206	10	et	et	PROPN
ct-10840	206	11	al	al	PROPN
ct-10840	206	12	:	:	PUNCT
ct-10840	206	13	granulosa	granulosa	PROPN
ct-10840	206	14	cell	cell	NOUN
ct-10840	206	15	tumours	tumour	NOUN
ct-10840	206	16	of	of	ADP
ct-10840	206	17	the	the	DET
ct-10840	206	18	equine	equine	NOUN
ct-10840	206	19	ovary	ovary	NOUN
ct-10840	206	20	.	.	PUNCT
ct-10840	207	1	vet	vet	NOUN
ct-10840	207	2	clin	clin	PROPN
ct-10840	207	3	north	north	PROPN
ct-10840	207	4	am	be	AUX
ct-10840	207	5	:	:	PUNCT
ct-10840	207	6	equine	equine	NOUN
ct-10840	207	7	pract	pract	NOUN
ct-10840	207	8	2006;22:799	2006;22:799	PROPN
ct-10840	207	9	-	-	SYM
ct-10840	207	10	817	817	NUM
ct-10840	207	11	.	.	PUNCT
ct-10840	208	1	https://doi.org/10.1016/j.cveq.2006.08.008	https://doi.org/10.1016/j.cveq.2006.08.008	NOUN
ct-10840	208	2	24	24	NUM
ct-10840	208	3	.	.	PUNCT
ct-10840	209	1	el	el	PROPN
ct-10840	209	2	-	-	PUNCT
ct-10840	209	3	sheikh	sheikh	PROPN
ct-10840	209	4	ali	ali	PROPN
ct-10840	209	5	h	h	PROPN
ct-10840	209	6	,	,	PUNCT
ct-10840	209	7	kitahara	kitahara	PROPN
ct-10840	209	8	g	g	PROPN
ct-10840	209	9	,	,	PUNCT
ct-10840	209	10	nibe	nibe	PROPN
ct-10840	209	11	k	k	PROPN
ct-10840	209	12	,	,	PUNCT
ct-10840	209	13	et	et	PROPN
ct-10840	209	14	al	al	PROPN
ct-10840	209	15	:	:	PUNCT
ct-10840	209	16	plasma	plasma	NOUN
ct-10840	209	17	anti	anti	ADJ
ct-10840	209	18	-	-	ADJ
ct-10840	209	19	müllerian	müllerian	ADJ
ct-10840	209	20	hormone	hormone	NOUN
ct-10840	209	21	as	as	ADP
ct-10840	209	22	a	a	DET
ct-10840	209	23	biomarker	biomarker	NOUN
ct-10840	209	24	for	for	ADP
ct-10840	209	25	bovine	bovine	ADJ
ct-10840	209	26	granulosa	granulosa	NOUN
ct-10840	209	27	-	-	PUNCT
ct-10840	209	28	theca	theca	NOUN
ct-10840	209	29	cell	cell	NOUN
ct-10840	209	30	tumours	tumour	VERB
ct-10840	209	31	:	:	PUNCT
ct-10840	209	32	comparison	comparison	NOUN
ct-10840	209	33	with	with	ADP
ct-10840	209	34	immunoreactive	immunoreactive	ADJ
ct-10840	209	35	inhibin	inhibin	ADJ
ct-10840	209	36	and	and	CCONJ
ct-10840	209	37	ovarian	ovarian	ADJ
ct-10840	209	38	steroid	steroid	NOUN
ct-10840	209	39	concentrations	concentration	NOUN
ct-10840	209	40	.	.	PUNCT
ct-10840	210	1	theriogenology	theriogenology	NOUN
ct-10840	210	2	2013;80:940	2013;80:940	NOUN
ct-10840	210	3	-	-	SYM
ct-10840	210	4	949	949	NUM
ct-10840	210	5	.	.	PUNCT
ct-10840	211	1	https://doi	https://doi	X
ct-10840	211	2	.	.	PUNCT
ct-10840	212	1	org/10.1016	org/10.1016	PROPN
ct-10840	212	2	/	/	SYM
ct-10840	212	3	j.theriogenology.2013.07.022	j.theriogenology.2013.07.022	PROPN
ct-10840	212	4	25	25	NUM
ct-10840	212	5	.	.	PUNCT
ct-10840	213	1	daels	dael	VERB
ct-10840	213	2	p	p	NOUN
ct-10840	213	3	,	,	PUNCT
ct-10840	213	4	chang	chang	PROPN
ct-10840	213	5	g	g	PROPN
ct-10840	213	6	,	,	PUNCT
ct-10840	213	7	hansen	hansen	PROPN
ct-10840	213	8	b	b	PROPN
ct-10840	213	9	,	,	PUNCT
ct-10840	213	10	et	et	PROPN
ct-10840	213	11	al	al	PROPN
ct-10840	213	12	:	:	PUNCT
ct-10840	213	13	testosterone	testosterone	NOUN
ct-10840	213	14	secretions	secretion	NOUN
ct-10840	213	15	during	during	ADP
ct-10840	213	16	early	early	ADJ
ct-10840	213	17	pregnancy	pregnancy	NOUN
ct-10840	213	18	in	in	ADP
ct-10840	213	19	mares	mare	NOUN
ct-10840	213	20	.	.	PUNCT
ct-10840	214	1	theriogenology	theriogenology	NOUN
ct-10840	214	2	1996;45:1211	1996;45:1211	PROPN
ct-10840	214	3	-	-	SYM
ct-10840	214	4	1219	1219	NUM
ct-10840	214	5	.	.	PUNCT
ct-10840	215	1	https://doi.org/10.1016/0093-691x(96)00076-3	https://doi.org/10.1016/0093-691x(96)00076-3	ADP
ct-10840	215	2	26	26	NUM
ct-10840	215	3	.	.	PUNCT
ct-10840	216	1	ball	ball	PROPN
ct-10840	216	2	b	b	PROPN
ct-10840	216	3	,	,	PUNCT
ct-10840	216	4	almeida	almeida	PROPN
ct-10840	216	5	j	j	PROPN
ct-10840	216	6	,	,	PUNCT
ct-10840	216	7	conley	conley	PROPN
ct-10840	216	8	a	a	PRON
ct-10840	216	9	:	:	PUNCT
ct-10840	216	10	determination	determination	NOUN
ct-10840	216	11	of	of	ADP
ct-10840	216	12	serum	serum	NOUN
ct-10840	216	13	anti-/	anti-/	VERB
ct-10840	216	14	mullerian	mullerian	ADJ
ct-10840	216	15	hormone	hormone	NOUN
ct-10840	216	16	concentrations	concentration	NOUN
ct-10840	216	17	for	for	ADP
ct-10840	216	18	the	the	DET
ct-10840	216	19	diagnosis	diagnosis	NOUN
ct-10840	216	20	of	of	ADP
ct-10840	216	21	granulosa	granulosa	NOUN
ct-10840	216	22	-	-	PUNCT
ct-10840	216	23	cell	cell	NOUN
ct-10840	216	24	tumours	tumour	NOUN
ct-10840	216	25	in	in	ADP
ct-10840	216	26	mares	mare	NOUN
ct-10840	216	27	.	.	PUNCT
ct-10840	217	1	equine	equine	NOUN
ct-10840	217	2	vet	vet	NOUN
ct-10840	217	3	j	j	PROPN
ct-10840	217	4	2013;45:199	2013;45:199	X
ct-10840	217	5	-	-	PUNCT
ct-10840	217	6	203	203	NUM
ct-10840	217	7	.	.	PUNCT
ct-10840	218	1	https://	https://	PROPN
ct-10840	218	2	doi.org/10.1111/j.2042-3306.2012.00594.x	doi.org/10.1111/j.2042-3306.2012.00594.x	PROPN
ct-10840	218	3	27	27	NUM
ct-10840	218	4	.	.	PUNCT
ct-10840	219	1	nambo	nambo	PROPN
ct-10840	219	2	y	y	PROPN
ct-10840	219	3	,	,	PUNCT
ct-10840	219	4	nagata	nagata	PROPN
ct-10840	219	5	s	s	PROPN
ct-10840	219	6	,	,	PUNCT
ct-10840	219	7	oikawa	oikawa	PROPN
ct-10840	219	8	m	m	PROPN
ct-10840	219	9	,	,	PUNCT
ct-10840	219	10	et	et	PROPN
ct-10840	219	11	al	al	PROPN
ct-10840	219	12	:	:	PUNCT
ct-10840	219	13	high	high	ADJ
ct-10840	219	14	concentrations	concentration	NOUN
ct-10840	219	15	of	of	ADP
ct-10840	219	16	immunoreactive	immunoreactive	ADJ
ct-10840	219	17	inhibin	inhibin	NOUN
ct-10840	219	18	in	in	ADP
ct-10840	219	19	the	the	DET
ct-10840	219	20	plasma	plasma	NOUN
ct-10840	219	21	of	of	ADP
ct-10840	219	22	mares	mare	NOUN
ct-10840	219	23	and	and	CCONJ
ct-10840	219	24	fetal	fetal	ADJ
ct-10840	219	25	gonads	gonad	NOUN
ct-10840	219	26	during	during	ADP
ct-10840	219	27	the	the	DET
ct-10840	219	28	second	second	ADJ
ct-10840	219	29	half	half	NOUN
ct-10840	219	30	of	of	ADP
ct-10840	219	31	pregnancy	pregnancy	NOUN
ct-10840	219	32	.	.	PUNCT
ct-10840	220	1	reprod	reprod	PROPN
ct-10840	220	2	fertil	fertil	AUX
ct-10840	220	3	dev	dev	VERB
ct-10840	220	4	1996;8:1137	1996;8:1137	NUM
ct-10840	220	5	-	-	SYM
ct-10840	220	6	1145	1145	NUM
ct-10840	220	7	.	.	PUNCT
ct-10840	221	1	https://doi.org/10.1071/rd9961137	https://doi.org/10.1071/rd9961137	X
ct-10840	222	1	28	28	NUM
ct-10840	222	2	.	.	PUNCT
ct-10840	223	1	josso	josso	PROPN
ct-10840	223	2	n	n	PROPN
ct-10840	223	3	,	,	PUNCT
ct-10840	223	4	di	di	PROPN
ct-10840	223	5	clemente	clemente	PROPN
ct-10840	223	6	n	n	CCONJ
ct-10840	223	7	:	:	PUNCT
ct-10840	223	8	tgf	tgf	PROPN
ct-10840	223	9	-	-	PUNCT
ct-10840	223	10	β	β	PROPN
ct-10840	223	11	family	family	NOUN
ct-10840	223	12	members	member	NOUN
ct-10840	223	13	and	and	CCONJ
ct-10840	223	14	gonadal	gonadal	NOUN
ct-10840	223	15	development	development	NOUN
ct-10840	223	16	.	.	PUNCT
ct-10840	224	1	trends	trend	NOUN
ct-10840	224	2	endocrinol	endocrinol	VERB
ct-10840	224	3	metab	metab	ADJ
ct-10840	224	4	1999;10:216	1999;10:216	NOUN
ct-10840	224	5	-	-	NUM
ct-10840	224	6	222	222	NUM
ct-10840	224	7	.	.	PUNCT
ct-10840	225	1	29	29	NUM
ct-10840	225	2	.	.	PUNCT
ct-10840	226	1	holst	holst	NOUN
ct-10840	226	2	b	b	X
ct-10840	226	3	:	:	PUNCT
ct-10840	226	4	diagnostic	diagnostic	ADJ
ct-10840	226	5	possibilities	possibility	NOUN
ct-10840	226	6	from	from	ADP
ct-10840	226	7	a	a	DET
ct-10840	226	8	serum	serum	NOUN
ct-10840	226	9	sample	sample	NOUN
ct-10840	226	10	–	–	PUNCT
ct-10840	226	11	clinical	clinical	ADJ
ct-10840	226	12	value	value	NOUN
ct-10840	226	13	of	of	ADP
ct-10840	226	14	new	new	ADJ
ct-10840	226	15	methods	method	NOUN
ct-10840	226	16	within	within	ADP
ct-10840	226	17	small	small	ADJ
ct-10840	226	18	animal	animal	NOUN
ct-10840	226	19	reproduction	reproduction	NOUN
ct-10840	226	20	,	,	PUNCT
ct-10840	226	21	with	with	ADP
ct-10840	226	22	focus	focus	NOUN
ct-10840	226	23	on	on	ADP
ct-10840	226	24	anti	anti	ADJ
ct-10840	226	25	-	-	ADJ
ct-10840	226	26	müllerian	müllerian	ADJ
ct-10840	226	27	hormone	hormone	NOUN
ct-10840	226	28	.	.	PUNCT
ct-10840	227	1	reprod	reprod	PROPN
ct-10840	227	2	domest	domest	PROPN
ct-10840	227	3	anim	anim	PROPN
ct-10840	227	4	2017;52:303	2017;52:303	NOUN
ct-10840	227	5	-	-	NUM
ct-10840	227	6	309	309	NUM
ct-10840	227	7	.	.	PUNCT
ct-10840	228	1	https://doi.org/10.1111/rda.12856	https://doi.org/10.1111/rda.12856	PROPN
ct-10840	228	2	30	30	NUM
ct-10840	228	3	.	.	PUNCT
ct-10840	229	1	nagashima	nagashima	PROPN
ct-10840	229	2	jb	jb	PROPN
ct-10840	229	3	,	,	PUNCT
ct-10840	229	4	hansen	hansen	PROPN
ct-10840	229	5	bs	bs	PROPN
ct-10840	229	6	,	,	PUNCT
ct-10840	229	7	songsasen	songsasen	NOUN
ct-10840	229	8	n	n	CCONJ
ct-10840	229	9	,	,	PUNCT
ct-10840	229	10	et	et	PROPN
ct-10840	229	11	al	al	PROPN
ct-10840	229	12	:	:	PUNCT
ct-10840	229	13	anti	anti	ADJ
ct-10840	229	14	-	-	ADJ
ct-10840	229	15	müllerian	müllerian	ADJ
ct-10840	229	16	hormone	hormone	NOUN
ct-10840	229	17	in	in	ADP
ct-10840	229	18	the	the	DET
ct-10840	229	19	domestic	domestic	ADJ
ct-10840	229	20	dog	dog	NOUN
ct-10840	229	21	during	during	ADP
ct-10840	229	22	the	the	DET
ct-10840	229	23	anestrus	anestrus	NOUN
ct-10840	229	24	to	to	ADP
ct-10840	229	25	oestrous	oestrous	ADJ
ct-10840	229	26	transition	transition	NOUN
ct-10840	229	27	.	.	PUNCT
ct-10840	230	1	reprod	reprod	PROPN
ct-10840	230	2	domest	domest	PROPN
ct-10840	230	3	anim	anim	NOUN
ct-10840	230	4	2016;51:158	2016;51:158	NUM
ct-10840	230	5	-	-	SYM
ct-10840	230	6	164	164	NUM
ct-10840	230	7	.	.	PUNCT
ct-10840	231	1	https://doi	https://doi	PROPN
ct-10840	231	2	.	.	PUNCT
ct-10840	231	3	org/10.1111	org/10.1111	NOUN
ct-10840	231	4	/	/	SYM
ct-10840	231	5	rda.12660	rda.12660	SYM
ct-10840	231	6	31	31	NUM
ct-10840	231	7	.	.	PUNCT
ct-10840	232	1	olson	olson	PROPN
ct-10840	232	2	p	p	PROPN
ct-10840	232	3	,	,	PUNCT
ct-10840	232	4	thrall	thrall	NOUN
ct-10840	232	5	m	m	PRON
ct-10840	232	6	,	,	PUNCT
ct-10840	232	7	wykes	wyke	VERB
ct-10840	232	8	p	p	NOUN
ct-10840	232	9	,	,	PUNCT
ct-10840	232	10	et	et	PROPN
ct-10840	232	11	al	al	PROPN
ct-10840	232	12	:	:	PUNCT
ct-10840	232	13	vaginal	vaginal	ADJ
ct-10840	232	14	cytology	cytology	NOUN
ct-10840	232	15	:	:	PUNCT
ct-10840	232	16	part	part	NOUN
ct-10840	232	17	1	1	NUM
ct-10840	232	18	.	.	PUNCT
ct-10840	233	1	a	a	DET
ct-10840	233	2	useful	useful	ADJ
ct-10840	233	3	tool	tool	NOUN
ct-10840	233	4	for	for	ADP
ct-10840	233	5	staging	stage	VERB
ct-10840	233	6	the	the	DET
ct-10840	233	7	canine	canine	NOUN
ct-10840	233	8	estrous	estrous	ADJ
ct-10840	233	9	cycle	cycle	NOUN
ct-10840	233	10	.	.	PUNCT
ct-10840	234	1	compend	compend	VERB
ct-10840	234	2	contin	contin	PROPN
ct-10840	234	3	educ	educ	PROPN
ct-10840	234	4	vet	vet	PROPN
ct-10840	234	5	1984;6:288	1984;6:288	NUM
ct-10840	234	6	-	-	SYM
ct-10840	234	7	298	298	NUM
ct-10840	234	8	.	.	PUNCT
ct-10840	234	9	32	32	NUM
ct-10840	234	10	.	.	PUNCT
ct-10840	235	1	johnston	johnston	PROPN
ct-10840	235	2	s	s	PROPN
ct-10840	235	3	,	,	PUNCT
ct-10840	235	4	kustritz	kustritz	PROPN
ct-10840	235	5	m	m	PROPN
ct-10840	235	6	,	,	PUNCT
ct-10840	235	7	olson	olson	NOUN
ct-10840	235	8	p	p	NOUN
ct-10840	235	9	:	:	PUNCT
ct-10840	235	10	vaginal	vaginal	ADJ
ct-10840	235	11	cytology	cytology	NOUN
ct-10840	235	12	.	.	PUNCT
ct-10840	236	1	in	in	ADP
ct-10840	236	2	:	:	PUNCT
ct-10840	236	3	johnston	johnston	PROPN
ct-10840	236	4	s	s	PROPN
ct-10840	236	5	,	,	PUNCT
ct-10840	236	6	kustritz	kustritz	PROPN
ct-10840	236	7	m	m	PROPN
ct-10840	236	8	,	,	PUNCT
ct-10840	236	9	olson	olson	NOUN
ct-10840	236	10	p	p	NOUN
ct-10840	236	11	:	:	PUNCT
ct-10840	236	12	editors	editor	NOUN
ct-10840	236	13	.	.	PUNCT
ct-10840	237	1	canine	canine	NOUN
ct-10840	237	2	and	and	CCONJ
ct-10840	237	3	feline	feline	ADJ
ct-10840	237	4	theriogenology	theriogenology	NOUN
ct-10840	237	5	.	.	PUNCT
ct-10840	238	1	1st	1st	PROPN
ct-10840	238	2	edition	edition	PROPN
ct-10840	238	3	,	,	PUNCT
ct-10840	238	4	philadelphia	philadelphia	PROPN
ct-10840	238	5	;	;	PUNCT
ct-10840	238	6	saunders	saunder	NOUN
ct-10840	238	7	:	:	PUNCT
ct-10840	238	8	2001	2001	NUM
ct-10840	238	9	.	.	PUNCT
ct-10840	239	1	p.	p.	NOUN
ct-10840	239	2	32	32	NUM
ct-10840	239	3	-	-	SYM
ct-10840	239	4	40	40	NUM
ct-10840	239	5	.	.	PUNCT
ct-10840	240	1	33	33	NUM
ct-10840	240	2	.	.	PUNCT
ct-10840	241	1	kustritz	kustritz	PROPN
ct-10840	241	2	m	m	PROPN
ct-10840	241	3	:	:	PUNCT
ct-10840	241	4	canine	canine	VERB
ct-10840	241	5	techniques	technique	NOUN
ct-10840	241	6	.	.	PUNCT
ct-10840	242	1	in	in	ADP
ct-10840	242	2	:	:	PUNCT
ct-10840	242	3	kustritz	kustritz	PROPN
ct-10840	242	4	m	m	PROPN
ct-10840	242	5	:	:	PUNCT
ct-10840	242	6	editor	editor	NOUN
ct-10840	242	7	.	.	PUNCT
ct-10840	243	1	clinical	clinical	ADJ
ct-10840	243	2	canine	canine	NOUN
ct-10840	243	3	and	and	CCONJ
ct-10840	243	4	feline	feline	ADJ
ct-10840	243	5	reproduction	reproduction	NOUN
ct-10840	243	6	evidence	evidence	NOUN
ct-10840	243	7	-	-	PUNCT
ct-10840	243	8	based	base	VERB
ct-10840	243	9	answers	answer	NOUN
ct-10840	243	10	.	.	PUNCT
ct-10840	244	1	1st	1st	PROPN
ct-10840	244	2	edition	edition	PROPN
ct-10840	244	3	,	,	PUNCT
ct-10840	244	4	singapore	singapore	PROPN
ct-10840	244	5	;	;	PUNCT
ct-10840	244	6	wiley	wiley	NOUN
ct-10840	244	7	-	-	PUNCT
ct-10840	244	8	blackwell	blackwell	PROPN
ct-10840	244	9	:	:	PUNCT
ct-10840	244	10	2010	2010	NUM
ct-10840	244	11	.	.	PUNCT
ct-10840	245	1	p.	p.	NOUN
ct-10840	245	2	5	5	NUM
ct-10840	245	3	-	-	SYM
ct-10840	245	4	11	11	NUM
ct-10840	245	5	.	.	PUNCT
ct-10840	246	1	34	34	NUM
ct-10840	246	2	.	.	PUNCT
ct-10840	247	1	kustritz	kustritz	PROPN
ct-10840	247	2	m	m	PROPN
ct-10840	247	3	:	:	PUNCT
ct-10840	247	4	vaginal	vaginal	ADJ
ct-10840	247	5	cytology	cytology	NOUN
ct-10840	247	6	in	in	ADP
ct-10840	247	7	the	the	DET
ct-10840	247	8	bitch	bitch	NOUN
ct-10840	247	9	and	and	CCONJ
ct-10840	247	10	queen	queen	NOUN
ct-10840	247	11	.	.	PUNCT
ct-10840	248	1	in	in	ADP
ct-10840	248	2	:	:	PUNCT
ct-10840	248	3	sharkey	sharkey	PROPN
ct-10840	248	4	l	l	PROPN
ct-10840	248	5	,	,	PUNCT
ct-10840	248	6	radin	radin	PROPN
ct-10840	248	7	m	m	PROPN
ct-10840	248	8	,	,	PUNCT
ct-10840	248	9	seelig	seelig	PROPN
ct-10840	248	10	d	d	NOUN
ct-10840	248	11	:	:	PUNCT
ct-10840	248	12	editors	editor	NOUN
ct-10840	248	13	.	.	PUNCT
ct-10840	249	1	veterinary	veterinary	ADJ
ct-10840	249	2	cytology	cytology	NOUN
ct-10840	249	3	.	.	PUNCT
ct-10840	250	1	1st	1st	PROPN
ct-10840	250	2	edition	edition	PROPN
ct-10840	250	3	,	,	PUNCT
ct-10840	250	4	hoboken	hoboken	PROPN
ct-10840	250	5	;	;	PUNCT
ct-10840	250	6	wiley	wiley	NOUN
ct-10840	250	7	-	-	PUNCT
ct-10840	250	8	blackwell	blackwell	PROPN
ct-10840	250	9	:	:	PUNCT
ct-10840	250	10	2021	2021	NUM
ct-10840	250	11	.	.	PUNCT
ct-10840	251	1	p.	p.	NOUN
ct-10840	251	2	552	552	NUM
ct-10840	251	3	-	-	SYM
ct-10840	251	4	558	558	NUM
ct-10840	251	5	.	.	PUNCT
ct-10840	251	6	35	35	NUM
ct-10840	251	7	.	.	PUNCT
ct-10840	252	1	reckers	recker	NOUN
ct-10840	253	1	f	f	X
ct-10840	253	2	,	,	PUNCT
ct-10840	253	3	klopfleisch	klopfleisch	ADV
ct-10840	253	4	r	r	NOUN
ct-10840	253	5	,	,	PUNCT
ct-10840	253	6	belik	belik	VERB
ct-10840	253	7	v	v	NOUN
ct-10840	253	8	,	,	PUNCT
ct-10840	253	9	et	et	PROPN
ct-10840	253	10	al	al	PROPN
ct-10840	253	11	:	:	PUNCT
ct-10840	253	12	canine	canine	PROPN
ct-10840	253	13	vaginal	vaginal	PROPN
ct-10840	253	14	cytology	cytology	NOUN
ct-10840	253	15	:	:	PUNCT
ct-10840	253	16	a	a	DET
ct-10840	253	17	revised	revise	VERB
ct-10840	253	18	definition	definition	NOUN
ct-10840	253	19	of	of	ADP
ct-10840	253	20	exfoliated	exfoliated	ADJ
ct-10840	253	21	vaginal	vaginal	ADJ
ct-10840	253	22	cells	cell	NOUN
ct-10840	253	23	.	.	PUNCT
ct-10840	254	1	front	front	ADJ
ct-10840	254	2	vet	vet	NOUN
ct-10840	254	3	sci	sci	PROPN
ct-10840	254	4	2022;9:834031	2022;9:834031	NOUN
ct-10840	254	5	.	.	PUNCT
ct-10840	255	1	https://doi.org/10.3389/fvets.2022.834031	https://doi.org/10.3389/fvets.2022.834031	PROPN
ct-10840	255	2	36	36	NUM
ct-10840	255	3	.	.	PUNCT
ct-10840	255	4	arlt	arlt	PROPN
ct-10840	255	5	sp	sp	PROPN
ct-10840	255	6	,	,	PUNCT
ct-10840	255	7	haimerl	haimerl	NOUN
ct-10840	255	8	p	p	X
ct-10840	255	9	:	:	PUNCT
ct-10840	255	10	cystic	cystic	ADJ
ct-10840	255	11	ovaries	ovary	NOUN
ct-10840	255	12	and	and	CCONJ
ct-10840	255	13	ovarian	ovarian	ADJ
ct-10840	255	14	neoplasia	neoplasia	NOUN
ct-10840	255	15	in	in	ADP
ct-10840	255	16	the	the	DET
ct-10840	255	17	female	female	ADJ
ct-10840	255	18	dog	dog	NOUN
ct-10840	255	19	–	–	PUNCT
ct-10840	255	20	a	a	DET
ct-10840	255	21	systematic	systematic	ADJ
ct-10840	255	22	review	review	NOUN
ct-10840	255	23	.	.	PUNCT
ct-10840	256	1	reprod	reprod	PROPN
ct-10840	256	2	domest	domest	PROPN
ct-10840	256	3	anim	anim	NOUN
ct-10840	256	4	2016;51:311	2016;51:311	NUM
ct-10840	256	5	.	.	PUNCT
ct-10840	257	1	https://doi.org/10.1111/rda.12781	https://doi.org/10.1111/rda.12781	PROPN
ct-10840	258	1	37	37	NUM
ct-10840	258	2	.	.	PUNCT
ct-10840	259	1	ivaldi	ivaldi	PROPN
ct-10840	259	2	f	f	PROPN
ct-10840	259	3	,	,	PUNCT
ct-10840	259	4	ogdon	ogdon	PROPN
ct-10840	259	5	c	c	PROPN
ct-10840	259	6	,	,	PUNCT
ct-10840	259	7	khan	khan	PROPN
ct-10840	259	8	f	f	PROPN
ct-10840	259	9	,	,	PUNCT
ct-10840	259	10	et	et	PROPN
ct-10840	259	11	al	al	PROPN
ct-10840	259	12	:	:	PUNCT
ct-10840	259	13	a	a	DET
ct-10840	259	14	rare	rare	ADJ
ct-10840	259	15	case	case	NOUN
ct-10840	259	16	of	of	ADP
ct-10840	259	17	vulvar	vulvar	NOUN
ct-10840	259	18	discharge	discharge	NOUN
ct-10840	259	19	associated	associate	VERB
ct-10840	259	20	with	with	ADP
ct-10840	259	21	exogenous	exogenous	ADJ
ct-10840	259	22	oestrogen	oestrogen	NOUN
ct-10840	259	23	exposure	exposure	NOUN
ct-10840	259	24	in	in	ADP
ct-10840	259	25	a	a	DET
ct-10840	259	26	spayed	spay	VERB
ct-10840	259	27	weimaraner	weimaraner	NOUN
ct-10840	259	28	bitch	bitch	NOUN
ct-10840	259	29	.	.	PUNCT
ct-10840	260	1	vet	vet	NOUN
ct-10840	260	2	med	me	VERB
ct-10840	260	3	sci	sci	PROPN
ct-10840	260	4	2022;8:1872	2022;8:1872	PROPN
ct-10840	260	5	-	-	PUNCT
ct-10840	260	6	1876	1876	NUM
ct-10840	260	7	.	.	PUNCT
ct-10840	261	1	https://doi	https://doi	PROPN
ct-10840	261	2	.	.	PUNCT
ct-10840	261	3	org/10.1002	org/10.1002	PROPN
ct-10840	261	4	/	/	SYM
ct-10840	261	5	vms3.860	vms3.860	PROPN
ct-10840	261	6	38	38	NUM
ct-10840	261	7	.	.	PUNCT
ct-10840	262	1	meyers	meyer	NOUN
ct-10840	262	2	-	-	PUNCT
ct-10840	262	3	wallen	wallen	PROPN
ct-10840	262	4	v	v	NOUN
ct-10840	262	5	:	:	PUNCT
ct-10840	262	6	unusual	unusual	ADJ
ct-10840	262	7	and	and	CCONJ
ct-10840	262	8	abnormal	abnormal	ADJ
ct-10840	262	9	canine	canine	NOUN
ct-10840	262	10	estrous	estrous	ADJ
ct-10840	262	11	cycles	cycle	NOUN
ct-10840	262	12	.	.	PUNCT
ct-10840	263	1	theriogenology	theriogenology	NOUN
ct-10840	263	2	2007;68:1205	2007;68:1205	PROPN
ct-10840	263	3	-	-	SYM
ct-10840	263	4	1210	1210	NUM
ct-10840	263	5	.	.	PUNCT
ct-10840	264	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ct-10840	264	2	.	.	PUNCT
ct-10840	265	1	theriogenology.2007.08.019	theriogenology.2007.08.019	X
ct-10840	265	2	39	39	NUM
ct-10840	265	3	.	.	PUNCT
ct-10840	266	1	o’connor	o’connor	ADV
ct-10840	266	2	c	c	PROPN
ct-10840	266	3	,	,	PUNCT
ct-10840	266	4	schweizer	schweizer	PROPN
ct-10840	266	5	c	c	PROPN
ct-10840	266	6	,	,	PUNCT
ct-10840	266	7	gradil	gradil	NOUN
ct-10840	266	8	c	c	X
ct-10840	266	9	,	,	PUNCT
ct-10840	266	10	et	et	PROPN
ct-10840	266	11	al	al	PROPN
ct-10840	266	12	:	:	PUNCT
ct-10840	266	13	trisomy	trisomy	NOUN
ct-10840	266	14	-	-	PUNCT
ct-10840	266	15	x	x	NOUN
ct-10840	266	16	with	with	ADP
ct-10840	266	17	estrous	estrous	ADJ
ct-10840	266	18	cycle	cycle	NOUN
ct-10840	266	19	anomalies	anomaly	NOUN
ct-10840	266	20	in	in	ADP
ct-10840	266	21	two	two	NUM
ct-10840	266	22	female	female	ADJ
ct-10840	266	23	dogs	dog	NOUN
ct-10840	266	24	.	.	PUNCT
ct-10840	267	1	theriogenology	theriogenology	NOUN
ct-10840	267	2	2011;76:374380	2011;76:374380	NUM
ct-10840	267	3	.	.	PUNCT
ct-10840	267	4	https://doi.org/10.1016/j.theriogenology.2011.02.017	https://doi.org/10.1016/j.theriogenology.2011.02.017	NUM
ct-10840	267	5	40	40	NUM
ct-10840	267	6	.	.	PUNCT
ct-10840	268	1	castillo	castillo	PROPN
ct-10840	268	2	j	j	PROPN
ct-10840	268	3	,	,	PUNCT
ct-10840	268	4	tse	tse	PROPN
ct-10840	268	5	m	m	PROPN
ct-10840	268	6	,	,	PUNCT
ct-10840	268	7	dockweiler	dockweiler	PROPN
ct-10840	268	8	j	j	PROPN
ct-10840	268	9	,	,	PUNCT
ct-10840	268	10	et	et	PROPN
ct-10840	268	11	al	al	PROPN
ct-10840	268	12	:	:	PUNCT
ct-10840	268	13	bilateral	bilateral	ADJ
ct-10840	268	14	granulosa	granulosa	NOUN
ct-10840	268	15	cell	cell	NOUN
ct-10840	268	16	tumour	tumour	NOUN
ct-10840	268	17	in	in	ADP
ct-10840	268	18	a	a	DET
ct-10840	268	19	cycling	cycling	NOUN
ct-10840	268	20	mare	mare	NOUN
ct-10840	268	21	.	.	PUNCT
ct-10840	269	1	can	can	AUX
ct-10840	269	2	vet	vet	VERB
ct-10840	269	3	j	j	PROPN
ct-10840	269	4	2019;60:480	2019;60:480	NUM
ct-10840	269	5	.	.	PROPN
ct-10840	269	6	41	41	NUM
ct-10840	269	7	.	.	PUNCT
ct-10840	270	1	england	england	PROPN
ct-10840	270	2	g	g	PROPN
ct-10840	270	3	,	,	PUNCT
ct-10840	270	4	yeager	yeager	PROPN
ct-10840	270	5	a	a	DET
ct-10840	270	6	:	:	PUNCT
ct-10840	270	7	ultrasonographic	ultrasonographic	ADJ
ct-10840	270	8	appearance	appearance	NOUN
ct-10840	270	9	of	of	ADP
ct-10840	270	10	the	the	DET
ct-10840	270	11	ovary	ovary	NOUN
ct-10840	270	12	and	and	CCONJ
ct-10840	270	13	uterus	uterus	NOUN
ct-10840	270	14	of	of	ADP
ct-10840	270	15	the	the	DET
ct-10840	270	16	bitch	bitch	NOUN
ct-10840	270	17	during	during	ADP
ct-10840	270	18	oestrus	oestrus	NOUN
ct-10840	270	19	,	,	PUNCT
ct-10840	270	20	ovulation	ovulation	NOUN
ct-10840	270	21	and	and	CCONJ
ct-10840	270	22	early	early	ADJ
ct-10840	270	23	pregnancy	pregnancy	NOUN
ct-10840	270	24	.	.	PUNCT
ct-10840	271	1	reprod	reprod	PROPN
ct-10840	271	2	fertil	fertil	VERB
ct-10840	271	3	1993;47:107	1993;47:107	PROPN
ct-10840	271	4	-	-	SYM
ct-10840	271	5	117	117	NUM
ct-10840	271	6	.	.	PUNCT
ct-10840	272	1	42	42	NUM
ct-10840	272	2	.	.	PUNCT
ct-10840	273	1	maya	maya	NOUN
ct-10840	273	2	-	-	PUNCT
ct-10840	273	3	pulgarin	pulgarin	NOUN
ct-10840	273	4	d	d	NOUN
ct-10840	273	5	,	,	PUNCT
ct-10840	273	6	gonzalez	gonzalez	PROPN
ct-10840	273	7	-	-	PUNCT
ct-10840	273	8	dominguez	dominguez	PROPN
ct-10840	273	9	ms	ms	PROPN
ct-10840	273	10	,	,	PUNCT
ct-10840	273	11	aranzazu	aranzazu	ADJ
ct-10840	273	12	-	-	PUNCT
ct-10840	273	13	taborda	taborda	NOUN
ct-10840	273	14	d	d	NOUN
ct-10840	273	15	,	,	PUNCT
ct-10840	273	16	et	et	PROPN
ct-10840	273	17	al	al	PROPN
ct-10840	273	18	:	:	PUNCT
ct-10840	273	19	histopathologic	histopathologic	PROPN
ct-10840	273	20	findings	finding	NOUN
ct-10840	273	21	in	in	ADP
ct-10840	273	22	uteri	uteri	NOUN
ct-10840	273	23	and	and	CCONJ
ct-10840	273	24	ovaries	ovary	NOUN
ct-10840	273	25	collected	collect	VERB
ct-10840	273	26	from	from	ADP
ct-10840	273	27	clinically	clinically	ADV
ct-10840	273	28	healthy	healthy	ADJ
ct-10840	273	29	dogs	dog	NOUN
ct-10840	273	30	at	at	ADP
ct-10840	273	31	elective	elective	ADJ
ct-10840	273	32	ovariohysterectomy	ovariohysterectomy	NOUN
ct-10840	273	33	:	:	PUNCT
ct-10840	273	34	a	a	DET
ct-10840	273	35	cross	cross	ADJ
ct-10840	273	36	-	-	ADJ
ct-10840	273	37	sectional	sectional	ADJ
ct-10840	273	38	study	study	NOUN
ct-10840	273	39	.	.	PUNCT
ct-10840	274	1	j	j	PROPN
ct-10840	274	2	vet	vet	NOUN
ct-10840	274	3	sci	sci	PROPN
ct-10840	274	4	2017;18:407	2017;18:407	NUM
ct-10840	274	5	.	.	PUNCT
ct-10840	275	1	https://doi	https://doi	X
ct-10840	275	2	.	.	PUNCT
ct-10840	276	1	org/10.4142	org/10.4142	PROPN
ct-10840	276	2	/	/	SYM
ct-10840	276	3	jvs.2017.18.3.407	jvs.2017.18.3.407	PROPN
ct-10840	276	4	43	43	NUM
ct-10840	276	5	.	.	PUNCT
ct-10840	277	1	simpson	simpson	PROPN
ct-10840	277	2	i	i	PROPN
ct-10840	277	3	,	,	PUNCT
ct-10840	277	4	albright	albright	PROPN
ct-10840	277	5	s	s	PROPN
ct-10840	277	6	,	,	PUNCT
ct-10840	277	7	wolfe	wolfe	PROPN
ct-10840	277	8	b	b	PROPN
ct-10840	277	9	,	,	PUNCT
ct-10840	277	10	et	et	PROPN
ct-10840	277	11	al	al	PROPN
ct-10840	277	12	:	:	PUNCT
ct-10840	277	13	age	age	NOUN
ct-10840	277	14	at	at	ADP
ct-10840	277	15	gonadectomy	gonadectomy	NOUN
ct-10840	277	16	and	and	CCONJ
ct-10840	277	17	risk	risk	NOUN
ct-10840	277	18	of	of	ADP
ct-10840	277	19	overweight	overweight	ADJ
ct-10840	277	20	/	/	SYM
ct-10840	277	21	obesity	obesity	NOUN
ct-10840	277	22	and	and	CCONJ
ct-10840	277	23	orthopedic	orthopedic	ADJ
ct-10840	277	24	injury	injury	NOUN
ct-10840	277	25	in	in	ADP
ct-10840	277	26	a	a	DET
ct-10840	277	27	cohort	cohort	NOUN
ct-10840	277	28	of	of	ADP
ct-10840	277	29	golden	golden	ADJ
ct-10840	277	30	retrievers	retriever	NOUN
ct-10840	277	31	.	.	PUNCT
ct-10840	278	1	plos	plos	PROPN
ct-10840	278	2	one	one	NUM
ct-10840	278	3	2019;14:1	2019;14:1	NUM
ct-10840	278	4	-	-	SYM
ct-10840	278	5	12	12	NUM
ct-10840	278	6	.	.	PUNCT
ct-10840	279	1	https://doi.org/10.1371/journal.pone.0209131	https://doi.org/10.1371/journal.pone.0209131	PROPN
ct-10840	279	2	44	44	NUM
ct-10840	279	3	.	.	PUNCT
ct-10840	280	1	simpson	simpson	PROPN
ct-10840	280	2	m	m	PROPN
ct-10840	280	3	,	,	PUNCT
ct-10840	280	4	searfoss	searfoss	PROPN
ct-10840	280	5	e	e	PROPN
ct-10840	280	6	,	,	PUNCT
ct-10840	280	7	albright	albright	PROPN
ct-10840	280	8	s	s	PROPN
ct-10840	280	9	,	,	PUNCT
ct-10840	280	10	et	et	PROPN
ct-10840	280	11	al	al	PROPN
ct-10840	280	12	:	:	PUNCT
ct-10840	280	13	population	population	NOUN
ct-10840	280	14	characteristics	characteristic	NOUN
ct-10840	280	15	of	of	ADP
ct-10840	280	16	golden	golden	ADJ
ct-10840	280	17	retriever	retriever	PROPN
ct-10840	280	18	lifetime	lifetime	NOUN
ct-10840	280	19	study	study	NOUN
ct-10840	280	20	enrollees	enrollee	NOUN
ct-10840	280	21	.	.	PUNCT
ct-10840	281	1	canine	canine	PROPN
ct-10840	281	2	genet	genet	PROPN
ct-10840	281	3	epidemiol	epidemiol	PROPN
ct-10840	281	4	2017;4:14	2017;4:14	PROPN
ct-10840	281	5	-	-	PUNCT
ct-10840	281	6	21	21	NUM
ct-10840	281	7	.	.	PUNCT
ct-10840	281	8	45	45	NUM
ct-10840	281	9	.	.	PUNCT
ct-10840	282	1	diez	diez	PROPN
ct-10840	282	2	-	-	PUNCT
ct-10840	282	3	bru	bru	NOUN
ct-10840	282	4	n	n	CCONJ
ct-10840	282	5	,	,	PUNCT
ct-10840	282	6	garcia	garcia	PROPN
ct-10840	282	7	-	-	PUNCT
ct-10840	282	8	real	real	PROPN
ct-10840	282	9	i	i	PROPN
ct-10840	282	10	,	,	PUNCT
ct-10840	282	11	martinez	martinez	PROPN
ct-10840	282	12	em	em	PRON
ct-10840	282	13	,	,	PUNCT
ct-10840	282	14	et	et	PROPN
ct-10840	282	15	al	al	PROPN
ct-10840	282	16	:	:	PUNCT
ct-10840	282	17	ultrasonographic	ultrasonographic	ADJ
ct-10840	282	18	appearance	appearance	NOUN
ct-10840	282	19	of	of	ADP
ct-10840	282	20	ovarian	ovarian	ADJ
ct-10840	282	21	tumours	tumour	NOUN
ct-10840	282	22	in	in	ADP
ct-10840	282	23	10	10	NUM
ct-10840	282	24	dogs	dog	NOUN
ct-10840	282	25	.	.	PUNCT
ct-10840	283	1	vet	vet	NOUN
ct-10840	283	2	radiol	radiol	NOUN
ct-10840	283	3	ultrasound	ultrasound	VERB
ct-10840	283	4	1998;39:226	1998;39:226	NUM
ct-10840	283	5	-	-	SYM
ct-10840	283	6	233	233	NUM
ct-10840	283	7	.	.	PUNCT
ct-10840	284	1	https://doi.org/10.1111/j.1740-8261.1998	https://doi.org/10.1111/j.1740-8261.1998	PROPN
ct-10840	284	2	.	.	PUNCT
ct-10840	285	1	tb00345.x	tb00345.x	NOUN
ct-10840	285	2	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	285	3	https://doi.org/10.2460/javma.1995.207.08.1063	https://doi.org/10.2460/javma.1995.207.08.1063	X
ct-10840	286	1	https://doi.org/10.1111/j.1751-0813.2001.tb14571.x	https://doi.org/10.1111/j.1751-0813.2001.tb14571.x	NOUN
ct-10840	286	2	https://doi.org/10.1111/j.1751-0813.2001.tb14571.x	https://doi.org/10.1111/j.1751-0813.2001.tb14571.x	NOUN
ct-10840	286	3	https://doi.org/10.1053/svms.2002.34642	https://doi.org/10.1053/svms.2002.34642	PROPN
ct-10840	286	4	https://doi.org/10.1016/j.theriogenology.2008.05.059	https://doi.org/10.1016/j.theriogenology.2008.05.059	PROPN
ct-10840	286	5	https://doi.org/10.1111/rda.14407	https://doi.org/10.1111/rda.14407	PROPN
ct-10840	286	6	https://doi.org/10.1111/rda.14407	https://doi.org/10.1111/rda.14407	PROPN
ct-10840	286	7	https://doi.org/10.1016/j.theriogenology.2008.05.035	https://doi.org/10.1016/j.theriogenology.2008.05.035	PROPN
ct-10840	286	8	https://doi.org/10.1016/j.theriogenology.2008.05.035	https://doi.org/10.1016/j.theriogenology.2008.05.035	PROPN
ct-10840	286	9	https://doi.org/10.1111/evj.13279	https://doi.org/10.1111/evj.13279	VERB
ct-10840	286	10	https://doi.org/10.1111/rda.13171	https://doi.org/10.1111/rda.13171	PROPN
ct-10840	286	11	https://doi.org/10.1016/j.theriogenology.2017.12.003	https://doi.org/10.1016/j.theriogenology.2017.12.003	NOUN
ct-10840	286	12	https://doi.org/10.1016/j.theriogenology.2017.12.003	https://doi.org/10.1016/j.theriogenology.2017.12.003	NOUN
ct-10840	286	13	https://doi.org/10.1016/j.cveq.2006.08.008	https://doi.org/10.1016/j.cveq.2006.08.008	NOUN
ct-10840	286	14	https://doi.org/10.1016/j.theriogenology.2013.07.022	https://doi.org/10.1016/j.theriogenology.2013.07.022	NOUN
ct-10840	286	15	https://doi.org/10.1016/j.theriogenology.2013.07.022	https://doi.org/10.1016/j.theriogenology.2013.07.022	NOUN
ct-10840	286	16	https://doi.org/10.1016/0093-691x(96)00076-3	https://doi.org/10.1016/0093-691x(96)00076-3	ADP
ct-10840	286	17	https://doi.org/10.1111/j.2042-3306.2012.00594.x	https://doi.org/10.1111/j.2042-3306.2012.00594.x	ADJ
ct-10840	286	18	https://doi.org/10.1111/j.2042-3306.2012.00594.x	https://doi.org/10.1111/j.2042-3306.2012.00594.x	CCONJ
ct-10840	286	19	https://doi.org/10.1071/rd9961137	https://doi.org/10.1071/rd9961137	X
ct-10840	287	1	https://doi.org/10.1111/rda.12856	https://doi.org/10.1111/rda.12856	PROPN
ct-10840	287	2	https://doi.org/10.1111/rda.12660	https://doi.org/10.1111/rda.12660	PROPN
ct-10840	287	3	https://doi.org/10.1111/rda.12660	https://doi.org/10.1111/rda.12660	PROPN
ct-10840	287	4	https://doi.org/10.3389/fvets.2022.834031	https://doi.org/10.3389/fvets.2022.834031	PROPN
ct-10840	287	5	https://doi.org/10.1111/rda.12781	https://doi.org/10.1111/rda.12781	PROPN
ct-10840	288	1	https://doi.org/10.1002/vms3.860	https://doi.org/10.1002/vms3.860	X
ct-10840	288	2	https://doi.org/10.1002/vms3.860	https://doi.org/10.1002/vms3.860	X
ct-10840	288	3	https://doi.org/10.1016/j.theriogenology.2007.08.019	https://doi.org/10.1016/j.theriogenology.2007.08.019	VERB
ct-10840	288	4	https://doi.org/10.1016/j.theriogenology.2007.08.019	https://doi.org/10.1016/j.theriogenology.2007.08.019	PRON
ct-10840	288	5	https://doi.org/10.1016/j.theriogenology.2011.02.017	https://doi.org/10.1016/j.theriogenology.2011.02.017	NUM
ct-10840	288	6	https://doi.org/10.4142/jvs.2017.18.3.407	https://doi.org/10.4142/jvs.2017.18.3.407	INTJ
ct-10840	288	7	https://doi.org/10.4142/jvs.2017.18.3.407	https://doi.org/10.4142/jvs.2017.18.3.407	INTJ
ct-10840	288	8	https://doi.org/10.1371/journal.pone.0209131	https://doi.org/10.1371/journal.pone.0209131	PROPN
ct-10840	288	9	https://doi.org/10.1371/journal.pone.0209131	https://doi.org/10.1371/journal.pone.0209131	INTJ
ct-10840	288	10	https://doi.org/10.1111/j.1740-8261.1998.tb00345.x	https://doi.org/10.1111/j.1740-8261.1998.tb00345.x	INTJ
ct-10840	288	11	https://doi.org/10.1111/j.1740-8261.1998.tb00345.x	https://doi.org/10.1111/j.1740-8261.1998.tb00345.x	PROPN
ct-10840	288	12	citation	citation	NOUN
ct-10840	288	13	:	:	PUNCT
ct-10840	288	14	clinical	clinical	ADJ
ct-10840	288	15	theriogenology	theriogenology	NOUN
ct-10840	288	16	2024	2024	NUM
ct-10840	288	17	,	,	PUNCT
ct-10840	288	18	16	16	NUM
ct-10840	288	19	,	,	PUNCT
ct-10840	288	20	10840	10840	NUM
ct-10840	288	21	,	,	PUNCT
ct-10840	288	22	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	NOUN
ct-10840	288	23	9	9	NUM
ct-10840	288	24	46	46	NUM
ct-10840	288	25	.	.	PUNCT
ct-10840	289	1	bourne	bourne	PROPN
ct-10840	289	2	t	t	PROPN
ct-10840	289	3	,	,	PUNCT
ct-10840	289	4	campbell	campbell	PROPN
ct-10840	289	5	s	s	PROPN
ct-10840	289	6	,	,	PUNCT
ct-10840	289	7	steer	steer	VERB
ct-10840	289	8	c	c	NOUN
ct-10840	289	9	,	,	PUNCT
ct-10840	289	10	et	et	PROPN
ct-10840	289	11	al	al	PROPN
ct-10840	289	12	:	:	PUNCT
ct-10840	289	13	transvaginal	transvaginal	ADJ
ct-10840	289	14	colour	colour	NOUN
ct-10840	289	15	flow	flow	NOUN
ct-10840	289	16	imaging	imaging	NOUN
ct-10840	289	17	:	:	PUNCT
ct-10840	289	18	a	a	DET
ct-10840	289	19	possible	possible	ADJ
ct-10840	289	20	new	new	ADJ
ct-10840	289	21	screening	screening	NOUN
ct-10840	289	22	technique	technique	NOUN
ct-10840	289	23	for	for	ADP
ct-10840	289	24	ovarian	ovarian	ADJ
ct-10840	289	25	cancer	cancer	NOUN
ct-10840	289	26	.	.	PUNCT
ct-10840	290	1	bmj	bmj	PROPN
ct-10840	290	2	1989;299:1367	1989;299:1367	NUM
ct-10840	290	3	.	.	PUNCT
ct-10840	291	1	https://doi.org/10.1136/bmj.299.6712.1367	https://doi.org/10.1136/bmj.299.6712.1367	PROPN
ct-10840	291	2	47	47	NUM
ct-10840	291	3	.	.	PUNCT
ct-10840	292	1	hollinshead	hollinshead	PROPN
ct-10840	292	2	f	f	PROPN
ct-10840	292	3	,	,	PUNCT
ct-10840	292	4	walker	walker	PROPN
ct-10840	292	5	c	c	PROPN
ct-10840	292	6	,	,	PUNCT
ct-10840	292	7	hanlon	hanlon	NOUN
ct-10840	292	8	d	d	NOUN
ct-10840	292	9	:	:	PUNCT
ct-10840	292	10	determination	determination	NOUN
ct-10840	292	11	of	of	ADP
ct-10840	292	12	the	the	DET
ct-10840	292	13	normal	normal	ADJ
ct-10840	292	14	reference	reference	NOUN
ct-10840	292	15	interval	interval	NOUN
ct-10840	292	16	for	for	ADP
ct-10840	292	17	anti	anti	ADJ
ct-10840	292	18	-	-	ADJ
ct-10840	292	19	mullerian	mullerian	ADJ
ct-10840	292	20	hormone	hormone	NOUN
ct-10840	292	21	(	(	PUNCT
ct-10840	292	22	amh	amh	PROPN
ct-10840	292	23	)	)	PUNCT
ct-10840	292	24	in	in	ADP
ct-10840	292	25	bitches	bitch	NOUN
ct-10840	292	26	and	and	CCONJ
ct-10840	292	27	use	use	NOUN
ct-10840	292	28	of	of	ADP
ct-10840	292	29	amh	amh	PROPN
ct-10840	292	30	as	as	ADP
ct-10840	292	31	a	a	DET
ct-10840	292	32	potential	potential	ADJ
ct-10840	292	33	predictor	predictor	NOUN
ct-10840	292	34	of	of	ADP
ct-10840	292	35	litter	litter	NOUN
ct-10840	292	36	size	size	NOUN
ct-10840	292	37	.	.	PUNCT
ct-10840	293	1	reprod	reprod	PROPN
ct-10840	293	2	domest	domest	PROPN
ct-10840	293	3	anim	anim	NOUN
ct-10840	293	4	2017;52:35	2017;52:35	NOUN
ct-10840	293	5	-	-	SYM
ct-10840	293	6	40	40	NUM
ct-10840	293	7	.	.	PUNCT
ct-10840	294	1	https://doi.org/10.1111/	https://doi.org/10.1111/	PROPN
ct-10840	294	2	rda.12822	rda.12822	NUM
ct-10840	294	3	48	48	NUM
ct-10840	294	4	.	.	PUNCT
ct-10840	295	1	stabenfeldt	stabenfeldt	PROPN
ct-10840	295	2	g	g	PROPN
ct-10840	295	3	,	,	PUNCT
ct-10840	295	4	hughes	hughes	PROPN
ct-10840	295	5	j	j	PROPN
ct-10840	295	6	,	,	PUNCT
ct-10840	295	7	kennedy	kennedy	PROPN
ct-10840	295	8	p	p	X
ct-10840	295	9	,	,	PUNCT
ct-10840	295	10	et	et	PROPN
ct-10840	295	11	al	al	PROPN
ct-10840	295	12	:	:	PUNCT
ct-10840	295	13	clinical	clinical	ADJ
ct-10840	295	14	findings	finding	NOUN
ct-10840	295	15	,	,	PUNCT
ct-10840	295	16	pathological	pathological	ADJ
ct-10840	295	17	changes	change	NOUN
ct-10840	295	18	and	and	CCONJ
ct-10840	295	19	endocrinological	endocrinological	ADJ
ct-10840	295	20	secretory	secretory	NOUN
ct-10840	295	21	patterns	pattern	NOUN
ct-10840	295	22	in	in	ADP
ct-10840	295	23	mares	mare	NOUN
ct-10840	295	24	with	with	ADP
ct-10840	295	25	ovarian	ovarian	ADJ
ct-10840	295	26	tumours	tumour	NOUN
ct-10840	295	27	.	.	PUNCT
ct-10840	296	1	j	j	PROPN
ct-10840	296	2	reprod	reprod	PROPN
ct-10840	296	3	fertil	fertil	VERB
ct-10840	296	4	1979;27:277	1979;27:277	PROPN
ct-10840	296	5	-	-	PUNCT
ct-10840	296	6	285	285	NUM
ct-10840	296	7	.	.	PUNCT
ct-10840	296	8	49	49	NUM
ct-10840	296	9	.	.	PUNCT
ct-10840	297	1	bailey	bailey	PROPN
ct-10840	297	2	m	m	PROPN
ct-10840	297	3	,	,	PUNCT
ct-10840	297	4	troedsson	troedsson	PROPN
ct-10840	297	5	m	m	PROPN
ct-10840	297	6	,	,	PUNCT
ct-10840	297	7	wheato	wheato	PROPN
ct-10840	297	8	j	j	PROPN
ct-10840	297	9	:	:	PUNCT
ct-10840	297	10	inhibin	inhibin	ADJ
ct-10840	297	11	concentrations	concentration	NOUN
ct-10840	297	12	in	in	ADP
ct-10840	297	13	mares	mare	NOUN
ct-10840	297	14	with	with	ADP
ct-10840	297	15	granulosa	granulosa	NOUN
ct-10840	297	16	cell	cell	NOUN
ct-10840	297	17	tumors	tumor	NOUN
ct-10840	297	18	.	.	PUNCT
ct-10840	298	1	theriogenology	theriogenology	NOUN
ct-10840	298	2	2002;57:18851895	2002;57:18851895	NUM
ct-10840	298	3	.	.	PUNCT
ct-10840	299	1	https://doi.org/10.1016/s0093-691x(02)00658-1	https://doi.org/10.1016/s0093-691x(02)00658-1	NUM
ct-10840	299	2	50	50	NUM
ct-10840	299	3	.	.	PUNCT
ct-10840	300	1	zelli	zelli	PROPN
ct-10840	300	2	r	r	NOUN
ct-10840	300	3	,	,	PUNCT
ct-10840	300	4	monaci	monaci	NOUN
ct-10840	300	5	m	m	PROPN
ct-10840	300	6	,	,	PUNCT
ct-10840	300	7	stradaioli	stradaioli	ADP
ct-10840	300	8	g	g	PROPN
ct-10840	300	9	,	,	PUNCT
ct-10840	300	10	et	et	PROPN
ct-10840	300	11	al	al	PROPN
ct-10840	300	12	:	:	PUNCT
ct-10840	300	13	gonadotropin	gonadotropin	PROPN
ct-10840	300	14	secretion	secretion	NOUN
ct-10840	300	15	and	and	CCONJ
ct-10840	300	16	pituitary	pituitary	ADJ
ct-10840	300	17	responsiveness	responsiveness	NOUN
ct-10840	300	18	to	to	ADP
ct-10840	300	19	gnrh	gnrh	NOUN
ct-10840	300	20	in	in	ADP
ct-10840	300	21	mares	mare	NOUN
ct-10840	300	22	with	with	ADP
ct-10840	300	23	granulosa	granulosa	NOUN
ct-10840	300	24	-	-	PUNCT
ct-10840	300	25	theca	theca	NOUN
ct-10840	300	26	cell	cell	NOUN
ct-10840	300	27	tumor	tumor	NOUN
ct-10840	300	28	.	.	PUNCT
ct-10840	301	1	theriogenology	theriogenology	NOUN
ct-10840	301	2	2006;66:1210	2006;66:1210	PROPN
ct-10840	301	3	-	-	SYM
ct-10840	301	4	1218	1218	NUM
ct-10840	301	5	.	.	PUNCT
ct-10840	302	1	https://doi	https://doi	X
ct-10840	302	2	.	.	PUNCT
ct-10840	303	1	org/10.1016	org/10.1016	PROPN
ct-10840	303	2	/	/	SYM
ct-10840	303	3	j.theriogenology.2006.03.030	j.theriogenology.2006.03.030	PROPN
ct-10840	303	4	51	51	NUM
ct-10840	303	5	.	.	PUNCT
ct-10840	304	1	bertazzolo	bertazzolo	PROPN
ct-10840	304	2	w	w	PROPN
ct-10840	304	3	,	,	PUNCT
ct-10840	304	4	dell’orco	dell’orco	NOUN
ct-10840	304	5	m	m	PROPN
ct-10840	304	6	,	,	PUNCT
ct-10840	304	7	bonfanti	bonfanti	PROPN
ct-10840	304	8	u	u	NOUN
ct-10840	304	9	,	,	PUNCT
ct-10840	304	10	et	et	PROPN
ct-10840	304	11	al	al	PROPN
ct-10840	304	12	:	:	PUNCT
ct-10840	304	13	cytological	cytological	ADJ
ct-10840	304	14	features	feature	NOUN
ct-10840	304	15	of	of	ADP
ct-10840	304	16	canine	canine	ADJ
ct-10840	304	17	ovarian	ovarian	ADJ
ct-10840	304	18	tumours	tumour	NOUN
ct-10840	304	19	:	:	PUNCT
ct-10840	304	20	a	a	DET
ct-10840	304	21	retrospective	retrospective	ADJ
ct-10840	304	22	study	study	NOUN
ct-10840	304	23	of	of	ADP
ct-10840	304	24	19	19	NUM
ct-10840	304	25	cases	case	NOUN
ct-10840	304	26	.	.	PUNCT
ct-10840	305	1	j	j	PROPN
ct-10840	305	2	small	small	PROPN
ct-10840	305	3	anim	anim	NOUN
ct-10840	305	4	pract	pract	NOUN
ct-10840	305	5	2004;45:539	2004;45:539	PROPN
ct-10840	305	6	-	-	SYM
ct-10840	305	7	545	545	NUM
ct-10840	305	8	.	.	PUNCT
ct-10840	306	1	https://doi.org/10	https://doi.org/10	PROPN
ct-10840	306	2	.	.	PUNCT
ct-10840	307	1	1111/	1111/	NUM
ct-10840	307	2	j.1748	j.1748	NOUN
ct-10840	307	3	-	-	PUNCT
ct-10840	307	4	5827.2004.tb00200.x	5827.2004.tb00200.x	NUM
ct-10840	307	5	52	52	NUM
ct-10840	307	6	.	.	PUNCT
ct-10840	308	1	röcken	röcken	PROPN
ct-10840	308	2	m	m	PROPN
ct-10840	308	3	,	,	PUNCT
ct-10840	308	4	mosel	mosel	PROPN
ct-10840	308	5	g	g	PROPN
ct-10840	308	6	,	,	PUNCT
ct-10840	308	7	seyrek	seyrek	NOUN
ct-10840	308	8	-	-	PUNCT
ct-10840	308	9	intas	inta	NOUN
ct-10840	309	1	k	k	PROPN
ct-10840	309	2	,	,	PUNCT
ct-10840	309	3	et	et	PROPN
ct-10840	309	4	al	al	PROPN
ct-10840	309	5	:	:	PUNCT
ct-10840	309	6	unilateral	unilateral	ADJ
ct-10840	309	7	and	and	CCONJ
ct-10840	309	8	bilateral	bilateral	ADJ
ct-10840	309	9	laparoscopic	laparoscopic	NOUN
ct-10840	309	10	ovariectomy	ovariectomy	NOUN
ct-10840	309	11	in	in	ADP
ct-10840	309	12	157	157	NUM
ct-10840	309	13	mares	mare	NOUN
ct-10840	309	14	:	:	PUNCT
ct-10840	309	15	a	a	DET
ct-10840	309	16	retrospective	retrospective	ADJ
ct-10840	309	17	multicenter	multicenter	ADJ
ct-10840	309	18	study	study	NOUN
ct-10840	309	19	.	.	PUNCT
ct-10840	310	1	vet	vet	NOUN
ct-10840	310	2	surg	surg	NOUN
ct-10840	310	3	2011;40:1009	2011;40:1009	NUM
ct-10840	310	4	-	-	SYM
ct-10840	310	5	1014	1014	NUM
ct-10840	310	6	.	.	PUNCT
ct-10840	311	1	https://doi	https://doi	PROPN
ct-10840	311	2	.	.	PUNCT
ct-10840	311	3	org/10.1111	org/10.1111	PROPN
ct-10840	311	4	/	/	SYM
ct-10840	311	5	j.1532	j.1532	PROPN
ct-10840	311	6	-	-	PUNCT
ct-10840	311	7	950x.2011.00884.x	950x.2011.00884.x	PROPN
ct-10840	311	8	53	53	NUM
ct-10840	311	9	.	.	PUNCT
ct-10840	311	10	seyrek	seyrek	NOUN
ct-10840	311	11	-	-	PUNCT
ct-10840	311	12	intas	inta	VERB
ct-10840	311	13	k	k	NOUN
ct-10840	311	14	,	,	PUNCT
ct-10840	311	15	wehrend	wehrend	ADJ
ct-10840	311	16	a	a	PRON
ct-10840	311	17	,	,	PUNCT
ct-10840	311	18	nak	nak	PROPN
ct-10840	311	19	y	y	PROPN
ct-10840	311	20	,	,	PUNCT
ct-10840	311	21	et	et	PROPN
ct-10840	311	22	al	al	PROPN
ct-10840	311	23	:	:	PUNCT
ct-10840	311	24	unilateral	unilateral	ADJ
ct-10840	311	25	hysterectomy	hysterectomy	NOUN
ct-10840	311	26	(	(	PUNCT
ct-10840	311	27	cornuectomy	cornuectomy	NOUN
ct-10840	311	28	)	)	PUNCT
ct-10840	311	29	in	in	ADP
ct-10840	311	30	the	the	DET
ct-10840	311	31	bitch	bitch	NOUN
ct-10840	311	32	and	and	CCONJ
ct-10840	311	33	its	its	PRON
ct-10840	311	34	effect	effect	NOUN
ct-10840	311	35	on	on	ADP
ct-10840	311	36	subsequent	subsequent	ADJ
ct-10840	311	37	fertility	fertility	NOUN
ct-10840	311	38	.	.	PUNCT
ct-10840	312	1	theriogenology	theriogenology	NOUN
ct-10840	312	2	2004;61:1713	2004;61:1713	PROPN
ct-10840	312	3	-	-	SYM
ct-10840	312	4	1717	1717	NUM
ct-10840	312	5	.	.	PUNCT
ct-10840	313	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ct-10840	313	2	.	.	PUNCT
ct-10840	314	1	theriogenology.2003.09.015	theriogenology.2003.09.015	X
ct-10840	315	1	54	54	NUM
ct-10840	315	2	.	.	PUNCT
ct-10840	316	1	stratmann	stratmann	PROPN
ct-10840	316	2	n	n	CCONJ
ct-10840	316	3	,	,	PUNCT
ct-10840	316	4	wehrend	wehrend	VERB
ct-10840	316	5	a	a	DET
ct-10840	316	6	:	:	PUNCT
ct-10840	316	7	unilateral	unilateral	ADJ
ct-10840	316	8	ovariectomy	ovariectomy	NOUN
ct-10840	316	9	and	and	CCONJ
ct-10840	316	10	cystectomy	cystectomy	NOUN
ct-10840	316	11	due	due	ADJ
ct-10840	316	12	to	to	ADP
ct-10840	316	13	multiple	multiple	ADJ
ct-10840	316	14	ovarian	ovarian	ADJ
ct-10840	316	15	cysts	cyst	NOUN
ct-10840	316	16	with	with	ADP
ct-10840	316	17	subsequent	subsequent	ADJ
ct-10840	316	18	pregnancy	pregnancy	NOUN
ct-10840	316	19	in	in	ADP
ct-10840	316	20	a	a	DET
ct-10840	316	21	belgian	belgian	ADJ
ct-10840	316	22	shepherd	shepherd	ADJ
ct-10840	316	23	dog	dog	NOUN
ct-10840	316	24	.	.	PUNCT
ct-10840	317	1	vet	vet	NOUN
ct-10840	317	2	rec	rec	X
ct-10840	317	3	2007;160:740	2007;160:740	NUM
ct-10840	317	4	-	-	SYM
ct-10840	317	5	741	741	NUM
ct-10840	317	6	.	.	PUNCT
ct-10840	318	1	https://doi	https://doi	PROPN
ct-10840	318	2	.	.	PUNCT
ct-10840	318	3	org/10.1136	org/10.1136	NOUN
ct-10840	318	4	/	/	SYM
ct-10840	318	5	vr.160.21.740	vr.160.21.740	ADJ
ct-10840	318	6	55	55	NUM
ct-10840	318	7	.	.	PUNCT
ct-10840	319	1	van	van	PROPN
ct-10840	319	2	nimwegen	nimwegen	PROPN
ct-10840	319	3	s	s	PROPN
ct-10840	319	4	,	,	PUNCT
ct-10840	319	5	goethem	goethem	PROPN
ct-10840	319	6	b	b	NOUN
ct-10840	319	7	,	,	PUNCT
ct-10840	319	8	de	de	X
ct-10840	319	9	gier	gier	PROPN
ct-10840	319	10	j	j	PROPN
ct-10840	319	11	et	et	PROPN
ct-10840	319	12	al	al	PROPN
ct-10840	319	13	:	:	PUNCT
ct-10840	319	14	a	a	DET
ct-10840	319	15	laparoscopic	laparoscopic	NOUN
ct-10840	319	16	approach	approach	NOUN
ct-10840	319	17	for	for	ADP
ct-10840	319	18	removal	removal	NOUN
ct-10840	319	19	of	of	ADP
ct-10840	319	20	ovarian	ovarian	ADJ
ct-10840	319	21	remnant	remnant	ADJ
ct-10840	319	22	tissue	tissue	NOUN
ct-10840	319	23	in	in	ADP
ct-10840	319	24	32	32	NUM
ct-10840	319	25	dogs	dog	NOUN
ct-10840	319	26	.	.	PUNCT
ct-10840	320	1	bmc	bmc	ADJ
ct-10840	320	2	vet	vet	NOUN
ct-10840	320	3	res	re	NOUN
ct-10840	320	4	2018;14:333	2018;14:333	NOUN
ct-10840	320	5	-	-	SYM
ct-10840	320	6	346	346	NUM
ct-10840	320	7	.	.	PUNCT
ct-10840	321	1	https://doi.org/10.1186/s12917-018-1658-y	https://doi.org/10.1186/s12917-018-1658-y	NOUN
ct-10840	321	2	56	56	NUM
ct-10840	321	3	.	.	PUNCT
ct-10840	322	1	tsutsui	tsutsui	PROPN
ct-10840	322	2	t	t	PROPN
ct-10840	322	3	,	,	PUNCT
ct-10840	322	4	hori	hori	PROPN
ct-10840	322	5	t	t	PROPN
ct-10840	322	6	,	,	PUNCT
ct-10840	322	7	takahashi	takahashi	PROPN
ct-10840	322	8	f	f	PROPN
ct-10840	322	9	,	,	PUNCT
ct-10840	322	10	et	et	PROPN
ct-10840	322	11	al	al	PROPN
ct-10840	322	12	:	:	PUNCT
ct-10840	322	13	ovulation	ovulation	NOUN
ct-10840	322	14	compensatory	compensatory	ADJ
ct-10840	322	15	function	function	NOUN
ct-10840	322	16	after	after	ADP
ct-10840	322	17	unilateral	unilateral	ADJ
ct-10840	322	18	ovariectomy	ovariectomy	NOUN
ct-10840	322	19	in	in	ADP
ct-10840	322	20	dogs	dog	NOUN
ct-10840	322	21	.	.	PUNCT
ct-10840	323	1	reprod	reprod	PROPN
ct-10840	323	2	dom	dom	PROPN
ct-10840	323	3	anim	anim	PROPN
ct-10840	323	4	2012;47:43	2012;47:43	PROPN
ct-10840	323	5	-	-	SYM
ct-10840	323	6	46	46	NUM
ct-10840	323	7	.	.	PUNCT
ct-10840	324	1	https://doi.org/10.1111/rda.12075	https://doi.org/10.1111/rda.12075	PROPN
ct-10840	324	2	57	57	NUM
ct-10840	324	3	.	.	PUNCT
ct-10840	325	1	england	england	PROPN
ct-10840	325	2	g	g	PROPN
ct-10840	325	3	,	,	PUNCT
ct-10840	325	4	moxon	moxon	PROPN
ct-10840	325	5	r	r	PROPN
ct-10840	325	6	,	,	PUNCT
ct-10840	325	7	freeman	freeman	PROPN
ct-10840	325	8	s	s	PART
ct-10840	325	9	:	:	PUNCT
ct-10840	325	10	delayed	delay	VERB
ct-10840	325	11	uterine	uterine	ADJ
ct-10840	325	12	fluid	fluid	ADJ
ct-10840	325	13	clearance	clearance	NOUN
ct-10840	325	14	and	and	CCONJ
ct-10840	325	15	reduced	reduce	VERB
ct-10840	325	16	uterine	uterine	ADJ
ct-10840	325	17	perfusion	perfusion	NOUN
ct-10840	325	18	in	in	ADP
ct-10840	325	19	bitches	bitch	NOUN
ct-10840	325	20	with	with	ADP
ct-10840	325	21	endometrial	endometrial	ADJ
ct-10840	325	22	hyperplasia	hyperplasia	NOUN
ct-10840	325	23	and	and	CCONJ
ct-10840	325	24	clinical	clinical	ADJ
ct-10840	325	25	management	management	NOUN
ct-10840	325	26	with	with	ADP
ct-10840	325	27	postmating	postmate	VERB
ct-10840	325	28	antibiotic	antibiotic	ADJ
ct-10840	325	29	.	.	PUNCT
ct-10840	326	1	theriogenology	theriogenology	NOUN
ct-10840	326	2	2012;78:1611	2012;78:1611	PROPN
ct-10840	326	3	-	-	SYM
ct-10840	326	4	1617	1617	NUM
ct-10840	326	5	.	.	PUNCT
ct-10840	327	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ct-10840	327	2	.	.	PUNCT
ct-10840	328	1	theriogenology.2012.07.009	theriogenology.2012.07.009	X
ct-10840	329	1	58	58	NUM
ct-10840	329	2	.	.	PUNCT
ct-10840	330	1	freshman	freshman	NOUN
ct-10840	330	2	jl	jl	PROPN
ct-10840	330	3	:	:	PUNCT
ct-10840	330	4	clinical	clinical	ADJ
ct-10840	330	5	approach	approach	NOUN
ct-10840	330	6	to	to	ADP
ct-10840	330	7	infertility	infertility	NOUN
ct-10840	330	8	in	in	ADP
ct-10840	330	9	the	the	DET
ct-10840	330	10	cycling	cycling	NOUN
ct-10840	330	11	bitch	bitch	NOUN
ct-10840	330	12	.	.	PUNCT
ct-10840	331	1	vet	vet	NOUN
ct-10840	331	2	clin	clin	PROPN
ct-10840	331	3	north	north	PROPN
ct-10840	331	4	am	be	AUX
ct-10840	331	5	small	small	ADJ
ct-10840	331	6	anim	anim	NOUN
ct-10840	331	7	pract	pract	NOUN
ct-10840	331	8	1991;21:427	1991;21:427	NUM
ct-10840	331	9	-	-	SYM
ct-10840	331	10	435	435	NUM
ct-10840	331	11	.	.	PUNCT
ct-10840	332	1	https://	https://	PROPN
ct-10840	332	2	doi.org/10.1016/s0195-5616(91)50052-8	doi.org/10.1016/s0195-5616(91)50052-8	PROPN
ct-10840	332	3	59	59	NUM
ct-10840	332	4	.	.	PUNCT
ct-10840	332	5	moxon	moxon	PROPN
ct-10840	332	6	r	r	PROPN
ct-10840	332	7	,	,	PUNCT
ct-10840	332	8	whiteside	whiteside	PROPN
ct-10840	332	9	h	h	PROPN
ct-10840	332	10	,	,	PUNCT
ct-10840	332	11	england	england	PROPN
ct-10840	332	12	g	g	NOUN
ct-10840	332	13	:	:	PUNCT
ct-10840	332	14	prevalence	prevalence	NOUN
ct-10840	332	15	of	of	ADP
ct-10840	332	16	ultrasound	ultrasound	NOUN
ct-10840	332	17	-	-	PUNCT
ct-10840	332	18	determined	determine	VERB
ct-10840	332	19	cystic	cystic	ADJ
ct-10840	332	20	endometrial	endometrial	ADJ
ct-10840	332	21	hyperplasia	hyperplasia	NOUN
ct-10840	332	22	and	and	CCONJ
ct-10840	332	23	the	the	DET
ct-10840	332	24	relationship	relationship	NOUN
ct-10840	332	25	with	with	ADP
ct-10840	332	26	age	age	NOUN
ct-10840	332	27	in	in	ADP
ct-10840	332	28	dogs	dog	NOUN
ct-10840	332	29	.	.	PUNCT
ct-10840	333	1	theriogenology	theriogenology	NOUN
ct-10840	333	2	2016;86:976	2016;86:976	NOUN
ct-10840	333	3	-	-	PUNCT
ct-10840	333	4	980	980	NUM
ct-10840	333	5	.	.	PUNCT
ct-10840	334	1	https://doi	https://doi	NOUN
ct-10840	334	2	.	.	PUNCT
ct-10840	335	1	org/10.1016	org/10.1016	PROPN
ct-10840	335	2	/	/	SYM
ct-10840	335	3	j.theriogenology.2016.03.022	j.theriogenology.2016.03.022	NOUN
ct-10840	335	4	60	60	NUM
ct-10840	335	5	.	.	PUNCT
ct-10840	336	1	snider	snider	PROPN
ct-10840	336	2	t	t	PROPN
ct-10840	336	3	,	,	PUNCT
ct-10840	336	4	sepoy	sepoy	PROPN
ct-10840	336	5	c	c	NOUN
ct-10840	336	6	,	,	PUNCT
ct-10840	336	7	holyoak	holyoak	VERB
ct-10840	336	8	g	g	NOUN
ct-10840	336	9	:	:	PUNCT
ct-10840	336	10	equine	equine	NOUN
ct-10840	336	11	endometrial	endometrial	ADJ
ct-10840	336	12	biopsy	biopsy	NOUN
ct-10840	336	13	reviewed	review	VERB
ct-10840	336	14	:	:	PUNCT
ct-10840	337	1	observation	observation	NOUN
ct-10840	337	2	,	,	PUNCT
ct-10840	337	3	interpretation	interpretation	NOUN
ct-10840	337	4	,	,	PUNCT
ct-10840	337	5	and	and	CCONJ
ct-10840	337	6	application	application	NOUN
ct-10840	337	7	of	of	ADP
ct-10840	337	8	histopathologic	histopathologic	ADJ
ct-10840	337	9	data	datum	NOUN
ct-10840	337	10	.	.	PUNCT
ct-10840	338	1	theriogenology	theriogenology	NOUN
ct-10840	338	2	2011;75:1567	2011;75:1567	NUM
ct-10840	338	3	-	-	SYM
ct-10840	338	4	1581	1581	NUM
ct-10840	338	5	.	.	PUNCT
ct-10840	339	1	https://doi	https://doi	X
ct-10840	339	2	.	.	PUNCT
ct-10840	340	1	org/10.1016	org/10.1016	PROPN
ct-10840	340	2	/	/	SYM
ct-10840	340	3	j.theriogenology.2010.12.013	j.theriogenology.2010.12.013	PROPN
ct-10840	340	4	http://dx.doi.org/10.58292/ct.v16.10840	http://dx.doi.org/10.58292/ct.v16.10840	PROPN
ct-10840	340	5	https://doi.org/10.1136/bmj.299.6712.1367	https://doi.org/10.1136/bmj.299.6712.1367	PROPN
ct-10840	340	6	https://doi.org/10.1111/rda.12822	https://doi.org/10.1111/rda.12822	PROPN
ct-10840	340	7	https://doi.org/10.1111/rda.12822	https://doi.org/10.1111/rda.12822	PROPN
ct-10840	340	8	https://doi.org/10.1016/s0093-691x(02)00658-1	https://doi.org/10.1016/s0093-691x(02)00658-1	PROPN
ct-10840	340	9	https://doi.org/10.1016/j.theriogenology.2006.03.030	https://doi.org/10.1016/j.theriogenology.2006.03.030	PROPN
ct-10840	340	10	https://doi.org/10.1016/j.theriogenology.2006.03.030	https://doi.org/10.1016/j.theriogenology.2006.03.030	PROPN
ct-10840	340	11	https://doi.org/10.​1111/j.1748-5827.2004.tb00200.x	https://doi.org/10.​1111/j.1748-5827.2004.tb00200.x	PROPN
ct-10840	340	12	https://doi.org/10.​1111/j.1748-5827.2004.tb00200.x	https://doi.org/10.​1111/j.1748-5827.2004.tb00200.x	PROPN
ct-10840	341	1	https://doi.org/10.1111/j.1532-950x.2011.00884.x	https://doi.org/10.1111/j.1532-950x.2011.00884.x	PROPN
ct-10840	341	2	https://doi.org/10.1111/j.1532-950x.2011.00884.x	https://doi.org/10.1111/j.1532-950x.2011.00884.x	PROPN
ct-10840	341	3	https://doi.org/10.1016/j.theriogenology.2003.09.015	https://doi.org/10.1016/j.theriogenology.2003.09.015	PROPN
ct-10840	341	4	https://doi.org/10.1016/j.theriogenology.2003.09.015	https://doi.org/10.1016/j.theriogenology.2003.09.015	AUX
ct-10840	341	5	https://doi.org/10.1136/vr.160.21.740	https://doi.org/10.1136/vr.160.21.740	NOUN
ct-10840	342	1	https://doi.org/10.1136/vr.160.21.740	https://doi.org/10.1136/vr.160.21.740	NOUN
ct-10840	343	1	https://doi.org/10.1186/s12917-018-1658-y	https://doi.org/10.1186/s12917-018-1658-y	PROPN
ct-10840	344	1	https://doi.org/10.1111/rda.12075	https://doi.org/10.1111/rda.12075	PROPN
ct-10840	344	2	https://doi.org/10.1016/j.theriogenology.2012.07.009	https://doi.org/10.1016/j.theriogenology.2012.07.009	PROPN
ct-10840	344	3	https://doi.org/10.1016/j.theriogenology.2012.07.009	https://doi.org/10.1016/j.theriogenology.2012.07.009	PROPN
ct-10840	344	4	https://doi.org/10.1016/s0195-5616(91)50052-8	https://doi.org/10.1016/s0195-5616(91)50052-8	PROPN
ct-10840	344	5	https://doi.org/10.1016/s0195-5616(91)50052-8	https://doi.org/10.1016/s0195-5616(91)50052-8	PROPN
ct-10840	344	6	https://doi.org/10.1016/j.theriogenology.2016.03.022	https://doi.org/10.1016/j.theriogenology.2016.03.022	PROPN
ct-10840	344	7	https://doi.org/10.1016/j.theriogenology.2016.03.022	https://doi.org/10.1016/j.theriogenology.2016.03.022	PROPN
ct-10840	344	8	https://doi.org/10.1016/j.theriogenology.2010.12.013	https://doi.org/10.1016/j.theriogenology.2010.12.013	VERB
ct-10840	344	9	https://doi.org/10.1016/j.theriogenology.2010.12.013	https://doi.org/10.1016/j.theriogenology.2010.12.013	VERB